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Chapter 1 
 
Introduction and Goal of the Thesis 
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Goepferich AM. Hydrogel wound dressings for a bioactive treatment of acute and chronic 
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1. Introduction 
1.1 Wound Healing 
An injury of the skin is a severe intervention to the normal function of the human body, as 
thermal insulation, body fluid retention, protection from exogenous pathogens, and hosting 
of different sensing receptors are only some of the many important functionalities of the 
intact skin barrier.1 To enable fast recovery, the endogenous healing process starts almost 
instantly.2 The blood flow is stopped within minutes by the aggregation of platelets and 
fibrin clot formation (Figure 1A). Thereby released growth factors (GFs) and cell 
mediators recruit inflammatory cells like neutrophils and monocytes to the wound site 
(Figure 1B). The aim of the following inflammatory response is the removal of foreign 
bodies, bacteria, and damaged endogenous tissue.3 
 
Figure 1. Schematic illustration of the healing process, including the coagulation (A), the inflammation (B), 
the proliferation (C), and the remodeling (D) phase.4 The upper light pink layer represents the epidermis; the 
lower pink layer represents the dermis.  
 
Towards the end of the inflammatory phase, macrophage GFs induce the proliferation and 
migration of fibroblasts and epithelial cells into the wound (Figure 1C). During the so-
called proliferative phase, new blood vessels are formed (in red), the synthesis of 
strengthening collagen fibers begins (in blue), and granulation tissue (in yellow) is built 
from epithelial cells, fibroblasts, and keratinocytes. Complete wound healing takes several 
weeks or month (Figure 1D).4 The wound finally contracts and the granulation tissue is 
transformed into the more stable extracellular matrix (ECM).5 The overall duration of the 
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healing process depends on the age and the health status of the patient (impairing factors 
are e.g. diabetes or venous insufficiency), and external factors such as the presence of 
foreign bodies or infections in the wound. In acute wounds, the healing process follows the 
above described phases and the wound closure occurs after 8 to 12 weeks.6 In contrast, 
chronic wounds mainly remain in the inflammation phase, accompanied by large numbers 
of wound exudate, heavy infections, pain, and tissue necrosis. Thus, chronic wounds fail to 
heal over a period of minimum 12 weeks, sometimes it even takes several months or years 
to full recovery. 
 
1.2 Wound Dressing Requirements 
Chronic wounds are a big burden for the patients themselves, facing reduced quality of life, 
connected to frequent dressing changes, numerous hospital stays, and disabilities in daily 
life. Furthermore, the economic burden for the health care system is immense.7 
Approximately 20 million patients around the world suffer from chronic wounds and the 
global wound care market revenue rose to more than 20 billion dollars in 2016.8,9 
Therefore, appropriate wound dressings are required for an unproblematic healing process. 
Acute wounds should heal in a moist environment for reduced scar formation and 
facilitated epithelization and cell migration into the wound.10 Furthermore, the wound 
dressing should serve as a barrier to external threads like microbes, foreign bodies, or 
tissue damaging forces. Sufficient mechanical stability (under pressure and tension) is 
required during the application, the wearing, and the removal of the dressing.11 Yet, an 
elastic texture must be maintained, as the dressing should adapt to the specific wound 
profile and high dressing flexibility is necessary when the patient is moving. The 
requirements of chronic wound dressings are even more challenging. These dressings 
additionally have to deal with a high volume of wound exudate; up to 12 L·m–2 per day 
were described for example for venous leg ulcers.12 Moreover, low adherence to the 
underlying wound is necessary to protect newly formed tissue from destruction during 
frequent dressing changes. Especially for the treatment of chronic wounds, but also for the 
treatment of more complex acute wounds, an active intervention in the healing process is 
also required.6 The active wound healing capacity of dressing materials can be based on 
different components, such as released drugs, the dressing material itself, or incorporated 
cells. A detailed description of important approaches to bioactive wound dressings can be 
found below. In any case, the chosen wound dressing should be as supportive to healing as 
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possible, but at the same time it must be as cost-effective as possible for adoption in 
clinics. 
 
1.3 Hydrogel Wound Dressings 
There is a wide range of different wound dressing types and material compositions on the 
market, covering the requirements of various kinds of wounds.13 Traditional dressings like 
gauze and tulle mainly have a covering effect while maintaining proper gaseous exchange. 
However, their strong adherence to the wound site causes pain and further lesions during 
dressing changes. A modern dressing type that combines numerous advantageous 
properties in one single material is the hydrogel-based wound dressing. Hydrogels consist 
of around 90% water and 10% natural or synthetic polymers. Because of the high water 
content, hydrogel dressings are suitable for dry and necrotic wounds. The created moist 
environment enhances the healing process.14 Furthermore, it enables a debridement of 
necrotic tissue, likewise leading to improved healing. On the other hand, hydrogel 
dressings are also able to absorb high amounts of liquid in contact with exuding wounds. 
Dependent on the hydrogel composition, a liquid uptake of up to 1000 gram per gram of 
dressing is described.15 The permeable hydrogel structure further enables an undisturbed 
gaseous exchange of CO2, O2, and water vapor. In clinical studies, hydrogel dressings were 
found to reduce the pain for treated patients, induced by a cooling effect of the material, 
and by its non-adhering nature. The similarity of the hydrogel structure to the structure of 
the ECM, which is characterized by a vast (polymer) network in an aqueous environment, 
allows the establishment of a new and very effective wound healing feature, namely the 
incorporation of cells and biomolecules into the hydrogel polymer network. Further 
bioactive wound healing properties such as controlled drug release can easily be achieved 
by a precise chemical modification of the polymer network. For this purpose, various 
natural and synthetic precursors can be combined, and hydrogel wound dressings with 
defined wound healing properties can be developed.  
 
1.3.1 Available Hydrogel Base Materials 
A widely used hydrogel component with a biological origin is the polysaccharide alginate 
(Figure 2). Alginate forms hydrogels by ionic cross-linking via –COO– or, when 
structurally modified, by chemical cross-linking between additional side chains.16  
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Figure 2. Representative parts of the alginate structure and its ionic cross-linking reaction. 
 
Alginate dressings can absorb high amounts of wound exudate, because of their 
hydrophilic nature. In contact with bleeding wounds they exhibit a hemostatic effect. But 
most importantly, they can actively support the wound healing process. Alginate has been 
proven to enhance cell migration into the wound, to increase the angiogenesis and the 
production of collagen I, and to reduce the concentration of proinflammatory cytokines in 
chronic wounds.17,18 The advantageous material properties of alginate are reflected in the 
high number of commercially available alginate containing dressings. Alginate dressings 
are available as various hydrogels (e.g. Nu-Gel® (Systagenix), Tegagel® (3M GmbH)), 
cryogels (e.g. Algosteril® (4M Medical GmbH), Curasorb® Alginate (Medtronic), 
Sorbsan® (B. Braun Melsungen AG)), or hydrocolloids (e.g. Comfeel Plus Flexible® 
(Coloplast AG), Kendall™ Hydrocolloid Dressing (Medtronic)).  
Another suitable polysaccharide for medical application is chitosan. Animal studies and 
clinical trials detected an overall faster healing in chitosan treated wounds.19–21 Chitosan is 
hemostatic, bacteriostatic, and fungistatic. Furthermore, it encourages cell proliferation and 
collagen and hyaluronic acid (HA) formation. However, there are only a few commercial 
chitosan containing wound dressings, e.g. KytoCel® (MasterCare Medical GmbH), a 
chitosan cryogel, and Chitoderm® plus (Trusetal Verbandstoffwerk GmbH), a chitosan 
coated dressing. The big discrepancy between the scientific interest in chitosan dressings 
and its commercialization might be explained by the animal origin of chitosan; it is a 
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derivate from chitin, found in shrimp and crab shells. As a natural product, however, it 
bears a high risk of batch variations, for example concerning the molecular weight.22 Yet, 
the biological activity of chitosan is dependent on the molecular weight of the 
macromolecules.23–26 Additional drawbacks are the low elasticity of chitosan materials and 
the difficulty in producing fibrous wound dressings.1 
The protein collagen is, together with alginate, one of the most frequently used materials in 
wound coverage. In the human body, collagen occurs inter alia in the ECM, in blood 
vessels, in bones, and in tendons.27 The three main forms, Collagen I, II and III, constitute 
around 75% of dry human skin. Therefore, it is a well-tolerated material that is particularly 
suitable for wound dressing and tissue engineering applications. For medical use, the main 
sources are bovine, porcine, and avian derived collagen.28 Collagen dressings are applied 
in the form of hydrogels (e.g. CellerateRX® (Wound Care Innovations LLC), Regenecare® 
Wound Gel (MPM Medical Inc.), Wun’Dres® (Coloplast AG)), fibrous cryogels (e.g. 
Biobrane® (Smith & Nephew), CollaSorb® (Paul Hartmann AG), Fibracol® (Acelity)), and 
grounded cryogels (e.g. Medifil® (Human Bio Science, Inc.), Stimulen™ (Southwest 
Technologies, Inc.)). Collagen is chosen for its high liquid absorbance capacity and its 
mechanical strength.29 Furthermore, it plays an active role in wound healing. By recruiting 
fibroblasts, endothelial cells, and keratinocytes, the vascularization, granulation tissue 
formation, and collagen deposition is enhanced.30,31 Moreover, scaring and the rate of 
bacterial infections is reduced. In current studies, two major issues of collagen are faced; 
enzymatic degradation of collagen leads to a fast loss of dressing stability and shape, and 
dependent on the source of the collagen, there is a risk of pathogen transmission.32–34  
In contrast, wound dressing materials from synthetic precursors are non-infective, they 
have well defined chemical structures, and their properties can precisely be modified to 
fulfill the desired material requirements.13 However, synthetic hydrogels do not actively 
participate in the wound healing process. Therefore, combinations of natural and synthetic 
polymers are usually preferred. Examples of available (partially) synthetic wound 
dressings are the polyacrylamide/polysaccharide-based FlexiGel® (Smith & Nephew), the 
poly(ethylene glycol) (PEG)/oakin-based Oakin® hydrogel wound dressing (Amerigel), 
and the polyurethane (PU)-based AquaClear® dressing (Paul Hartmann AG).  
 
1.3.2 Double Network Hydrogels 
A general issue of hydrogel materials is their relatively low mechanical stability, which is 
for example related to structural inhomogeneities in the polymer network and the low 
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friction between single polymer chains, as hydrogels typically have a polymer content of 
only 5 to 10%.35 Yet, this drawback can be avoided by proper selection of the monomers, 
by chemical modifications of the precursor molecules, and in particular by physical 
modification of the hydrogel system. A physical hydrogel network modification, 
particularly aimed at enhancing mechanical resistance, was first described by Gong et al. 
The group developed hydrogels that consist of two separate polymer networks with 
internetwork entanglements, so called “double network” (DN) hydrogels (Figure 3).36  
 
Figure 3. Schematic structure of a double network hydrogel with the covalent network in dark blue and the 
ionic network in red. Dots represent the cross-linking points. 
 
A DN hydrogel is a special kind of interpenetrating polymer network (IPN) hydrogel, both 
consisting of two entangled polymer networks. The basic idea behind the use of two 
polymer networks is the combination of advantageous properties of each single network 
whilst overcoming their drawbacks. This might be related e.g. to the swelling properties, 
the biocompatibility, or the chemical stability of the hydrogel.37,38 DN hydrogels 
additionally show a disproportional enhancement of the mechanical properties in 
comparison to the single components.39 By this means, hydrogels with a maximum tensile 
stress of up to 10 MPa, a maximum compressive stress of up to 60 MPa, and a maximum 
strain of up to 2000% under tensile load and up to 95% under compressive load could be 
developed.35 The DN hydrogels described by Gong et al. consist of a rigid and densely 
cross-linked polyelectrolyte as main network (primary network), and a flexible and loosely 
cross-linked neutral polymer as a far less concentrated secondary network. A typical DN 
formulation is poly(2-acrylamido-2-methylpropanesulfonic acid) (PAMPS) as primary and 
polyacrylamide (PAAm) as secondary network.36 Yet, also “inverse” DN hydrogels with a 
neutral primary and an ionic secondary network were described to be highly load bearing. 
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For example, the combination of a neutral PEG network and an ionic poly(acrylic acid) 
(PAA) network resulted in hydrogels with a maximum tensile stress of up to 12 MPa and a 
pH-dependent maximum compressive stress of up to 4 MPa.40,41 Even triple network (TN) 
hydrogels e.g. consisting of PAMPS/PAAm, oxidized dextran/teleostean/N-carboxyethyl-
chitosan, or HA/poly(N,N-dimethylacrylamide) have been described.42–44 The mechanism 
behind the stabilizing effect in DN/TN/IPN hydrogels has been intensively investigated. 
Dependent on the exact nature of the networks (ionic/neutral primary/secondary network, 
covalently or ionically cross-linked polymers), different concepts have been established. 
When “classical” DN hydrogels are stretched, first the rigid primary network consumes 
energy.35,39 Its covalent bonds break and the network is divided into small clusters. 
Afterwards, the flexible secondary network can be stretched to a high extent. Hereby, great 
amounts of energy are dissipated. Additional stabilization comes from the clusters of the 
primary network, which serve as supplementary cross-links for the secondary network. 
Another theory points out the importance of voids in the primary network and therefore the 
high impact of the monomer molecular weight on the mechanical properties.45 Voids can 
serve as crack stops. Further energy dissipation takes place because of inter-network 
entanglements and more importantly, because of intra-network entanglements of the 
secondary network within the voids. Yet, it must be differentiated between so-called 
“connected” and “true” DN hydrogels.46 Nakajima and coworkers found that there might 
be unreacted functional groups in the primary network which polymerize during the 
formation of the secondary network. The resulting covalent connections between the two 
networks can likewise be responsible for the extraordinary stability of these “connected” 
DN hydrogels. In contrast, a strain hardening process based on the primary network was 
described for “true” DN hydrogels.47 At high strain the polymer chains in the irreversibly 
destroyed primary network get orientated in the direction of the applied load, thus 
enhancing the mechanical resistance against failure. In “inverse” DN hydrogels, the 
stabilizing effect comes from physical inter-network interactions, e.g. hydrogen bonding.39 
An important process in the inverse DN hydrogels is therefore strain hardening, which in 
this case means the enhanced accessibility of hydrogen bond capable sites under high 
tension, resulting in a stabilization of the respective material.40 Recently, Sun et al. also 
investigated IPN hydrogels of ionically cross-linked alginate and covalently cross-linked 
polyacrylamide with enhanced mechanical stability.48 Thereby, the group identified two 
important mechanisms of stabilization, namely the reversible breakage of ionic bonds and 
meanwhile crack bridging by the covalent network. 
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1.3.3 Bioactive Hydrogel Wound Dressings 
Considering the overall picture of hydrogel properties and in particular the properties of 
those consisting of two interpenetrating polymer networks, hydrogels are promising 
materials for wound dressing applications. In terms of liquid handling, the mechanical 
stability, the patient’s compliance, and their chemical versatility, they totally fulfill the 
wound dressing requirements. However, modern wound dressings should also provide an 
active intervention in the wound healing process, which can be achieved by the following 
means.  
 
1.3.3.1 Bioactive Hydrogel Precursors 
First, the dressing material itself can participate in the wound healing process. In terms of 
hydrogel forming materials, especially the biological precursors and their derivates can 
influence the healing process. Already mentioned examples are alginate, chitosan, and 
collagen containing hydrogels, which for example enhance cell migration and 
angiogenesis, or suppress microbial infections.17,20,31 In recent studies, their usage is 
proposed for different bioactive wound dressing applications. Straccia et al. reported on 
ionically cross-linked alginate/Zn2+ hydrogel wound dressings.49 In contrast to ordinary 
Ca2+ cross-linked alginate gels, the zinc containing hydrogels showed improved swelling 
properties and the release of Zn2+ ions resulted in antimicrobial activity against Escherichia 
Coli in vitro. Alginate/HA hydrogel disks gave convincing results in in vitro healing assays 
with keratinocytes and adipose derived multipotent adult stem cells, as well as in rat 
wound models.50 Furthermore, alginate hydrogels treated with non-thermal dielectric-
barrier discharge plasma were shown to be suitable candidates for antimicrobial wound 
dressing applications.51 Dependent on the plasma treatment time of the alginate gels and 
the type of bacterial strain, the pathogen load was significantly reduced or even eradicated 
in a period of seconds to minutes. The Murakami group used a combination of alginate, 
chitin, chitosan, and fucoidan to create bioactive hydrogel sheets that enhance the 
formation of granulation tissue and capillaries in wounds with impaired healing.52 
Furthermore, chitosan is frequently used as part of wound dressing materials because of its 
antimicrobial and hemostatic activity. In recent years, for example chitosan/PEG 
hydrogels, chitosan/PEG/poly(vinyl pyrrolidone) (PVP) coated cotton fibers, different 
chitosan/poly(vinyl alcohol) (PVA) sponges and hydrogels, chitosan/PVA/poly(ethylene 
oxide) (PEO) hydrogels, carboxymethylchitosan/gelatin hydrogels, chitosan/lactic acid 
cryogels were reported to be suitable wound dressing materials with healing-supportive 
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properties, regarding the overall healing time, the rate of granulation and epithelization, the 
formation of collagen and new blood vessels, and the suppression of a prolonged 
inflammation phase.53–59 Likewise HA, an ECM derived glycosaminoglycan, can 
encourage the wound healing process. Different studies described an enhanced collagen 
deposition, increased re-epithelization, and higher vascularization in wounds because of 
the treatment with HA containing dressings.60,61 In detail, HA interacts with endothelial 
cell receptors, which enhances the respective cell proliferation and thereby the formation 
of blood vessels.62 This mechanism can also support the healing of skin grafted wounds, 
where a high vascularization is crucial for a successful acceptance of the skin graft.63 
Hyalofill®, Hyalosafe® (both Anika Therapeutics), and Hyalo4 Regen (Fidia Pharma 
GmbH) are only some examples of commercial HA containing wound dressings.  
 
1.3.3.2 Drug Loaded Hydrogel Wound Dressings 
Another strategy of bioactive hydrogel wound dressings is the (controlled) release of drug 
molecules. The incorporated drug can target numerous fields that are essential for the 
wound healing process. Analgesics like ibuprofen, morphine, or lidocaine are of special 
interest in extensive burns, wounds with strong infections, or in palliative medicine.64–66 
Examined hydrogel release matrices are based on PVA, chitosan, and poloxamers. 
Comparable commercially available products are inter alia the foam dressing Biatain Ibu™ 
(0.5 mg·cm–1 ibuprofen; Coloplast AG) and the alginate/collagen hydrogel Regenecare® 
Wound Gel (2% lidocaine; MPM Medical, Inc.). For colonized wounds, hydrogel 
dressings loaded with antimicrobial drugs are the preferred choice. Despite the growing 
threat of antibiotic resistant bacterial strains, research was conducted for example on 
ciprofloxacin releasing alginate/chitosan membranes, tetracycline releasing alginate/ 
cellulose-based hydrogels, gentamycin sulfate releasing chitosan hydrogels, and sodium 
fusidate releasing PVA/PVP/propylene glycol hydrogels.67–70 On the other hand, Li et al. 
focused on the prevention of antibiotic resistances by providing imprinted N-isopropyl-
acrylamide (NIPAAm) hydrogel wound dressings which are capable of binding bacterial 
β-lactamase, the decisive molecule of resistant bacteria.71 By this means, the antibiotic 
sensitivity of methicillin-resistant Staphylococcus Aureus (MRSA) against Penicillin G 
was regained successfully. Another strategy to avoid the development of resistant bacterial 
strains is the use of antimicrobial drugs based for example on bioactive proteins, metals, or 
natural derived materials. Intensive research has been done on the antimicrobial activity of 
nanoparticles (NPs) containing silver, titanium dioxide, or zinc oxide. Neibert et al. 
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developed a competitive antimicrobial dressing material by the incorporation of silver NPs 
in covalently cross-linked alginate fibers.72 Moreover, the silver NP fibers enhanced the 
wound healing process, resulting in containment of the inflammation reaction, decreased 
healing time, and better quality (e.g. concerning collagen deposition, epidermal thickness, 
and mechanical stability) of the rebuilt tissue. TiO2 NPs in combination inter alia with a 
chitosan/pectin or a chitosan/PVP film exhibit a strong antimicrobial activity and likewise 
improve the wound healing in animal models.73,74 To overcome the potential concentration 
dependent cell toxicity of the mentioned nanoparticles, other researchers focused on the 
identification of natural antimicrobial agents. This includes essential oil (cinnamon, 
lavender, tea tree, lemon etc.) encapsulated in an alginate film, lysine dendrimers or its 
Schiff base with vanillin in burn wound dressings, melatonin released from chitosan/ 
Pluronic® F127 microspheres, and seaweed extract in PVA/PVP cryogels.75–79 Widely used 
antiseptics are octenidine, poly(hexamethylene biguanide) hydrochloride (PHMB), and 
povidone-iodine.80,81 PHMB controlled release and antimicrobial activity studies were 
conducted in combination with HA nanocapsules which are degradable in contact with 
hyaluronidase, a bacterial enzyme.82 As part of cellulose dressings, PHMB was superior to 
povidone-iodine and its activity against Bacillus Subtilis, S. Aureus, MRSA, E. Coli, 
Acinetobacter Baumannii, and Pseudomonas Aeruginosa was proven.83,84 In the clinics, 
infected wounds can be treated by Iodosorb gel (0.9% w/w iodine; Smith & Nephew), 
Kerlix® AMD sponge (0.2% PHMB; Covidien), XCell antimicrobial dressing (0.3% 
PHMB; Xylos), Hydrogel Ag (1% silver sulfadiazine; Gentell), SilvaSorb® sheet (0.13% 
silver chloride; Medline), Anasept® Antimicrobial Skin & Wound Gel (0.057% sodium 
hypochlorite; Anacapa Technologies), and many more. 
 
1.3.3.3 Cell and Cell-Derived Protein Loaded Hydrogel Wound Dressings 
The most recent class of bioactive hydrogel wound dressings is based on the supportive 
healing activity of growth factors, cytokines, and (stem) cells. The thorough investigation 
of the complex wound healing cascade enabled the identification of cell derived proteins 
that mediate important wound healing processes like cell proliferation and angiogenesis. In 
this context, the impact of epidermal growth factor (EGF), fibroblast growth factor (FGF), 
keratinocyte growth factor (KGF), platelet-derived growth factor (PDGF), vascular 
endothelial growth factor (VEGF), and different forms of platelet-rich plasma (PRP; 
containing inter alia insulin-like growth factor (IGF-1), PDGF, transforming growth 
factor-β (TGF-β), and VEGF) have been described.24,85–88 Human EGF which was 
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incorporated e.g. in a heparin/PEG or in a IR responsive NIPAAm hydrogel could 
significantly enhance wound closure in mice, resulting in increased granulation, 
epithelization, and vascularization.89,90 Li et al. proposed the combined release of EGF and 
the antioxidant curcumin from poly(lactic acid) (PLA) NPs in a PLA hydrogel to further 
enhance the healing process.91 The group confirmed a positive effect on the formation of 
collagen, granulation tissue, and new blood vessels. Yet, the transdermal delivery 
efficiency and the stability of GFs were limited. To overcome this problem, EGF was 
bound to HA whilst retaining its biological activity.92 A detailed analysis of the involved 
wound cytokines revealed a reduction of the inflammatory molecules tumor necrosis 
factor-α (TNF-α) and interleukin-1 (IL-1), and increased values of the cell proliferation 
promoting TGF-β and β-defensin-2, because of the EGF-HA treatment. Gelatin gels 
containing FGF, chitosan hydrogels containing KGF, and chitosan/HA cryogels containing 
fibrin NPs with VEGF are further examples of recently developed bioactive hydrogel 
wound dressings.93–95 Nevertheless, there are indications that the administration of more 
than one GF might give a better outcome, as the different processes in wound healing 
include complex interactions between numerous GFs.85 The application of a GF mixture 
exceeds the single GF treatment by promoting faster wound healing and a higher rate of 
epithelization and capillary formation. Relevant approaches are dressing materials with 
multiple GF loading, such as chitosan/PEO fibers containing PDGF-BB and VEGF, or 
dressings with (activated) PRP or platelet lysate.96,97 Appropriate release matrices for PRP 
derived materials can be chitosan, gelatin, or fibrin.86,98,99 Spanò et al. even described a 
bioactive membrane of different blood plasma derived components (PRP, platelet poor 
plasma, and thrombin) for the treatment of skin ulcers.100 
A more elegant way to deliver multiple cell-derived proteins to a wound is the direct 
incorporation of the respective cells into the wound dressing material. This strategy 
includes fibroblasts, keratinocytes, and stem cells from numerous origins.88 Differentiated 
cells (fibroblasts, keratinocytes) are mainly used to produce skin analogues based on 
degradable, biological matrices like alginate, chitosan, collagen, and gelatin.101–105 The 
cellular production of KGF, promoting the epithelization, and VEGF, promoting the 
vascularization, as well as the direct delivery of the cells to the wound site were found to 
enhance the wound healing significantly.103,106 However, the development and application 
of stem cell containing materials seem to be more promising. Stem cells exhibit a high 
potential for self-renewal and the ability to differentiate into various cell types, dependent 
on the surrounding environment. By cell recruitment, the differentiation into dermal cells, 
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and the secretion of growth factors and cytokines, stem cells can very effectively 
participate in wound healing.107 They thereby improve the granulation, the angiogenesis, 
the epithelization, the production of collagen, and the overall healing time. Prenatal stem 
cells from the amniotic fluid and neonatal stem cells from the umbilical cord have been 
successfully integrated in hydrogel wound dressings.108,109 Even more attention has been 
paid to adult mesenchymal stem cells (MSCs) and adipose-derived stem cells (ASCs). 
Chen et al. precisely investigated the impact of bone marrow MSCs containing NIPAAm/ 
poly(amidoamine) hydrogels on wound healing in diabetic mice.110 The increased 
expression of basic FGF is connected to increased angiogenesis and reduced scar 
formation. A high TGF-β1 level is responsible for enhanced ECM/collagen production, 
and increased granulation and epithelization, all leading to a better healing of the diabetic 
wounds. The production of VEGF and PDGF, and therefore the amount of angiogenesis, 
can be further increased by a hypoxia treatment of the MSCs.111 Suitable matrices for 
ASCs may be thermogelling PEG, HA/chitosan, pullan/collagen, or poly(3-hydroxy-
butyrate-co-hydroxyvalerate) gels.112–115 Involved factors in wound healing were identified 
to be inter alia VEGF and stromal cell derived factor SDF-1 for increased angiogenesis, 
and matrix metalloproteinase MMP1 and MMP9 for enhanced remodeling of the skin 
structure. Even ASCs gained from burn wound debridement were able to differentiate into 
epithelia, dermal and vascular cells, likewise enhancing the healing process.116,117 Despite 
the high research interest, the only available GF application to date has been the 0.01% 
PBGF-BB containing Regranex® Gel (Smith & Nephew). Cell containing wound dressings 
are limited to skin substitutes with incorporated fibroblasts and keratinocytes. They can be 
developed from autologous (e.g. PermaDerm™ (Amarantus BioScience Holdings Inc.), 
clinical phase 2) or allogeneic (neonatal foreskin + bovine collagen; e.g. Apligraft® 
(Organogenesis Inc.), OrCel® (I-Horus Inc.)) origin.2 Stem cell wound dressings are still 
under development. Issues which are responsible for the high discrepancy between the 
scientific interest and the relevance for clinical applications are the high costs of GFs, the 
loss of therapeutic activity during prolonged or improper storage, and the risk of cancer 
which is related to extensive GF and PRP application.6,97,100 Furthermore, GFs are rapidly 
degraded by increased MMP concentrations in the chronic wound environment, which 
leads to the adverse need of frequent dressing changes (e.g. two times a day for Regranex® 
Gel).88,118,119 Besides, cell treatment always bears the risk of contamination, related to the 
donor (transmission of diseases) or the production procedure.88 Especially concerning stem 
cells there is no standard procedure for their isolation, processing, and application.107 This 
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is furthermore critical, because the microenvironment of stem cells is strongly related to 
the survival rate and the cell differentiation, both affecting wound healing.  
 
1.4 Concluding Remarks and Future Perspectives 
In the field of wound care, there are still many challenges to overcome. The above 
discussed promising performance of hydrogel wound dressings must be further expanded 
to correspond to the increasing need for acute and chronic wound treatment options. 
Especially the development of bioactive dressing materials should be tackled by current 
research. Yet, big obstacles such as the materials’ cost-effectiveness (related to expensive 
drugs, production procedures, and dressing materials) and reproducibility (related to 
natural derived products), as well as the patients’ safety (related to allogeneic or 
xenogeneic materials) need to be considered. Hence, alternative concepts including new 
materials or different modes of action have to come to the fore. One promising approach 
for the treatment of non-healing wounds might be the readjustment of the wound pH.120,121 
Both, excessive alkaline and acidic pH values were measured in chronic wounds.122,123 The 
non-physiological pH milieu has a major impact on numerous processes of the wound 
healing cascade. In particular, the ability of cells to migrate and proliferate, the biological 
activity of crucial proteins (GFs, cytokines, MMPs), the supply with oxygen, and the 
liability to wound infections are all dependent on the wound pH.123–126 Therefore, the 
combination of several basic concepts, such as pH-modifying properties, bioactive 
precursors, and controlled drug release, to one outstanding wound dressing material should 
be considered in future health care research. 
 
2. Goal of the Thesis 
Hydrogel-based wound dressings are one of the most promising materials in wound care, 
because they fulfill important dressing requirements such as keeping the wound moist 
whilst absorbing extensive exudate, adhesion-free coverage of the sensitive underlying 
tissue, pain reduction through a cooling effect, and good biocompatibility. Furthermore, 
hydrogel wound dressings enable an active intervention in the wound healing process, for 
example through controlled drug release or cell incorporation. Although hydrogel-based 
dressings are already on the market, general problems of wound care products still exist. 
Immense costs of complex technologies, safety concerns regarding drugs or allogeneic/ 
xenogeneic materials, insufficient technical possibilities for an industrial up-scaling, as 
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well as special hydrogel-specific issues, such as the lack of mechanical stability, are 
impeding the clinical implementation of many novel approaches. Yet, new treatment 
options are urgently requested in view of the current situation in health care. Due to the 
aging society, clinicians have to face a growing number of severe, acute and chronic 
wounds in clinical daily life. To meet the clinical needs, the development of new hydrogel 
wound dressings with enhanced material properties, regarding inter alia the mechanical 
performance and the fluid handling, is necessary. Further, novel hydrogel dressings should 
actively promote the wound healing process in an applicable and cost-effective way. For 
the treatment of acute wounds, antimicrobial dressings are of interest because they can 
prevent infections that are one of the mayor issues in this field. Chronic wounds are even 
more complex to handle than acute wounds because crucial cellular processes of the 
healing cascade are impeded, inter alia caused by a non-physiological pH shift. Therefore, 
the controlled adaption of the wound pH might be a promising new concept of reviving 
wound healing by efficient means. 
After a general overview of the literature in Chapter 1, regarding the current development 
in the field of bioactive hydrogel-base wound dressings, some of the main drawbacks of 
hydrogel dressings are addressed within this thesis. In Chapter 2, the combination of 
biocompatible poly(ethylene glycol) diacrylate (PEGDA) and bioactive alginate in one 
material to exploit the favorable effect of interpenetrating polymer networks (IPNs) is 
discussed. Especially the impact of an altered network density and different polymerization 
mechanisms on the mechanical properties of the resulting IPN hydrogels were analyzed. 
Furthermore, the IPN’s suitability for the treatment of acute wounds was evaluated by 
analyzing its performance as antimicrobial, poly(hexamethylene biguanide) hydrochloride 
(PHMB) containing dressing.  
Further research focused on the development of pH-modifying chronic wound dressings. 
To address this, the IPN hydrogel system PEGDA/alginate was supplemented with acrylic 
acid (AA). Different AA containing formulations were assessed for their material and 
pH-modulating properties. Moreover, cell viability assays and wound healing experiments 
with alkalosis wound models were conducted to investigate their bioactive properties. The 
results are presented in Chapter 3.  
Structural modifications of IPN systems directly influence their material properties, 
including the mechanical stability and the liquid handling capacity. Hence, the 
optimization of the PEGDA/AA/alginate hydrogel network structure discussed in 
Chapter 4 corresponds to an adaption of its wound healing properties. Particularly the 
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impact of the PEGDA molecular weight on the material properties was analyzed in detail. 
Moreover, the decisive structural interactions between the two interpenetrating networks 
PEGDA/AA and alginate were studied by comparing them to equivalent IPN hydrogel 
formulations without ionizable functional groups.  
Alkaline dressing materials might be an effective tool for the treatment of skin grafted and 
acidosis chronic wounds. To investigate this assumption, different precursors were 
screened for their ability to serve as basic, pH-modulating part of PEGDA-based IPN 
hydrogels in Chapter 5. Dependent on the targeted wound type, pH-active molecules with 
different pKa values were used and the secondary network (alginate or chitosan) was 
adapted accordingly. The superficial seeding of human dermal fibroblasts induced 
additional bioactive properties in terms of a potential cell or cell-derived protein release.  
Based on the findings discussed in the previous chapters, a universal approach to pH-
modifying chronic wound treatment was conducted and discussed in Chapter 6. Mono- 
and bimolecular buffer systems were chosen as potential pH-active components and 
combined with the mechanically stabilized IPN hydrogel system PEGDA/alginate. The 
most promising hydrogel formulation was identified by a bottom-up approach, regarding 
the wound healing capacity, and further characterized for its overall material performance. 
An antimicrobial activity by PHMB incorporation and its pH-sensitive release 
supplemented the bioactive healing properties of the buffering hydrogels. 
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Abstract 
Critical microbial colonialization of dermal wounds is a serious reason for impaired wound 
healing. Due to the rising threat of antibiotic resistant bacterial strains, the prevention of 
wound infections and the treatment of infected wounds are getting more and more 
challenging. Thus, the aim of this study was to develop alternative antimicrobial wound 
dressings with a universal field of action. To this end, the concept of interpenetrating 
polymer networks (IPNs) was applied to poly(ethylene glycol) diacrylate (PEGDA)/ 
alginate-based hydrogels, resulting in IPN materials with favorable wound dressing 
properties. The developed IPN hydrogels resisted a maximum tensile stress of 80 kPa with 
a maximum elasticity of 175%. Furthermore, the systematic alteration of the PEGDA 
network density enabled a significant enhancement of the hydrogel swelling capacity, from 
2 to 40%. The most promising IPN hydrogel formulation, photopolymerized PEGDA 
6 kDA/alginate with a precursor content of 9.5 and 0.5%, respectively, was successfully 
used as antimicrobial drug carrier. The achieved release of 3.4 mg poly(hexamethylene 
biguanide) per gram of hydrogel is comparable to the properties of commercially available 
antimicrobial wound care products.  
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1. Introduction 
Infections are a big burden in wound care, because impaired healing and chronic wounds 
may result.1,2 Endangered acute wound types are e.g. burns with a high amount of tissue 
loss, animal bites, gunshots, and contaminated surgical wounds. The adequate treatment of 
infected wounds is very challenging, since the traditional, antibiotic treatment methods 
bear the risk of developing bacterial resistance, and a rising number of resistant bacterial 
strains has been detected in recent years.3 Therefore, antimicrobials are a valuable 
treatment alternative.1 Nevertheless, some antimicrobials, including silver and 
chlorhexidine, are discussed to cause bacterial resistance as well or harm the human 
organism.4–6 Yet, no resistant bacterial strains or harmful side-effects have been detected 
for poly(hexamethylene biguanide) hydrochloride (PHMB).7 Its antimicrobial properties 
are based on the cationic molecular structure, which is similar to endogenous antimicrobial 
peptides (Scheme 1). Recently published data by Chindera et al. suggest, that its 
mechanism of action includes the condensation of bacterial chromosomes, whilst not 
entering the mammalian nuclei.7 By this means, common wound site bacteria like 
Staphylococcus Aureus and in particular methicillin-resistant S. Aureus (MRSA), as well as 
Pseudomonas Aeruginosa can be defeated.8–10  
 
Scheme 1. Repeating unit of poly(hexamethylene biguanide) hydrochloride. 
 
In this study, PHMB was incorporated in optimized interpenetrating polymer network 
(IPN) hydrogels. IPNs are a special class of hydrogels, consisting of two separate polymer 
networks that are combined in one material. The interpenetrating network structure enables 
numerous material variations by simple means. Thus, the hydrogel stability, the capacity of 
liquid uptake, the microstructure, and biochemical properties, such as cell adhesion and 
cytotoxicity, can be adapted to particular requirements.11–14 Extensive research has focused 
on the remarkable IPN hydrogel mechanical properties.15,16 Due to the combination of a 
rigid and a flexible polymer network, highly load bearing materials can be formed. 
Decisive factors for the mechanical performance of IPNs were identified to be the cross-
linking density of both networks, the concentration and the ratio of the precursors, the 
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initiator concentrations, and environmental factors like the pH value and the salt 
concentration of the solvent.11,17,18 Besides mechanical resistance during the application, 
wearing, and removal process, an appropriate wound dressing material must also provide 
low adherence to the wound site.19 Furthermore, wound dressings should absorb excessive 
exudate, whilst maintaining a moist wound environment. For this purpose, a mechanically 
stable and moist material with a proper swelling capacity and gaseous exchange is 
required. Since hydrogels are very hydrophilic materials with a water content of around 
90%, their fluid handling capacity qualifies them for this particular application. As 
described above, applying the IPN concept additionally guarantees a proper mechanical 
performance. Further advantageous dressing features, that can likewise be achieved with 
hydrogel materials, are active healing-supportive properties like the release of growth 
factors, stem cells, or antimicrobial drugs.20–25  
In this study, IPN hydrogel wound dressings based on poly(ethylene glycol) diacrylate 
(PEGDA) as primary, dense network and alginate as secondary, loose network were 
developed. Both precursors are biocompatible and suitable for medical applications.25,26 
Additionally, alginate has a supportive healing effect, encouraging angiogenesis and cell 
migration.27 The conducted material optimization focused on the mechanical and fluid 
handling properties of the IPN hydrogels. Moreover, the most promising PEGDA/alginate 
IPN formulation was examined for its suitability as PHMB release matrix. 
 
2. Experimental Section 
2.1 Materials 
Toluene was purchased from Acros Organics (Geel, Belgium). Deuterated chloroform 
(CDCl3) and deuterated water (D2O) were obtained from Deutero GmbH (Kastellaun, 
Germany). 20% poly(hexamethylene biguanide) hydrochloride solution was purchased 
from Fagron (Barsbüttel, Germany). Alginate (Protanal® LF 10/60FT) was kindly provided 
by FMC BioPolymer (Wallingstown, Ireland). Dichloromethane (DCM), diethyl ether, and 
ethanol were obtained from CSC Jäcklechemie (Nürnberg, Germany). Phosphate buffered 
saline (PBS) was purchased from Life Technologies (Carlsbad, CA, USA). Hydrochloric 
acid, sodium acetate, sodium hydroxide, and triethylamine were obtained from Merck 
KGaA (Darmstadt, Germany). Poly(ethylene glycol) with a molecular weight of 4 kDa 
(PEG4k) was purchased from Riedel-de Haën (Seelze, Germany). Deionized water was 
obtained using a Milli-Q water purification system (Millipore, Schwabach, Germany). All 
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other chemicals were obtained from Sigma Aldrich (Taufkirchen, Germany). Poly(ethylene 
glycol) was dried by azeotropic distillation in toluene; all other chemicals were used as 
received. 
 
2.2 Precursor Synthesis 
Poly(ethylene glycol) diacrylate with a molecular weight of 6 kDa (PEGDA6k) was 
synthesized as previously described.28 PEGDA with a molecular weight of 2 kDa 
(PEGDA2k) and 4 kDa (PEGDA4k) was synthesized in the same manner, though the 
amount of reactants was adapted as follows: 20.00 g PEG2k (10.00 mmol), combined with 
2800 µL triethylamine (20.00 mmol) and 3250 µL acryloyl chloride (40.00 mmol); 25.01 g 
PEG4k (6.25 mmol), combined with 1742 µL triethylamine (12.50 mmol) and 2031 µL 
acryloyl chloride (25.00 mmol). A reaction yield of 66.9% (PEGDA2k), 61.6% 
(PEGDA4k), and 66.3% (PEGDA6k) was achieved.  
1H NMR PEGDA2k (300 MHz, CDCl3, δ): 3.64 ppm (m, 99 H, -CH2CH2O-), 4.31 ppm (t, 
2 H, -CH2OC(O)-), 5.85 ppm (dd, 1 H, CH2=CHC(O)O-), 6.16 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.45 ppm (dd, 1 H, CH2=CHC(O)O-). 
1H NMR PEGDA4k (300 MHz, CDCl3, δ): 3.63 ppm (m, 197 H, -CH2CH2O-), 4.30 ppm 
(t, 2 H, -CH2OC(O)-), 5.82 ppm (dd, 1 H, CH2=CHC(O)O-), 6.14 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.41 ppm (dd, 1 H, CH2=CHC(O)O-). 
1H NMR PEGDA6k (300 MHz, CDCl3, δ): 3.62 ppm (m, 310 H, -CH2CH2O-), 4.30 ppm 
(t, 2 H, -CH2OC(O)-), 5.82 ppm (dd, 1 H, CH2=CHC(O)O-), 6.13 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.41 ppm (dd, 1 H, CH2=CHC(O)O-). 
Alginate methacrylate (AMA) was obtained from the reaction of alginate with methacrylic 
anhydride.29 In brief, 5 N sodium hydroxide solution was added dropwise to 50 mL of an 
ice-cooled alginate solution (2 w%, 5.00 mmol) until pH 8 was reached. 2.965 mL of 
methacrylic anhydride (20.00 mmol) were slowly pipetted to the stirring solution and pH 8 
was maintained for further 24 h. Then, AMA was precipitated in 250 mL ethanol, washed, 
and dried to yield 1.06 g (86.1%).  
1H NMR (300 MHz, D2O, δ): 1.90 ppm (s, 0.40 H, -C(O)CCH3), 3.20 - 5.20 ppm (m, 
alginate backbone including H-2 at 4.41 ppm (1.00 H)), 5.73 and 6.17 ppm (d, 0.14 H, 
=CH2). The conversion rate of 14% was calculated from the ratio of the peak area at 5.73 
(=CH2) and 4.41 ppm (H-2). 
For the synthesis of N-carboxyethylchitosan (CEC), 2.00 g medium molecular weight 
chitosan with an acetylation degree of approximately 80% was dissolved in 100 mL of an 
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aqueous acrylic acid solution (0.10 mol·L–1). After stirring for 65 h at 50 °C, 11.00 mL of 
a 1 M sodium hydroxide solution were added dropwise. The product was precipitated in 
ice-cooled acetone, 50 h dialyzed against water (molecular weight cut-off 12000), dried 
under vacuum, and lyophilized to yield 2.01 g (85.0%).  
1H NMR (300 MHz, D2O, δ): 2.03 ppm (s, 0.27 H, -NHC(O)CH3), 2.37 ppm (m, 
0.32 H, -NHCH2CH2-), 2.70 ppm (m, 0.41 H, -NH(CH2CH2-)2), 3.02 - 4.10 ppm (m, H 
polysaccharide), 4.35 - 4.70 (m, 1 H, H-1 polysaccharide). A ratio of 63.8% -NH2, 
9.3% - NHC(O)CH3, 16.2% -NHR and 10.7% -NR2 with R = -NHCH2CH2- was calculated 
from the respective peak areas in relation to the peak area of H-1. 
 
2.3 Preparation of Hydrogels 
The components of the precursor mixture were successively blended in the following 
order: PEGDA solution, alginate/AMA solution (c = 41.68 mg·mL–1) or CEC solution in 
deionized water (final PBS to water ratio = 0.849), CaHPO4·2 H2O suspension, 2-hydroxy-
4′-(2-hydroxyethoxy)-2-methylpropiophenone (HHMP) suspension, N,N,N',N'-tetra-
methylethane-1,2-diamine (TEMED), gluconolactone solution (n(gluconolactone) = 
2 n(CaHPO4·2 H2O)), ammonium persulfate (APS) solution (m(APS) = 2 m(TEMED)). 
The respective formulations and amounts of cross-linking agent are displayed in Table 1, 
where m is the mass of the respective component in brackets.  
Table 1. Amount of cross-linking agent in the examined hydrogel formulations.  
Hydrogel m(TEMED)/0.5 m(APS) m(CaHPO4·2 H2O) m(HHMP) 
3% alginate - 0.13 m(alginate) - 
0.5% alginate 
9.5% PEGDA 
0.015 - 0.05 m(PEGDA) 0.13 m(alginate) - 
- 0 or 0.13 m(alginate) 0.018 m(PEGDA) 
0.5% AMA 
9.5% PEGDA - - 0.018 m(monomer) 
0.5% CEC 
9.5% PEGDA - - 0.018 m(PEGDA) 
10% PEGDA  
0.018 m(PEGDA) - - 
- - 0.018 m(PEGDA) 
 
If not stated otherwise, PBS was used as solvent. The hydrogels had a total polymer ratio 
of 10 w% (including the amount of AMA, alginate, CEC, and PEGDA), except for pure 
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alginate gels with a polymer ratio of 3 w%. For water vapor transmission studies and 
tensile testing, 10 mL of the precursor solution were cast into rectangular silicon molds; for 
all other experiments, cylindrical glass molds (0.7 mL volume, 1 cm diameter) were used. 
HHMP induced polymerization was initiated by UV radiation (1 h, 366 nm, 6 W). In all 
other cases, the molds were covered with a glass plate and left at room temperature for 
24 h.  
 
2.4 Tensile Strength 
Hydrogel sheets were cut into rectangular specimens of 8 cm length and 1 cm width (d). 
The thickness (h) of the specimens was determined using a MiniTest 600 gauge 
(ElektroPhysik, Köln, Germany). The maximum load (Fmax) and elongation until failure 
were measured using an Instron 5542 load frame with two serrated grips (Instron GmbH, 
Darmstadt, Germany). The maximum tensile stress (σt) was calculated according to 
Equation (1). !! = !!"#ℎ∙!           (1) 
The elastic modulus (Et) was calculated from the slope of the stress-strain curve between 
0.05 and 0.15 strain. The data are presented as mean ± standard deviation (n = 4). 
 
2.5 Swelling Capacity 
Hydrogel cylinders were incubated in 10 mL of PBS at 37 °C in a shaking water bath. 
Every 24 h, the gels were blotted dry and weighed. The swelling capacity (Qt) was 
calculated according to Equation (2) !! = !!!!!!! ∙ 100%          (2) 
where m0 is the initial mass of the hydrogel and mt is the mass of the gel at time point t. 
 
2.6 Water Vapor Transmission Rate 
The water vapor transmission rate (WVTR) was determined using the inverted water 
method (ASTM E96/E96M-12).30 For this purpose, the hydrogel sheet was fixed at a 
circular WVTR test dish (test area A = 10.18 cm2), filled with 5 mL of deionized water. 
Water loss at 21% relative humidity and 37 °C was measured gravimetrically every hour 
(0 – 10 h and ≥ 22 h) until a weight loss of 5 g had been be reached. The WVTR was 
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calculated from the average weight change per hour, corresponding to the slope of the 
time-water loss curve G, and the test area A, according to Equation (3). !"#$ =  !!          (3) 
 
2.7 Drug Release 
PHMB loading was performed at 37 °C by incubating hydrogel cylinders in 10 mL of a 
PHMB solution (c = 2 mg·mL–1) for 24 h. PHMB was dissolved either in water or saline. 
PHMB release was measured over a period of 7 days in 10 mL of PBS at 33 °C in a 
shaking water bath. 200 µL samples were taken at regular time intervals and replaced by 
fresh PBS. The samples were stored at 4 °C until the experiment was completed. Then, 
200 µL of the diluted PHMB solution, 10 µL of a sodium acetate solution (10 w% in 
deionized H2O), and 25 µL of an Eosin Y solution (0.025 w% in deionized H2O) were 
pipetted in a 96-well plate for the colorimetric concentration assay. After 15 min under 
light exclusion, PHMB absorbance at 545 nm was measured with a FluoStar Omega micro 
plate reader (BMG Labtech, Ortenberg, Germany). The PHMB concentrations were 
calculated based on calibration measurements.31 The amount of initial PHMB load was 
calculated from the remaining volume of PHMB incubation solution and its concentration. 
 
2.8 Statistical Analysis 
If not stated otherwise, the experiments were done in triplicate and the data are presented 
as mean ± standard deviation (SD). For statistical analysis, Brown Forsythe tests were run 
followed by one-way ANOVA/Tukey’ test or Kruskal-Wallis-ANOVA. Differences were 
considered statistically significant at p < 0.05. 
 
3. Results 
3.1 Optimization of the PEGDA Network Cross-Linking Density 
Alginate and poly(ethylene glycol) diacrylate with a molecular weight of 2 kDa were used 
as starting materials for the systematic development of antimicrobial IPN hydrogel wound 
dressing materials. First, the impact of the PEGDA network cross-linking density on the 
IPN hydrogel properties was evaluated. For this purpose, formulations consisting of 0.5% 
alginate and 9.5% PEGDA2k were polymerized by varying amounts of redox initiator 
TEMED/APS (1.5 – 5.0% TEMED; 3.0 – 10.0% APS) and the mechanical properties of 
the resulting hydrogels were examined under tensile load (Figure 1).  
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Figure 1. Tensile stress at maximum load (A) and calculated E-modulus (B) of 9.5% PEGDA2k/ 
0.5% alginate hydrogels polymerized with different initiator concentrations. Data are expressed as mean ± 
SD (n = 4); * indicates statistically significant differences versus the 1.5% and 1.8% TEMED samples 
(p < 0.05); # indicates statistically significant differences between the groups (p < 0.05). 
 
The brittle texture of the PEGDA2k/alginate IPN hydrogels hampered the sample 
preparation and handling. This resulted in high variations of the maximum tensile stress, 
σt, within each formulation (Figure 1A). Therefore, significant differences were only found 
between the σt values of 3.0%TEMED/6.0% APS and 5.0% TEMED/10.0% APS 
containing hydrogels. Further variations of the TEMED/APS content had no significant 
impact on the mechanical stability. However, regarding the absolute σt values, 1.8% 
TEMED/3.6% APS containing hydrogels seemed to be the strongest gels. The elastic 
modulus (E-modulus Et), a parameter that characterizes the material stiffness, was 
calculated to be around 110 kPa for hydrogels that were polymerized with 1.5% TEMED/ 
3.0% APS and 1.8% TEMED/3.6% APS, and significantly lower (60 - 80 kPa) for 
hydrogels that were polymerized with higher TEMED/APS concentrations (Figure 1B). 
Based on the data displayed in Figure 1, a radical initiator concentration of 1.8% TEMED/ 
3.6% APS was used for further experiments. 
 Another method to optimize the PEGDA network cross-linking density in the examined 
IPN hydrogel systems is the variation of the PEGDA precursor molecular weight 
(PEGDA2k/4k/6k), whereas the mass fraction of PEGDA remains constant. The impact of 
the PEGDA molecular weight on the mechanical properties of the IPN system 
9.5% PEGDA/0.5% alginate with 1.8% TEMED/3.6% APS was examined in tensile tests 
(Figure 2).  
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Figure 2. Tensile stress at maximum load (A) and calculated E-modulus (B) of pure alginate (0% PEGDA), 
pure 10% PEGDA, and 9.5% PEGDA/0.5% alginate IPN hydrogels (1.8% TEMED/3.6% APS content) with 
different PEGDA precursor molecular weights. Data are expressed as mean ± SD (n = 4); * indicates 
statistically significant differences versus all samples (p < 0.05); + indicates statistically significant 
differences versus the respective lower molecular weight samples (p < 0.05); # indicates statistically 
significant differences between the groups (p < 0.05). 
 
All tested IPN hydrogels resisted a higher maximum tensile stress than pure alginate 
(0% PEGDA) and pure PEGDA (10% PEGDA) samples did (Figure 2A). The σt values of 
PEGDA2k/alginate and PEGDA4k/alginate IPNs were even higher than the summed σt 
values of the single component hydrogels. A modified PEGDA molecular weight resulted 
in the highest maximum tensile stress for PEGDA4k IPN samples, followed by PEGDA2k 
and 6k IPN samples. In contrast, the E-modulus of the examined PEGDA hydrogels was 
rather independent from the gel formulation (Figure 2B). 
Besides sufficient mechanical stability and elasticity, an appropriate liquid uptake is an 
important parameter of wound dressing materials. Therefore, the TEMED/APS 
polymerized PEGDA/alginate IPN hydrogels were additionally examined for their swelling 
capacity in PBS (Figure 3).  
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Figure 3. Swelling capacity of pure alginate (0% PEGDA), pure 10% PEGDA, and 9.5% PEGDA/ 
0.5% alginate IPN hydrogels (1.8% TEMED/3.6% APS content) with different PEGDA molecular weights, 
after 24 h and 7 days of incubation. Data are expressed as mean ± SD (n = 3). + indicates statistically 
significant differences versus the respective alginate free samples (p < 0.05); * indicates statistically 
significant differences versus lower molecular weight samples (p < 0.05); ** indicates statistically significant 
differences versus the respective alginate free and lower molecular weight samples (p < 0.05). 
 
The detected liquid uptake significantly increased with rising PEGDA molecular weight 
and by the incorporation of alginate, resulting in swelling capacities of 1 and 2% 
(PEGDA2k/alginate), 20 and 25% (PEGDA4k/alginate), and 50 and 56% (PEGDA6k/ 
alginate) for 24 hours and 7 days of incubation, respectively.  
Considering the assessed swelling properties, PEGDA2k containing hydrogels were no 
longer regarded as valuable candidates for wound dressing applications, whereas further 
optimization on PEGDA4k and PEGDA6k containing IPNs appeared promising. 
 
3.2 Optimization of the Initiator Type 
A draw-back of the so far used initiator system TEMED/APS is its reaction time, taking 
around 24 hours for full completion.32,33 For faster manufacturing, PEGDA polymerization 
with the UV-light sensitive initiator HHMP was examined. Furthermore, concerning the 
secondary network, the impact of additional ionic gelation with Ca2+ in comparison to pure 
physically entangled alginate polymer chains was evaluated.  
The HHMP induced polymerization influenced the mechanical properties of the PEGDA4k 
and the PEGDA6k containing hydrogels in an opposite manner (Figure 4). The PEGDA4k/ 
alginate/HHMP hydrogels did not benefit from the characteristic IPN stabilizing effect 
described for the respective TEMED/APS polymerized hydrogels (see Figure 2 for 
comparison), whereas PEGDA6k/alginate IPNs showed a specific mechanical stabilization 
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(σt(PEGDA6k/alginate) > σt(alginate) + σt(PEGDA6k)) related to the use of HHMP. Yet, 
the calculated E-modulus decreased, independent from the hydrogel composition.  
 
Figure 4. Tensile stress at maximum load (A) and calculated E-modulus (B) of pure 10% PEGDA and 
9.5% PEGDA/0.5% alginate IPN hydrogels (1.8% HHMP content) with and without Ca2+ polymerization. 
Data are expressed as mean ± SD (n = 4); * indicates statistically significant differences versus all samples 
(p < 0.05); *4/*6 indicates statistically significant differences versus all PEGDA4k/6k samples (p < 0.05); 
# indicates statistically significant differences between the groups (p < 0.05). 
 
The incorporation of divalent calcium ions for additional cross-linking influenced both, the 
hydrogel stability and stiffness (Figure 4). The E-modulus of Ca2+ containing PEGDA4k/ 
alginate IPNs (70.3 ± 7.7 kPa) was significantly lower compared to the Et of Ca2+-free 
PEGDA4k/alginate IPNs (116.1 ± 12.0 kPa). However, σt was around 53 kPa in both 
cases. In contrast, PEGDA6k/alginate IPNs showed more stable but stiffer behavior 
without Ca2+ polymerization. In further experiments, PEGDA6k/alginate IPNs were 
consequently prepared without Ca2+. 
Comparing the mechanical properties of the so far examined materials, no significant 
differences were found for the maximally achieved tensile stress of redox 
(σt(PEGDA4k/alginate + Ca2+) = 91.0 ± 17.8 kPa) and UV-light (σt(PEGDA6k/alginate) = 
80.1 ± 13.8 kPa) polymerized hydrogels. Since easy and fast manufacturing is preferred 
(HHMP instead of TEMED/APS initiator) and a sufficient liquid uptake (PEGDA6k 
instead of PEGDA4k containing IPNs) should be guaranteed, only PEGDA6k/alginate/ 
HHMP IPN hydrogels were further analyzed for their suitability as wound dressing 
material. First, their liquid handling characteristics were determined (Table 2).  
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Table 2. Liquid handling capacity of PEGDA6k/alginate/HHMP IPNs in comparison to the single 
component hydrogels. 
Hydrogel WVTR (g·h–1·m–2) Q24h (%) Q7d (%) 
3.0% alginate 198.48 ± 1.13 46.6 ± 4.5 111.4 ± 10.4 
10.0% PEGDA6k 175.35 ± 0.58 13.5 ± 0.4 15.5 ± 0.4 
9.5% PEGDA6k  
0.5% alginate 
171.40 ± 0.30 40.0 ± 5.7 41.2 ± 5.7 
 
The formation of an IPN system resulted in a significant enhancement of the swelling 
capacity (Q24h) in comparison to the pure PEGDA6k hydrogels, and was comparable to 
Q24h of pure alginate hydrogels. Extending the incubation time to 7 days did not alter the 
swelling capacity of PEGDA and PEGDA/alginate hydrogels, whereas pure alginate 
hydrogels could absorb approximately double the amount of liquid after 7 days. The water 
vapor transmission rate of PEGDA6k/alginate IPN hydrogels was 171.4 g·h–1·m–2, the 
WVTRs of the single components were 2 - 16% higher. 
 
3.3 Optimization of the Drug Release Properties 
The final goal of this study was the development of antimicrobial wound dressings. As 
potential antimicrobial drug, poly(hexamethylene biguanide) hydrochloride was therefore 
incorporated into PEGDA6k-based hydrogels. Antimicrobial hydrogels produced by two 
different loading processes, incubation in an aqueous and in a saline solution of PHMB, 
were analyzed for their release behavior. In comparison to pure PEGDA6k hydrogels, that 
showed a PHMB release of 83% for the water loading process, the PHMB release from 
PEGDA6k/alginate IPN hydrogels was much smaller (34%, Figure 5A). To understand the 
processes that limit the drug release from PEGDA6k/alginate IPN hydrogels, an exchange 
of the secondary network was conducted, facing the nature of its reactive functional 
groups. To this end, alginate, which carries carboxylic acid groups, was substituted by 
AMA, which has a lower amount of carboxylic acid groups, or N-carboxyethylchitosan 
(CEC), which offers carboxylic acid and amino groups. PEGDA/AMA IPNs showed a 
slightly increased maximum release (37% PHMB release) in comparison to the PEGDA/ 
alginate IPNs, whereas 53% release could be detected from PEGDA/CEC IPNs. Yet, all 
formulations released comparable absolute amounts of PHMB per gram of hydrogel 
(Figure 5B). The differences in percentage PHMB release were based on the initially 
incorporated PHMB mass, which varied between 2.7 and 6.2 mg.  
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Figure 5. Relative release (A, C) and absolute load/release (B, D) of PHMB from different PEGDA6k-based 
hydrogels. PHMB was diluted in water (A, B) or saline (C, D). Data are expressed as mean ± SD (n = 3). 
 
The PHMB release could be enhanced by drug loading in saline solution (Figure 5C). 
Especially alginate and CEC containing hydrogels showed substantially increased 
maximum release rates (42 and 71%, respectively). The initial PHMB load and the 
absolute amount of released PHMB increased for all hydrogel formulations (Figure 5D). 
The release kinetics was independent from the loading process and the hydrogel 
formulation; a burst release during the first 24 hours and marginal further release until 
day 3 were detected. 
 
4. Discussion 
The aim of this study was the precise network optimization of the IPN system PEGDA/ 
alginate, leading to a suitable wound dressing material for acute wounds. The reason for 
choosing an IPN system was, that favorable properties of the two polymer components 
(high swelling capacity of alginate hydrogels, hydrolysis resistance of PEGDA hydrogels) 
could be combined, and material issues (low mechanical stability and low hydrolysis 
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resistance of alginate hydrogels, rigidity and marginal liquid uptake of PEGDA hydrogels) 
could be compensated. By this means, an enhanced mechanical performance and sufficient 
liquid uptake should be available in one material. The cross-linking density of the primary 
(dense) network is known to have a high impact on the mechanical performance of IPN 
hydrogels.11,17,34 It can be controlled by the initiator concentration of the primary network 
(c(TEMED/APS)) and the molecular weight of the precursors (M(PEGDA)). The optimal 
initiator concentration was found to be 1.8% TEMED/3.6% APS (Figure 1). Extensive 
initiator ratios might cause enhanced amounts of network irregularities, resulting in less 
stable (reduced σt values) and less stiff (reduced Et values) hydrogels.34 On the other hand, 
insufficient amounts of initiator enable polymer chain entanglements because of prolonged 
reaction times.35 The thereby reduced mobility of the reactive sites consequently results in 
a lower degree of cross-linking, likewise leading to reduced σt values, but comparable 
E-moduli. 
The characteristic stabilizing effect of IPN structures in contrast to single polymer 
networks (PEGDA2k and 4k/alginate/TEMED/APS IPNs in Figure 2) is caused by inter-
network entanglements that enable a load transfer between the two interpenetrating 
polymer networks (see Figure 6 for illustration).11  
 
Figure 6. Schematic illustration of the suggested hydrogel network structure as a function of the initiator 
(TEMED/APS or HHMP) and the PEGDA molecular weight (PEGDA4k or 6k). 
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Apparently, insufficient entanglement occurs in PEGDA6k/alginate/TEMED/APS IPNs, as 
they had the same maximum tensile stress as pure PEGDA6k/TEMED/APS hydrogels 
(Figure 2). The reduced number of cross-links in the covalent PEGDA6k network (in 
comparison to the PEGDA4k network) is not responsible for this behavior, since the 
mechanical stability of pure PEGDA gels is hardly changing with altered PEGDA 
molecular weight. More likely, this effect is related to an increasing PEGDA mesh-size, 
favoring rather intra-network entanglement of alginate chains than inter-network 
entanglement of the two networks. The reduction in E-modulus with increasing molecular 
weight is in agreement with a decrease in cross-links, causing less stiff materials.36  
The effect of the PEGDA molecular weight is considerably more pronounced concerning 
the swelling capacity of the respective hydrogels (Figure 3). As expected, a reduced 
number of covalent bonds by the altered PEGDA molecular weight, the partial substitution 
of PEGDA by alginate, and longer polymer chains between cross-links (PEGDA2k < 4k < 
6k) enable a higher extent of hydrogel volume increase and therefore, higher liquid 
uptake.37 A sufficient swelling capacity is mandatory for wound dressing materials. Yet, 
hard data on occurring exudate amounts are rarely recorded. Mostly, clinicians 
differentiate between “moderately”, “medium”, and “excessively” exuding wounds.38,39 
Based on recently published calculations, dressings with a swelling capacity of 57% or 
higher might be applied on excessively exuding wounds.28 In regard to the swelling data 
displayed in Figure 3, PEGDA6k/alginate IPN hydrogels might be considered universally, 
whilst PEGDA4k/alginate IPNs might not be applied on strongly exuding wounds. 
PEGDA2k/alginate hydrogels (around 2% swelling) do not fulfill the requirements for 
exuding wounds in any case. 
Besides offering advantageous material properties, wound dressings should also be cost-
effective. A preparation process of 24 hours (TEMED/APS initiator) is economically less 
favorable than a polymerization reaction taking only 1 hour for full completion (UV 
induced reaction).33 Besides, concerns about the TEMED/APS cytocompatibility were 
published recently, whereas no negative side-effects were found for HHMP.40,41 Even 
though wound dressing materials are purified prior to the application, there is a risk of still 
remaining initiator. Therefore, further material optimization was conducted concerning the 
initiator system. Regarding UV cross-linked hydrogels, the incorporation of alginate had a 
favorable effect on PEGDA6k containing hydrogels only (Figure 4). This might be 
explained as follows. The shortened reaction time of HHMP has a great impact on the 
hydrogel structure (see Figure 6 for illustration). The number of kinetic chains is increased 
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whilst the chain length is reduced.42 The resulting polymer structure provides numerous 
dense polymer zones (DPZs) in contrast to the more uniform network structure in redox 
hydrogels. In PEGDA4k containing hydrogels, the mesh size in the DPZs is expected to be 
even smaller, caused by the shorter distance between cross-links. Apparently, an inter-
network entanglement in PEGDA4k/alginate/HHMP IPNs is therefore impeded, leading to 
hydrogels with reduced σt and Et values, whereas beneficial entanglement occurs in the 
dense polymer zones of PEGDA6k/alginate/HHMP IPNs.  
The exclusion of calcium ions has two contrary effects on the IPN structure. Missing ionic 
bonds between alginate macromolecules reduce the material stability and E-modulus.43 On 
the other hand, more flexible alginate chains might facilitate an entanglement in the DPZs, 
resulting in rising σt and Et values. These two effects were balanced out concerning 
σt(PEGDA4k/alginate). However, the E-modulus was higher in Ca2+-free PEGDA4k/ 
alginate IPNs, since polymer chain entanglements have a stronger stiffening effect than 
ionic bonds.44 The findings for PEGDA6k/alginate IPNs underlined the theory discussed 
above; network entanglements in DPZs are dominating with higher PEGDA molecular 
weight, leading to further increased σt values. Probably because of the already existing 
high number of entanglements in the DPZs of PEGDA6k/alginate + Ca2+ IPNs, the 
E-modulus is lower for only physically entangled Ca2+-free samples.  
With a maximum tensile stress of 80.1 ± 13.8 kPa and a maximum elasticity of 174.7 ± 
22.9% (data not shown), the most favorable hydrogel formulation PEGDA6k/alginate/ 
HHMP/no Ca2+ possessed sufficient mechanical properties for an easy handling of the 
dressing sheets. In general, wound dressings need to be stable and flexible enough to 
sustain the forces applied during the application and wearing process, whilst adapting to 
the actual wound shape.19 In view of the elasticity of the human skin (around 70%), the 
developed dressing materials provide sufficient ductility.45 As hydrogels often serve as 
primary dressing covered by a secondary dressing with a stabilizing function, the 
requirements for these particular wound dressings are even lower.46 Values of 1.5 to 
5.0 kPa maximum tensile stress were described to already meet the requirements for 
wound dressing applications.47,48  
The great advantage of an IPN hydrogel formulation is also visible in the liquid handling 
properties of the developed PEGDA6k/alginate IPN gels (Table 2). The presence of 
alginate, which is known for its excellent absorption properties, together with a slightly 
decreased PEGDA network density, which is caused by partial substitution of PEGDA by 
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alginate, resulted in a significantly increased swelling capacity.43 Yet, it was a fast process 
and the maximum liquid uptake of the non-degrading PEGDA containing hydrogels had 
already been reached after 24 h. Further swelling of pure alginate gels is related to an ion 
exchange of the cross-linking Ca2+ ions by monovalent, non-cross-linking Na+ ions of the 
incubation medium.49 A satisfying liquid handling capacity of wound dressings is also 
defined by the water vapor transmission rate, classifying the amount of excessive exudate 
that can be removed by evaporation or the ability of preventing tissue from desiccation.50 
The here detected values are in accordance with typical WVTRs of (hydrogel) wound 
dressings.51 In comparison to water evaporation from uncovered surfaces (323.88 ± 
1.39 g·h–1·m–2), the treatment with the examined hydrogel dressings reduced the water loss 
by 39 – 47%. 
The need for antimicrobial dressings is founded on the high rate of wound infections and 
the related risk for serious healing issues.3,52,53 Therefore, the favorable PEGDA6k/alginate 
IPN hydrogels were tested for their suitability as PHMB releasing antimicrobial dressing 
materials. The PHMB release was observed at 33 °C, which corresponds to the average 
wound bed temperature.54 Fast and almost complete drug release from pure PEGDA6k 
hydrogels indicates a diffusion controlled mechanism.55 Reduced release rates from 
PEGDA6k/alginate IPN hydrogels must therefore be caused by an interaction of the 
positively charged PHMB molecules and the negatively charged carboxylic acid groups of 
alginate. This theory could be verified by the examination of AMA and CEC containing 
PEGDA6k IPN hydrogels. A reduced amount of carboxylic acid groups in the drug carrier 
(alginate > AMA > CEC) and additional incorporation of potential positive charges 
(-NH2 ↔ -NH3+; CEC) decreased the amount of interaction sites with PHMB (Table 3), 
and therefore significantly increased the release rates.  
Table 3. Amount of functional groups per gram of hydrogel and impact of saline shielding. 
 
9.5% PEGDA6k 
0.5% alginate 
9.5% PEGDA6k 
0.5% AMA 
9.5% PEGDA6k 
0.5% CEC 
n(-COOH) (mmol) 0.0253 0.0210 0.0094 
n(-NH2) (mmol) - - 0.0160 
Effect of saline shielding 
on the % PHMB release + 24% + 2% + 37% 
 
Discussion 
 51 
The percentage release from PEGDA6k/alginate gels was successfully enhanced by 24%, 
when the PHMB loading process was modified so that the positively charged PHMB imino 
groups were shielded by an increased number of chloride ions, and ionized alginate 
carboxylic groups were shielded by an increased number of sodium ions from the saline 
loading solution. The intensity of the saline induced shielding was dependent on the 
character of the secondary network (Table 3). This effect might be explained by 
differences in the steric hindrance around the respective carboxylic acid groups. In CEC 
containing hydrogels, the carboxyl groups are easily accessible as they have a -NRCH2CH2 
spacer to the chitosan saccharide ring system. In alginate and AMA containing gels, the 
carboxyl groups are directly bound to the folded saccharide ring chains. Additional steric 
hindrance in AMA containing hydrogels is induced by chemical bonds between the AMA 
and PEGDA molecules. Nevertheless, PHMB release should also be evaluated regarding 
the absolute amount of PHMB release per gram of hydrogel. In accordance with the 
swelling capacity of the different formulations, PHMB uptake was highest in alginate and 
AMA containing IPNs (Figure 5).56 The data on PHMB/saline loaded gels suggests that 
functional groups in the hydrogel do not only alter the release rate, but also influence the 
loading process. Commercially available wound dressings contain 0.1 – 0.5% PHMB (e.g. 
Suprasorb X + PHMB (Lohmann & Rauscher), Kendall (AMD), Prontosan (B. Braun 
Medical Ltd)). In the light of the facts, the here described PEGDA/alginate IPN hydrogels 
(0.8% maximal loading and 0.3% maximal release of PHMB) can therefore be seen as 
promising candidates for an antimicrobial wound dressing application. 
 
5. Conclusion 
Different approaches were taken to develop antimicrobial hydrogel wound dressings, 
consisting of interpenetrating alginate and poly(ethylene glycol) diacrylate polymer 
networks. The conducted research focused on a systematic optimization of the initiator 
system, using redox-, UV-, and ionically induced cross-linking. Furthermore, a variation of 
the polymer network cross-linking density enabled the adaption of important wound 
dressing properties, such as the liquid uptake and the mechanical stability. The 
photopolymerized hydrogel 9.5% PEGDA6k/0.5% alginate/HHMP was identified to be the 
most promising gel formulation. Its suitability for an antimicrobial drug release was 
furthermore proven, using poly(hexamethylene biguanide) hydrochloride as model 
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substance. Further research should focus on the evaluation of the hydrogel 
biocompatibility and its wound healing capacity, both in vitro and in vivo. 
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Abstract 
The development of chronic wounds has been frequently associated with alkaline pH 
values. The application of pH-modulating wound dressings could, therefore, be a 
promising treatment option to promote normal wound healing. This study reports on the 
development and characterization of acidic hydrogel dressings based on interpenetrating 
poly(ethylene glycol) diacrylate/acrylic acid/alginate networks. The incorporation of 
ionizable carboxylic acid groups results in high liquid uptake up to 500%. The combination 
of two separate polymer networks significantly improves the tensile and compressive 
stability. In a 2D cell migration assay, the application of hydrogels (0 to 1.5% acrylic acid) 
results in complete “wound” closure; hydrogels with 0.25% acrylic acid significantly 
increase the cell migration velocity to 19.8 ± 1.9 µm·h–1. The most promising formulation 
(hydrogels with 0.25% acrylic acid) is tested on 3D human skin constructs, increasing 
keratinocyte ingrowth into the wound by 164%.  
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1. Introduction 
Normal wound healing proceeds in three major stages. Directly after coagulation and clot 
formation, neutrophils and monocytes enter the wound site. This process is mediated by 
cytokines and growth factors and marks the beginning of the inflammatory phase.1 During 
the proliferative phase, epithelial cells, fibroblasts, and keratinocytes migrate to the injured 
area and start to proliferate. This phase is characterized by the synthesis of collagen and the 
formation of blood vessels.2,3 In the remodeling phase, final healing occurs by tissue 
strengthening and replacement of provisional tissue.2,4 This sequence is disrupted in 
non-healing or chronic wounds. Wounds that do not heal over a period of several months 
or years affect 2% of the population of the United States and generate costs of more than 
50 billion U.S. dollar per year.5 Finding new treatment options for chronic wounds is, 
therefore, a pressing problem in healthcare. 
Clinical studies indicate that chronic wounds are often characterized by elevated pH 
values,6,7 which may have a strong impact on different processes in the healing cascade.8,9 
At elevated pH, the availability of oxygen is reduced; this may affect the proliferation of 
fibroblasts and impair the synthesis of extracellular matrix (ECM).10,11 Furthermore, 
bacterial colonialization and biofilm formation are facilitated under these conditions.9 
Effects of the pH have also been described on the level of protein conformation. For 
example, the conformation of vitronectin, an important ECM protein, changes with the pH 
of the environment. This alters the ability of vitronectin to bind endothelial cells and 
osteonectin, which is an important factor for fibroblast migration and collagen 
synthesis.12,13 Furthermore, the activity of several enzymes depends on the wound pH.14 In 
particular, the concentration and activity of matrix metalloproteinases (MMPs) is increased 
in chronic wounds, whereas tissue inhibitors of metalloproteinases (TIMPs) are 
suppressed. This imbalance between MMPs and TIMPs favors the degradation of ECM 
and growth factors.  
Recent approaches tackle, amongst others, the problems of bacterial colonization and 
reduced oxygen levels; this has resulted in the development of advanced, rather expensive 
wound dressing materials.15 Restoring the physiological pH (pH 7.4) could be an 
alternative, more economical way to bring chronic wounds back to the natural healing 
cascade.7,8 For the development of pH-modulating wound dressings, physically cross-
linked alginate was combined with a chemically cross-linked network consisting of 
poly(ethylene glycol) diacrylate (PEGDA) and acrylic acid (AA). Alginate is a naturally 
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occurring polysaccharide consisting of 1,4-linked β-D-mannuronic acid and α-L-guluronic 
acid repeating units; it is widely used for the development of medical products.16–18 The 
hydrophilicity, excellent biocompatibility, and huge liquid absorbing capacity make 
alginate an attractive base material for wound dressings. Poly(ethylene glycol), on the 
other hand, is a synthetic hydrogel precursor that is widely used in the biomedical field, 
e.g., for cell encapsulation.19–21 By using different starting materials, different properties 
can be combined in one single material. In comparison with wound dressings made from a 
single polymer, these composite materials have shown superior mechanical properties and 
liquid handling capacity, and resulted in improved wound healing.15 In particular, alginate 
and PEGDA form an interpenetrating polymer network (IPN), which is characterized by 
enhanced mechanical stability.22–24 The incorporated AA groups are responsible for pH 
regulation and act, together with functional groups of alginate, as interconnection between 
the two networks. Different PEGDA and AA concentrations were used; their impact on the 
swelling capacity, mechanical properties, and base neutralizing capacity of the formed 
hydrogels was assessed. Furthermore, the performance of the IPN hydrogels was evaluated 
in two-dimensional (2D) cell culture and three-dimensional (3D) human skin constructs. 
 
2. Experimental Section 
2.1 Preparation of Hydrogels 
The synthesis of PEGDA is described in the supporting information. For hydrogel 
preparation, PEGDA was dissolved in phosphate buffered saline (PBS). To initiate 
polymerization, 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone was suspended 
in PBS and added to the stirred solution. Afterwards, the required amounts of alginate 
(solution in PBS, c = 41.7 mg·mL–1) and acrylic acid (AA) were added drop-wise. The 
PEGDA concentration ranged from 5.0 to 10.0%; the AA concentration was varied 
between 0 and 4.5%; the alginate concentration was either 0 or 0.5%. The overall 
concentration of all three components was 10.0% in all groups; the initiator concentration 
was 1.8%, based on the total monomer mass. For tensile testing and water vapor 
transmission studies, 8 mL of the solution were cast into rectangular silicon molds; for skin 
construct healing assays, 1.4 mL of the solution were cast into a 6-well plate. For all other 
experiments, cylindrical glass molds (1 cm diameter, 0.7 mL volume) were used. All 
samples were irradiated with UV light (366 nm, 6 W) for 1 h. If not stated otherwise, the 
hydrogels (initial weight m0) were placed in 10 mL of deionized water to leach out the 
Experimental Section 
 65 
initiator and unreacted monomers. The gels were removed after 24 h of incubation at 
37 °C. To remove the absorbed water, the gels were partially dried by exposing them to a 
stream of compressed air. The drying process was stopped after m0 had been reached; in 
this way, the water content (90%) was kept constant throughout all experiments. 
 
2.2 Swelling Capacity 
Hydrogel cylinders were prepared as described above (without pre-incubation in water) 
and incubated in 10 mL of PBS at 37 °C in a shaking water bath. Over a period of 7 days, 
the liquid was decanted every 24 h; the gels were blotted dry using a filter paper and 
weighed. The swelling capacity (Qt) was calculated according to Equation (1) !! = !!!!!!! ∙ 100%          (1) 
where mt is the mass of the gel cylinder at time point t, and m0 is the initial mass of the gel. 
 
2.3 Water Vapor Transmission Rate 
The water vapor transmission rate (WVTR) was determined according to the ASTM 
E96/E96M-12 inverted water method.25 Hydrogel sheets were prepared as described above 
and fixed at a circular WVTR test dish carrying 5 mL of deionized water. Water loss at 
37 °C and 21% relative humidity was measured gravimetrically every hour (0 – 10 h and 
≥ 24 h) until a weight loss of 5 g had been be reached. The WVTR was calculated 
according to Equation (2) !"#$ =  !! ∙ !!          (2) 
where G is the slope of the time–water loss curve, and A is the test area (10.18 cm2). 
 
2.4 Tensile Strength 
Hydrogel sheets were prepared as described above (without pre-incubation in water) and 
cut into rectangular specimens of 1 cm width (d) and 8 cm length. Prior to mechanical 
testing, the thickness (h) of the specimens (around 550 µm) was determined using a 
MiniTest 600 gauge (ElektroPhysik, Köln, Germany). Tensile testing was performed using 
an Instron 5542 load frame with two serrated grips (Instron GmbH, Darmstadt, Germany). 
The specimens were stretched until failure with a tensile velocity of 15 mm·min–1 and the 
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maximum load (Fmax, t) and elongation (lmax) were measured. The tensile stress (σt) was 
calculated according to Equation (3). !! = !!"#,!!∙!           (3) 
The elastic modulus (Et) was calculated from the slope of the stress-strain curve between 
0.05 and 0.15 strain. The data are presented as mean ± standard deviation (SD), based on 
the test results of n = 4 specimens. 
 
2.5 Compressive Strength 
Hydrogel cylinders were prepared as described above (with and without pre-incubation in 
water). Height (h) and diameter (d) of the gel cylinders were determined using a caliper 
(BORT GmbH, Weinstadt-Benzach, Germany). Compressive testing was carried out using 
an Instron 5542 load frame equipped with two cylindrical platens. The hydrogel cylinders 
were compressed at 0.5 mm·min–1 until a strain of 95% had been reached. Compressive 
stress (σc) and elastic modulus of compression (Ec) were calculated as described above. 
 
2.6 Scanning Electron Microscopy 
Hydrogel cylinders were shock-frozen in liquid nitrogen, lyophilized and coated with gold. 
The microstructure was examined by using a Crossbeam XB 340 scanning microscope 
(Zeiss, Jena, Germany) at an extra high tension voltage level of 3.0 kV. 
 
2.7 Base Neutralizing Capacity 
Hydrogel cylinders were prepared as described above and placed in 15 mL of a 0.1 M 
sodium chloride solution. To determine the base neutralizing capacity (BNC), a 0.1 M 
sodium hydroxide solution was added over 24 h using a TitroLine 7000 dosage system 
equipped with a BlueLine glass electrode (SI Analytics GmbH, Mainz, Germany); the pH 
was kept constant at 7.4 during the experiment (static pH titration). The BNC was 
calculated from the amount of neutralized sodium hydroxide, n(NaOH), and the initial 
mass of the gel cylinder, m0, according to Equation (4). !"# = !(NaOH)!!           (4) 
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2.8 Cell Viability 
The cell viability was determined according to ISO 10993-5 using adult human dermal 
fibroblasts (HDFa).26,27 A detailed description of the methods and experimental conditions 
can be found in the supporting information. 
 
2.9 Cell Migration Assay 
Cell culture inserts (Ibidi GmbH, Martinsried, Germany) were placed in a fibronectin-
coated 6-well plate (Corning, Corning, NY, USA); then, 140 µL of a HDFa suspension 
(300000 cells·mL–1) were pipetted into the inserts. After 24 h of incubation under standard 
cell culture conditions, the inserts were removed; 8 mL of pH-modified medium 
(medium 199 :  utrient mixture F12 (F12) 3 : 1, 10% fetal bovine serum (FBS), 1.10 mM 
hydrocortisone, adjusted to pH 8 with 1 M NaOH) were added. Hydrogels were placed in 
netwell inserts (Corning, Corning, NY, USA) and inserted into the cell culture plate. Every 
12 h, pH adjusted cell culture medium was replaced by fresh medium. The cell migration 
was observed over 48 h using a Leica DM IRB microscope (Leica Microsystems GmbH, 
Wetzlar, Germany) connected to a DS-5M digital camera (Nikon GmbH, Düsseldorf, 
Germany). The area of cell migration was calculated using the Eclipsenet software (Nikon 
GmbH, Düsseldorf, Germany); cell migration velocity was calculated from the slope of the 
area closure/time curve.  
 
2.10 3D Human Skin Constructs and Healing Assay* 
Normal human skin constructs were generated according to previously published 
procedures.28–30 Briefly, normal primary human keratinocytes and fibroblasts were isolated 
from juvenile foreskin, the remainder of circumcision surgery (with ethical consent) and 
cultivated according to standard protocols until skin construction. Fibroblasts (3.0·105/skin 
construct), FBS, Hank’s balanced salt solution and bovine collagen I were brought to 
neutral pH and poured into cell culture inserts with a growth area of 4.2 cm2. After 
cultivation for 2 h at 37 °C, keratinocyte growth medium (KGM) was added and the 
system was transferred to an incubator with 5% CO2 and 95% humidity for further 2 h. 
Primary keratinocytes (4.2·106/skin construct) resuspended in KGM were added on top of 
the collagen matrix. Skin constructs were lifted to the air-liquid interface 24 h later and a 
																																								 																				
* 3D human skin constructs were generated at the Institute of Pharmacy, Pharmacology and Toxicology, 
Freie Universität Berlin, with support and based on the method of S. Hedtrich and L. Wallmeyer. 
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high glucose Dulbecco’s modified eagle medium (DMEM)-based differentiation medium 
was added.  
After 2 days of skin construct cultivation, a wound was induced by cutting the epidermal 
layer with a scalpel. For reproducibility, defect size and operating person remained 
unchanged in all samples. The injured constructs were incubated with pH–defined 
medium, containing 2.5% hydroxyethyl cellulose to enhance the viscosity. In order to 
maintain induced pH variations during the healing assay, the differentiation medium was 
modified by substituting DMEM with medium 199 with reduced bicarbonate. Medium was 
adjusted to pH 8.0 by dropwise addition of 2 M NaOH.11 The respective hydrogels were 
punched out in circular shape (1 cm diameter) and applied onto the wound area. The 
pH-defined medium was changed every day and the hydrogels were replaced 2 days after 
wound induction. Injured constructs without hydrogels applied served as control. After 
further 2 days, the hydrogels were carefully removed from the skin constructs. The 
constructs were punched, embedded in tissue freezing medium (Leica Biosystems, 
Nussloch, Germany), and shock-frozen using liquid nitrogen. Subsequently, the skin 
constructs were cut vertically into slices (7 µm) using a Leica CM1510 S cryotome (Leica 
Biosystems, Nussloch, Germany) and stained with conventional hematoxylin and eosin 
(H&E) according to standard protocols. After picture capturing (BZ-8000 microscope, 
Keyence, Neu-Isenburg, Germany), the length of cell ingrowth was determined using 
ImageJ (National Institutes of Health, Bethesda, Maryland, USA). 
 
3. Results 
Interpenetrating polymer networks were prepared by radical polymerization of 
poly(ethylene glycol) diacrylate (PEGDA) and acrylic acid (AA) in combination with 
alginate.31 The resulting hydrogels had water contents of 90%, thus showing a flexible but 
stable texture. 
Table 1. Composition of the examined hydrogel formulations. 
Formulation PEGDA (%) AA (%) Alginate (%) 
PEGDA 10.00 – – 
PEGDA/alginate 9.50 – 0.50 
PEGDA/AA/alginate 5.00 – 9.25 0.25 – 4.50 0.50 
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The AA content ranged from 0 to 4.5% (Table 1); raising the AA concentration above 
4.5% was not possible. At low pH values, AA forms complexes with PEGDA via 
hydrogen bonds. These became visible as white precipitate when high volumes of AA 
(c ≥ 3.5%) were added to aqueous PEGDA solutions during precursor mixing.32,33 
 
3.1 Liquid Uptake and Water Vapor Transmission 
The swelling capacity of PEGDA, PEGDA/alginate, and PEGDA/AA/alginate hydrogels 
was calculated after 24 h and 7 days; the value determined after 7 days was regarded as 
equilibrium swelling ratio (Figure 1). Compared to pure PEGDA hydrogels, the addition of 
0.5% alginate caused a significant change in the swelling ratio, which increased from 15 to 
40% regardless of the incubation time. With the incorporation of AA, the swelling capacity 
further increased. After 24 h of incubation, the swelling ratio ranged from 63% (0.25% 
AA) to 253% (4.5% AA). After the equilibrium had been reached, swelling ratios between 
64 and 501% could be measured.		
 
Figure 1. Swelling capacity of PEGDA/AA/alginate hydrogels with different monomer concentrations after 
24 h and 7 days of incubation. Data are expressed as mean ± SD (n = 3). 
 
Exemplarily, the water vapor transmission rate of PEGDA, PEGDA/alginate and PEGDA/ 
AA/alginate (0.25% acrylic acid) hydrogels was determined; the measured values were 
175.35 ± 0.58, 171.40 ± 0.30 and 182.35 ± 0.38 g·h–1·m–2, respectively.  
 
3.2 Mechanical Properties and Microstructure 
To evaluate the mechanical properties of the developed hydrogels, their behavior in tensile 
and compressive testing was examined. The tensile stress at maximum load (σt) ranged 
from 38.0 ± 1.1 kPa (pure PEGDA hydrogels) to 80.1 ± 13.8 kPa (PEGDA/alginate gels, 
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Figure 2A); the compressive stress at maximum load (σc) ranged from 0.43 ± 0.16 MPa to 
2.85 ± 0.68 MPa, respectively (Figure 2C). The incorporation of AA had little effect on the 
tensile stress, which ranged between 65.5 and 91.5 kPa (Figure 2A). The compressive 
stress, on the other hand, was clearly influenced by the AA content; higher amounts of AA 
resulted in lower values of σc (Figure 2C). 
 
Figure 2. Mechanical properties and microstructure of different PEGDA/AA/alginate hydrogels. Tensile 
stress at maximum load (A) and calculated E-modulus (B); compressive stress at maximum load (C) and 
calculated E-modulus (D). Data are expressed as mean ± SD (n = 4); * indicates statistically significant 
differences versus the control (p < 0.05); # indicates statistically significant differences between the groups 
(p < 0.05). SEM images of lyophilized PEGDA (E), PEGDA/alginate (F), and PEGDA/AA/alginate (G) 
hydrogels. The length of the scale bars is 10 µm. 
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In tensile testing, the elastic modulus (Et) increased by approximately 45% when low 
concentrations of AA (0.25 to 0.75%) were incorporated into PEGDA/alginate hydrogels 
(Figure 2B). Further increasing the AA content resulted in lower values of Et similar to 
those of pure PEGDA/alginate hydrogels. In contrast to that, Ec showed the same trend as 
σc in compressive testing (Figure 2D). The compressive testing was repeated after 
incubating the gels in deionized water to check whether purification results in altered 
mechanical properties. As shown in Figure 2C and D, neither σc nor Ec changed 
significantly upon incubation in water. The investigation of the hydrogel microstructure 
was performed by scanning electron microscopy (SEM). Pure PEGDA gels had a low 
porosity, whereas PEGDA/alginate IPNs showed a considerable amount of pores at the 
surface (diameter around 4 µm; Figure 2E and F). The addition of AA generated fibrous 
structures and irregular pores with a high variation in diameter (0.5 – 30 µm, Figure 2G). 
 
3.3 Base Neutralizing Capacity 
The capacity for proton donation is an important parameter of pH-modulating wound 
dressings that can be estimated by the base neutralizing capacity (BNC).34,35 As it was 
expected, the BNC of the tested hydrogels increased with increasing AA content 
(Figure 3). Depending on the AA content, 0.012 to 0.88 mmol of sodium hydroxide were 
neutralized per gram hydrogel. 
 
Figure 3.	 Base neutralizing capacity of PEGDA/AA/alginate hydrogels with different monomer 
concentrations. Data are expressed as mean ± SD (n = 3); * indicates statistically significant differences 
versus the lower concentrated samples (p < 0.05). 
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3.4 Cell Viability Testing 
The cytotoxicity of the developed hydrogels was evaluated by a MTT assay. Since high 
AA concentrations gave rather fragile hydrogels (see Figure 2 for comparison), the cell 
viability testing was only performed on hydrogels with AA contents up to 2.5%. The 
results presented in Figure 4 demonstrate that hydrogels with AA concentrations between 0 
and 1.0% did not significantly affect the cell viability, independent from the hydrogel 
incubation time (12 – 48 h). However, hydrogels with AA concentrations between 1.5 and 
2.5% reduced the cell viability by approximately 20% during the first 12 h of incubation. 
Nevertheless, the cell viability was generally between 77 and 127%; therefore, all tested 
hydrogels were regarded as non-cytotoxic.26 
 
Figure 4. Viability of HDFa in contact with different PEGDA/AA/alginate hydrogel extracts. The broken 
line (---) marks the critical value of 70% cell viability.[21] Data are expressed as mean ± SD (n = 6); 
* indicates statistically significant differences versus the untreated control (p < 0.05). 
 
3.5 2D Cell Migration Assay 
The effects of pH-modulating hydrogels on cells were studied in 2D migration assays.11,36 
During the duration of the experiment, cells treated with PEGDA/alginate and PEGDA/ 
AA/alginate hydrogels (0.25 – 1.5% AA concentration) showed a complete gap closure 
(Figure 5A). However, when hydrogels with an AA concentration of 2.5% were applied, 
the percentage of gap closure decreased; the measured values were significantly lower than 
in the control group. Moreover, the application of PEGDA/alginate and individual 
PEGDA/AA/alginate hydrogels (0.25 and 0.50% AA concentration) significantly increased 
the cell migration velocity in comparison to the control group (Figure 5B). The maximum 
migration velocity (19.8 ± 1.9 µm·h–1) was measured when PEGDA/AA/alginate gels with 
an AA content of 0.25% were applied. 
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Figure 5. Percentage of gap closure (A) and cell migration velocity (B) in 2D migration experiments with 
different PEGDA/AA/alginate hydrogels applied. Data are expressed as mean ± SD (n = 3); * indicates 
statistically significant differences versus the untreated control (p < 0.05); # indicates statistically significant 
differences between the groups (p < 0.05). 
 
3.6 3D Human Skin Constructs and Healing Assay 
As a proof of concept, the developed hydrogels were applied on wounded human skin 
constructs supplied with alkaline cell culture medium (pH 8).28 To this end, the damaged 
stratum corneum (layer S in Figure 6) and epidermis (layer E in Figure 6) were covered 
with PEGDA/alginate or PEGDA/AA/alginate hydrogels (0.25% AA concentration); the 
degree of “wound healing” was evaluated by measuring the ingrowth of cells.  
 
Figure 6. H&E stained histological images of injured skin constructs after a healing period of 4 days. The 
untreated control is shown on the left (A); a skin construct treated with a PEGDA/AA/alginate hydrogel 
(0.25% AA content) is shown on the right (B). Stratum corneum (S), epidermis (E), and dermis equivalent 
(D) are clearly visible. The length of cell ingrowth is indicated by triangles; the insets show a magnification 
of this area. The length of the scale bars is 50 µm. 
 
In comparison to untreated constructs, the cell ingrowth increased significantly when 
PEGDA/AA/alginate hydrogels with an AA content of 0.25% were applied (Figure 7); the 
A B
#
a
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keratinocyte ingrowth could be enhanced by 164%. On the other hand, the application of 
hydrogels without pH-modulating properties (PEGDA/alginate) did not have any effect on 
“wound healing”.  
 
Figure 7. Ingrowth length in the untreated control at pH 8 (mean set as 100%), skin constructs treated with 
PEGDA/alginate gels, and skin constructs treated with PEGDA/AA/alginate hydrogels (0.25% AA content). 
Data are expressed as boxplot (10 - 90%); * indicates statistically significant difference versus the untreated 
control (p < 0.05). 
 
4. Discussion 
The treatment of chronic wounds is a great challenge in health care.5 Numerous studies 
indicate that impaired healing is often correlated with alkaline pH values of the wound. To 
neutralize the alkaline pH and stimulate the healing of chronic wounds, pH-modulating 
hydrogels consisting of poly(ethylene glycol) diacrylate, acrylic acid and alginate were 
developed. These hydrogels must meet strict requirements regarding swelling capacity, 
mechanical properties, and biocompatibility. For example, a sufficient swelling capacity is 
mandatory for wound dressings. In particular chronic wounds secrete large amounts of 
wound exudate, which should be absorbed by the dressing material. If not removed, 
excessive exudate can inhibit cell proliferation; furthermore, wound exudate contains high 
concentrations of cytokines and MMPs, which can cause degradation of the surrounding 
tissue and promote inflammation.2,37,38 For most wounds, exudate amounts between 1 and 
12 L·m–2 per day have been described in the literature.39,40 Transferring these values to the 
herein examined gel cylinders (approximate surface area: 4.37 cm2), the material should be 
able to absorb at least 0.4 mL of liquid to act as a dressing for heavily exuding wounds. 
Taking the volume of the hydrogel cylinders (approximately 0.7 mL) into account, a 
swelling capacity of at least 57% is required. As shown in Figure 1, the developed 
Discussion 
 75 
PEGDA/AA/alginate IPN hydrogels exhibited swelling ratios between 57.4 ± 1.5 and 
253.1 ± 33.6% after 24 h. The swelling capacity increased with increasing AA content, 
most likely due to the increasing charge density. A high charge density translates into 
strong repulsive forces within the polymer network; hence, there is a strong osmotic force 
directed into the hydrogel, which results in extensive swelling.41 The swelling capacity of 
hydrogel dressings usually depends on the composition of the material; furthermore, 
different ways of calculating the swelling capacity are used, which makes the available 
data difficult to compare.18,42,43 For example, the swelling ratio of PEG-based hydrogels is 
typically not exceeding 30%.42,44 Chen et al. reported the preparation of chitosan-based 
wound dressings with extremely high liquid absorbing capacity;43 however, the calculation 
of the swelling ratio (approximately 1000) was based on the mass of the dry polymer. 
Another parameter characterizing the fluid handling capacity of wound dressings is the 
water vapor transmission rate. The WVTR of commercially available products ranges from 
3.75 to 390 g·h–1·m–2, depending on the composition.45 The herein described hydrogels 
(WVTR around 175 g·h–1·m–2) are, therefore, suitable for wound coverage. 
The mechanical properties of the developed hydrogels were characterized by tensile and 
compressive testing. As it has been described by Gong et al.,22 the tensile strength of 
hydrogels, expressed as tensile stress at maximum load (σt), can be enhanced by generating 
interpenetrating polymer networks. In our study, the addition of alginate to PEGDA 
networks increased the tensile strength by 111%. This is remarkable since an increase by 
only 32% is expected from the sum of σt(alginate) and σt(PEGDA). The addition of AA is 
expected to change the architecture of the PEGDA network. Acrylic acid only contributes 
to chain growth, which typically results in less densely cross-linked networks with reduced 
mechanical strength.46,47 Indeed, changes in the hydrogel structure were identified on the 
microscopic scale, as can be seen in SEM images (Figure 2E – F). However, with regard to 
the tensile strength, the inserted carboxylic acid groups apparently counteract this effect. 
As already discussed before, carboxylic acid groups engage in hydrogen bonds with 
PEGDA (see Figure 8 for illustration).32,33 These interactions were found to contribute to 
the stability of hydrogels under tensile load.48 Furthermore, alginate might also engage in 
hydrogen bonds with PEGDA and AA, given the large number of hydroxyl and carboxylic 
acid groups of the molecule (see Figure 8 for illustration).49 The effect might be 
comparable to the formation of alginic acid gels at acidic pH.31 Apparently, the reduced 
cross-linking density of PEGDA/AA/alginate hydrogels is compensated by the stabilizing 
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effects of hydrogen bonds. As a result, the tensile strength and the E-modulus of PEGDA/ 
AA/alginate hydrogels were almost independent from the AA content (Figure 2A and B).  
 
Figure 8. Schematic representation showing the proposed network architecture of PEGDA/AA/alginate 
hydrogels with all relevant interactions. 
 
In contrast to the tensile strength, the compressive strength of PEGDA/AA/alginate 
hydrogels (expressed as stress at maximum load, σc) was clearly dependent on the AA 
concentration. Increasing the amount of AA resulted in significantly reduced compressive 
strength (Figure 2C); similarly, the elastic modulus (Ec) decreased with increasing AA 
content (Figure 2D). This behavior can be explained as follows. PEGDA/AA/alginate 
hydrogels have a pH of approximately 4.6 (data not shown), as measured using a 
luminescent pH sensor.* At this pH, the carboxylic acid groups (pKa = 4.25) are partially 
ionized and carry a negative charge. During compressive testing, the polymer chains are 
approaching and repulsive forces between negatively charged groups get more and more 
important (see Figure 8 for illustration); as a result, material failure might occur rather than 
polymer chain entanglement. Furthermore, the reverse of strain hardening might have an 
effect in compressive testing. Strain hardening describes the increased strength of a 
material under tensile load; it is explained by the better accessibility of hydrogen bonding 
functional groups in stretched polymer chains.48 During compression, the accessibility of 
these groups is declining; as a consequence, entanglements between polymer chains are no 
longer reinforced by hydrogen bonds and the compressive strength is decreasing.  
The obtained results are in line with previous reports indicating an inverse relationship 
between the E-modulus and hydrogel swelling (see Figure 1 and 2 for comparison).50 
Hydrogels with lower E-modulus are typically characterized by more flexible polymer 
chains, which result in higher swelling capacity. Besides the swelling capacity, further 
																																								 																				
* pH sensor data were obtained and analyzed by R. Meier, Institute of Analytical Chemistry, Chemo- and 
Biosensors, University of Regensburg, according to the method of Schreml et al.11 
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aspects need to be considered when defining the required mechanical strength of hydrogel 
dressings. Wound dressings should be both tough and flexible to withstand the mechanical 
forces occurring during application, wearing and removal; at the same time, the material 
should adapt to the irregular shape of the wound.2,47 The elasticity of the human skin, 
which lies between 70 and 100%, can be taken as a reference value.51,52 The herein 
described PEGDA/AA/alginate IPN hydrogels showed an elongation at break of around 
170%, which should be sufficient for wound dressings. Both fragile and tough wound 
dressings have been described in the literature. Several groups reported on PEG-based 
hydrogels with mechanical properties comparable to the herein described hydrogels. The 
tensile stress at maximum load (σt) typically ranged between 4 and 220 kPa; values 
between 0.04 and 3.73 MPa were reported for the compressive stress (σc). The maximum 
strain at break was 41 – 460% (tensile testing) and 40 – 95% (compressive testing), 
respectively.53–56 On the other hand, materials with a strength of up to 50.9 MPa have also 
been described in the literature.57,58  
Since it was our aim to develop pH-modulating wound dressings, the base neutralizing 
capacity of PEGDA/AA/alginate hydrogels was determined. The physiological pH of 
human tissue (pH 7.4) was taken as target value. The results presented in Figure 3 show 
that the BNC of PEGDA/AA/alginate hydrogels was proportional to the amount of 
incorporated AA. This means that the capacity for proton donation, and hence the 
pH-modulating effect, can be easily adjusted. However, the wound pH varies among the 
different wound types; furthermore, the specific needs in wound care are changing from 
patient to patient and over time.6,59 In clinical application, measurements of the wound pH 
(e.g., by using suitable pH sensors)11 can be used as supportive tool to choose the 
appropriate wound dressing. 
As a consequence, the safety and effectiveness of pH-modulating wound dressings must be 
carefully evaluated in organotypic cell culture models. In a first experiment, the cell 
viability after exposure to hydrogel extracts was evaluated by MTT assay. Although 
exposure to hydrogel extracts was generally well tolerated, the cell viability was 
significantly lower when hydrogels with AA contents of 1.5 and 2.5% were applied. As it 
can be expected from the high concentration of carboxylic acid groups, the pH of the cell 
culture medium dropped to 6.2 and 6.1, respectively (data not shown). The reduced cell 
viability is in accordance with the literature, which also showed reduced fibroblast 
proliferation and viability at pH ≤ 6.5.11,60 A more detailed study of the effects of 
pH-modulating hydrogels on primary human skin cells was done in 2D cell migration 
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experiments, which can be regarded as simplified wound models. As it can be seen from 
Figure 5B, alginate could promote cell migration in vitro. Alginate has been reported to 
modulate the concentration of cytokines and growth factors, which is, among others, 
related to fibroblast proliferation.61,62 Since PEGDA/alginate hydrogels had no detectable 
influence on the pH of the medium (data not shown), additional effects were expected from 
pH-modulating hydrogels. Indeed, the cell migration velocity further increased when 
PEGDA/AA/alginate hydrogels with an AA content of 0.25% were applied (pH shift to 
7.4). The application of hydrogels with AA contents of 0.5% and above reduced the cell 
migration velocity in comparison to PEGDA/alginate and PEGDA/AA/alginate (0.25% 
AA content) treated samples. Their capacity for proton donation is apparently not 
appropriate; consequently, the pH of the medium dropped to 5.8 - 6.8 (data not shown). 
Finally, the most promising formulation (PEGDA/AA/alginate hydrogel with 0.25% AA 
content) was tested in contact with 3D human skin constructs. Since the human skin is 
structurally different from the skin of commonly used laboratory animals, such as rodents, 
human skin constructs are regarded as promising in vitro alternative to animal testing.63–65 
Furthermore, animal models of chronic wounds are difficult to generate and often non-
reproducible, especially in combination with altered wound pH.66 To simulate the 
conditions of chronic wounds, we decided to supply the skin constructs with an alkaline 
cell culture medium. When pH-modulating PEGDA/AA/alginate IPN hydrogels (0.25% 
AA content) were applied, the ingrowth of keratinocytes increased by 164% as compared 
with the untreated control (Figure 7). In this experiment, the pH of the medium seemed to 
be the predominant factor, since the application of PEGDA/alginate gels did not have any 
positive effects on keratinocyte ingrowth. These results confirm the above-described 
findings. PEGDA/AA/alginate hydrogels proved to be biocompatible; the application of 
pH-modulating hydrogels is, therefore, regarded as promising option for the treatment of 
chronic wounds.  
 
5. Conclusion 
Since chronic wounds have been associated with alkaline pH values, the application of 
pH-modulating wound dressings could be a promising treatment option. Herein, we 
reported the development and characterization of novel pH-regulating hydrogel dressings 
based on alginate, PEGDA, and AA. Alginate and PEGDA form an interpenetrating 
polymer network, which is characterized by superior mechanical strength. Important 
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properties of wound dressings, such as swelling capacity and mechanical strength, can be 
adjusted by varying the AA concentration. The developed PEGDA/AA/alginate IPN 
hydrogels are both tough and flexible to withstand the mechanical forces occurring during 
application, wearing, and removal. Similarly, the base neutralizing capacity, which 
characterizes the pH-modulating effect, can be controlled by increasing or decreasing the 
AA content. The results of cell viability studies and cell migration assays indicate that the 
application of PEGDA/AA/alginate hydrogels is a promising strategy to overcome 
pH-related wound healing problems. More particularly, hydrogels with an AA 
concentration of 0.25% can increase the cell migration velocity and percentage of gap 
closure in a simplified 2D model for chronic wounds. These findings are corroborated by 
further tests involving human skin constructs supplied with an alkaline cell culture 
medium. Future research should focus on the incorporation and release of antiseptic drugs 
such as polyhexanide. Such hydrogels could be valuable for the treatment of infected 
wounds, which is another challenging problem in wound care. 
 
6. Supporting Information 
6.1 Materials 
Toluene was obtained from Acros Organics (Geel, Belgium). Bovine collagen I (PureCol®) 
was purchased from Advanced BioMatrix (San Diego, USA). Cell culture inserts were 
obtained from BD Bioscience (Heidelberg, Germany). Fetal bovine serum for skin 
constructs was purchased from Biochrom (Berlin, Germany). Formaldehyde solution (4%) 
and reagents for hematoxylin and eosin staining were obtained from Carl Roth (Karlsruhe, 
Germany). Deuterated chloroform (CDCl3) was purchased from Deutero GmbH 
(Kastellaun, Germany). Alginate (Protanal® LF 10/60FT) was kindly provided by FMC 
BioPolymer (Wallingstown, Ireland). Dichloromethane (DCM), diethyl ether, and ethanol 
were purchased from CSC Jäcklechemie (Nürnberg, Germany). Hydroxyethyl cellulose 
was purchased from Fagron (Barsbüttel, Germany). Dulbecco’s modified eagle 
medium/nutrient mixture F-12 (DMEM/F12), high glucose DMEM, Hank’s balanced salt 
solution, nutrient mixture F-12, penicillin–streptomycin, and PBS were obtained from Life 
Technologies (Carlsbad, CA, USA). Keratinocyte basal medium (KBM) and keratinocyte 
growth medium supplements were purchased from Lonza (Basel, Switzerland). Dimethyl 
sulfoxide (DMSO), glacial acetic acid, hydrochloric acid, sodium hydroxide, and 
triethylamine were purchased from Merck KGaA (Darmstadt, Germany). Deionized water 
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was obtained using a Milli-Q water purification system (Millipore, Schwabach, Germany). 
All other chemicals were purchased from Sigma Aldrich (Taufkirchen, Germany). 
Poly(ethylene glycol) with a molecular mass of 6 kDa (PEG6k) was dried by azeotropic 
distillation in toluene before use. All other chemicals were used as received. 
 
6.2 Synthesis of Poly(ethylene glycol) diacrylate 
Poly(ethylene glycol) diacrylate with a molecular mass of 6 kDa (PEGDA) was 
synthesized as previously described.67 In brief, 25.2 g of dried PEG6k (4.2 mmol) was 
dissolved in 100 mL of anhydrous DCM. The solution was cooled to 0 °C; then, 1400 µL 
of triethylamine (10.0 mmol) and 1625 µL of acryloyl chloride (20.0 mmol) were added 
drop-wise. The reaction mixture was stirred overnight under argon atmosphere, filtered, 
washed with 2 M potassium carbonate solution, and dried over anhydrous magnesium 
sulfate. The product was precipitated in ice-cold diethyl ether and dried under vacuum to 
yield 17.02 g (66.3%).  
1H NMR (300 MHz, CDCl3, δ): 3.62 ppm (m, 310 H, -CH2CH2O-), 4.30 ppm (t, 
2 H, -CH2OC(O)-), 5.82 ppm (dd, 1 H, CH2=CHC(O)O-), 6.13 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.41 ppm (dd, 1 H, CH2=CHC(O)O-). 
 
6.3 Cell Culture 
Adult human dermal fibroblasts (HDFa, Life Technologies, Carlsbad, CA, USA) were 
cultured in DMEM/F12 containing 10% FBS and 1% penicillin-streptomycin. Primary 
fibroblasts from juvenile foreskin were cultured in high glucose DMEM supplemented 
with 10% FBS. Primary keratinocytes from juvenile foreskin were cultured in KBM with 
keratinocyte growth medium supplements (KGM). HDFa were used in passage 3 to 7; 
juvenile foreskin cells were used in passage 2. 
 
6.4 Cell Viability 
Hydrogel cylinders were incubated in pH-modified medium (medium 199 : F12 3 : 1, 10% 
FBS, 1.10 mM hydrocortisone, adjusted to pH 8 with 1 M NaOH) for 48 h at 37 °C. The 
ratio of the hydrogel mass to the volume of the medium was approximately 0.1 g·mL–1. 
Every 12 h, the extracts were collected and replaced with fresh pH-modified medium, 
yielding 32 mL of extract per sample. HDFa (8000 cells per well) were seeded in a 96-well 
plate (Corning, Corning, NY, USA) and incubated for 24 h under standard cell culture 
conditions (37 °C, 5% CO2, 95% relative humidity). The cell culture medium was 
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aspirated and replaced with 100 µL of the hydrogel extracts; pH-modified cell culture 
medium served as a control. The plate was incubated for 24 h at 37 °C. The medium was 
removed; then, 50 µL of a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) solution (c = 2.5 mg·mL–1 in PBS), 130 µL of DMEM/F12, and 20 µL of FBS were 
added. After 4 h of incubation, the solution was gently aspirated; then, 100 µL of a sodium 
dodecyl sulfate solution (c = 0.35 mmol·mL–1 in glacial acetic acid : DMSO 1 : 159) were 
added. The absorbance (A) at 570 and 690 nm was measured after 3 h of incubation at 
room temperature using a FluoStar Omega micro plate reader (BMG Labtech, Ortenberg, 
Germany). The cell viability (v) was calculated according to Equation (S1). ! = !!"#,!"#!!!"#,!"#!!"#,!"#$!!!"#,!"#$  ∙ 100%          (S1) 
The data are presented as mean ± SD, based on the test results of n = 6 samples. 
 
6.5 Statistical Analysis 
If not stated otherwise, the experiments were done in triplicate and the data are presented 
as mean ± standard deviation. For statistical analysis, Brown Forsythe tests were run 
followed by one-way ANOVA/Tukey’ test or Kruskal-Wallis-ANOVA. Differences were 
considered statistically significant at p < 0.05. 
  
Chapter 3 - pH-Modulating Poly(ethylene glycol)/Alginate Hydrogel Dressings 
 82 
References 
1. Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound 
healing. Clin. Dermatol. 2007; 25: 19–25. 
2. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. Wound healing dressings and 
drug delivery systems: A review. J. Pharm. Sci. 2008; 97: 2892–2923. 
3. Moura LIF, Dias AMA, Carvalho E, Sousa HCd. Recent advances on the development 
of wound dressings for diabetic foot ulcer treatment-a review. Acta Biomater. 2013; 9: 
7093–7114. 
4. Schreml S, Szeimies R-M, Prantl L, Landthaler M, Babilas P. Wound healing in the 
21st century. J. Am. Acad. Dermatol. 2010; 63: 866–881. 
5. Fife CE, Carter MJ. Wound care outcomes and associated cost among patients treated 
in US outpatient wound centers: Data from the US wound registry. Wounds 2012; 24: 
10–17. 
6. Sharpe JR, Booth S, Jubin K, Jordan NR, Lawrence-Watt DJ, Dheansa BS. Progression 
of wound pH during the course of healing in burns. J. Burn Care Res. 2013; 34: e201-
e208. 
7. Schneider LA, Korber A, Grabbe S, Dissemond J. Influence of pH on wound-healing: 
A new perspective for wound-therapy? Arch. Dermatol. Res. 2007; 298: 413–420. 
8. Nagoba BS, Suryawanshi NM, Wadher B, Selkar S. Acidic environment and wound 
healing: A review. Wounds 2015; 27: 5–11. 
9. Percival SL, McCarty S, Hunt JA, Woods EJ. The effects of pH on wound healing, 
biofilms, and antimicrobial efficacy. Wound Repair Regen. 2014; 22: 174–186. 
10. Strohal R, Gerber V, Kröger K, Kurz P, Läuchli S, Protz K, Uttenweiler S, Dissemond 
J. Expert consensus to practical aspects of wound therapy with hemoglobin spray. 
Wund Management 2016; 10: 276–284. 
11. Schreml S, Meier RJ, Kirschbaum M, Kong SC, Gehmert S, Felthaus O, Küchler S, 
Sharpe JR, Wöltje K, Weiß KT, Albert M, Seidl U, Schröder J, Morsczeck C, Prantl L, 
Duschl C, Pedersen SF, Gosau M, Berneburg M, Wolfbeis OS, Landthaler M, Babilas 
P. Luminescent dual sensors reveal extracellular pH-gradients and hypoxia on chronic 
wounds that disrupt epidermal repair. Theranostics 2014; 4: 721–735. 
12. Bernards MT, Jiang S. pH-induced conformation changes of adsorbed vitronectin 
maximize its bovine aortic endothelial cell binding ability. J. Biomed. Mater. Res. A 
2008; 87: 505–514. 
References 
 83 
13. Sullivan MM, Puolakkainen PA, Barker TH, Funk SE, Sage EH. Altered tissue repair 
in hevin-null mice: Inhibition of fibroblast migration by a matricellular SPARC 
homolog. Wound Repair Regen. 2008; 16: 310–319. 
14. Gioia M, Fasciglione GF, Monaco S, Iundusi R, Sbardella D, Marini S, Tarantino U, 
Coletta M. pH dependence of the enzymatic processing of collagen I by MMP-1 
(fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain. J. Biol. 
Inorg. Chem. 2010; 15: 1219–1232. 
15. Boateng J, Catanzano O. Advanced therapeutic dressings for effective wound healing--
A review. J. Pharm. Sci. 2015; 104: 3653–3680. 
16. Matai I, Gopinath P. Chemically crosslinked hybrid nanogels of alginate and PAMAM 
dendrimers as efficient anticancer drug delivery vehicles. ACS Biomater. Sci. Eng. 
2016; 2: 213–223. 
17. Lee JY, Chung J, Chung W-J, Kim G. Fabrication and in vitro biocompatibilities of 
fibrous biocomposites consisting of PCL and M13 bacteriophage-conjugated alginate 
for bone tissue engineering. J. Mater. Chem. B Mater. Biol. Med. 2016; 4: 656–665. 
18. Jin SG, Kim KS, Kim DW, Kim DS, Seo YG, Go TG, Youn YS, Kim JO, Yong CS, 
Choi H-G. Development of a novel sodium fusidate-loaded triple polymer hydrogel 
wound dressing: Mechanical properties and effects on wound repair. Int. J. Pharm. 
2016; 497: 114–122. 
19. Li Y, Fukushima K, Coady DJ, Engler AC, Liu S, Huang Y, Cho JS, Guo Y, Miller LS, 
Tan JPK, Ee PLR, Fan W, Yang YY, Hedrick JL. Broad-spectrum antimicrobial and 
biofilm-disrupting hydrogels: Stereocomplex-driven supramolecular assemblies. 
Angew. Chem. Int. Ed. 2013; 52: 674–678. 
20. Dong Y, Hassan WU, Kennedy R, Greiser U, Pandit A, Garcia Y, Wang W. 
Performance of an in situ formed bioactive hydrogel dressing from a PEG-based 
hyperbranched multifunctional copolymer. Acta Biomater. 2014; 10: 2076–2085. 
21. Cantu DA, Kao WJ. Combinatorial biomatrix/cell-based therapies for restoration of 
host tissue architecture and function. Adv. Healthcare Mater. 2013; 2: 1544–1563. 
22. Gong JP, Katsuyama Y, Kurokawa T, Osada Y. Double-network hydrogels with 
extremely high mechanical strength. Adv. Mater. 2003; 15: 1155–1158. 
23. Matricardi P, Di Meo C, Coviello T, Hennink WE, Alhaique F. Interpenetrating 
polymer networks polysaccharide hydrogels for drug delivery and tissue engineering. 
Adv. Drug Deliver. Rev. 2013; 65: 1172–1187. 
Chapter 3 - pH-Modulating Poly(ethylene glycol)/Alginate Hydrogel Dressings 
 84 
24. Cao Z, Yang Q, Fan C, Liu L, Liao L. Biocompatible, ionic-strength-sensitive, double-
network hydrogel based on chitosan and an oligo(trimethylene carbonate)-
poly(ethylene glycol)-oligo(trimethylene carbonate) triblock copolymer. J. Appl. 
Polym. Sci. 2015; 132: 42459. 
25. E96/E96M-12, Standard test methods for water vapor transmission of materials. West 
Conshohocken, PA, USA: ASTM International; 2012. 
26. 10993-5:2009, Biological evaluation of medical devices - Part 5: Tests for in vitro 
cytotoxicity. Geneva, Switzerland: International Organization for Standardization; 
2009. 
27. 10993-12:2009, Biological evaluation of medical devices - Part 12: Sample preparation 
and reference materials. Geneva, Switzerland: International Organization for 
Standardization; 2009. 
28. Küchler S, Henkes D, Eckl K-M, Ackermann K, Plendl J, Korting H-C, Hennies H-C, 
Schäfer-Korting M. Hallmarks of atopic skin mimicked in vitro by means of a skin 
disease model based on FLG knock-down. ATLA-Altern. Lab. Anim. 2011; 39: 471–
480. 
29. Eckl K-M, Alef T, Torres S, Hennies HC. Full-thickness human skin models for 
congenital ichthyosis and related keratinization disorders. J. Invest. Dermatol. 2011; 
131: 1938–1942. 
30. Wallmeyer L, Lehnen D, Eger N, Sochorova M, Opalka L, Kovacik A, Vavrova K, 
Hedtrich S. Stimulation of PPARalpha normalizes the skin lipid ratio and improves the 
skin barrier of normal and filaggrin deficient reconstructed skin. J. Dermatol. Sci. 2015; 
80: 102–110. 
31. Andriamanantoanina H, Rinaudo M. Relationship between the molecular structure of 
alginates and their gelation in acidic conditions. Polym. Int. 2010; 59: 1531–1541. 
32. Waters DJ, Engberg K, Parke-Houben R, Ta CN, Jackson AJ, Toney MF, Frank CW. 
Structure and mechanism of strength enhancement in interpenetrating polymer network 
hydrogels. Macromolecules 2011; 44: 5776–5787. 
33. Myung D, Waters D, Wiseman M, Duhamel P-E, Noolandi J, Ta CN, Frank CW. 
Progress in the development of interpenetrating polymer network hydrogels. Polym. 
Adv. Technol. 2008; 19: 647–657. 
34. Ibanez JG, Hernandez-Esparza M, Doria-Serrano C, Fregoso-Infante A, Singh MM. 
Environmental Chemistry: Fundamentals. New York, NY, USA: Springer Science & 
Business Media; 2010. 
References 
 85 
35. Kerkhof NJ, Vanderlaan RK, White JL, Hem SL. pH-stat titration of aluminum 
hydroxide gel. J. Pharm. Sci. 1977; 66: 1528–1533. 
36. Manca ML, Castangia I, Zaru M, Nácher A, Valenti D, Fernàndez-Busquets X, Fadda 
AM, Manconi M. Development of curcumin loaded sodium hyaluronate immobilized 
vesicles (hyalurosomes) and their potential on skin inflammation and wound restoring. 
Biomaterials 2015; 71: 100–109. 
37. Wild T, Auböck J, editors. Manual der Wundheilung: Chirurgisch-dermatologischer 
Leitfaden der modernen Wundbehandlung. Wien: Springer-Verlag; 2007. 
38. Bianchi J. The effective management of exudate in chronic wounds. Wounds Int. 2012; 
3: 14–16. 
39. Cutting KF. Wound exudate: Composition and functions. Brit. J. Community Nurs. 
2003; 8: 4–9. 
40. Argenta LC, Morykwas MJ. Vacuum-assisted closure: A new method for wound 
control and treatment: Clinical experience. Ann. Plast. Surg. 1997; 38: 563–576. 
41. Ebara M, Kotsuchibashi Y, Narain R, Idota N, Kim Y-J, Hoffman JM, Uto K, Aoyagi 
T. Smart Biomaterials. Tokyo, Japan: Springer Japan; 2014. 
42. Xie Z, Aphale NV, Kadapure TD, Wadajkar AS, Orr S, Gyawali D, Qian G, Nguyen 
KT, Yang J. Design of antimicrobial peptides conjugated biodegradable citric acid 
derived hydrogels for wound healing. J. Biomed. Mater. Res. A 2015; 103: 3907–3918. 
43. Chen Y, Zhang Y, Wang F, Meng W, Yang X, Li P, Jiang J, Tan H, Zheng Y. 
Preparation of porous carboxymethyl chitosan grafted poly(acrylic acid) 
superabsorbent by solvent precipitation and its application as a hemostatic wound 
dressing. Mater. Sci. Eng. C Mater. Biol. Appl. 2016; 63: 18–29. 
44. Mathur AM, Hammonds KF, Klier J, Scranton AB. Equilibrium swelling of 
poly(methacrylic acid-g-ethylene glycol) hydrogels. J. Control. Release 1998; 54: 177–
184. 
45. Sahraro M, Yeganeh H, Sorayya M. Guanidine hydrochloride embedded polyurethanes 
as antimicrobial and absorptive wound dressing membranes with promising 
cytocompatibility. Mater. Sci. Eng. C Mater. Biol. Appl. 2016; 59: 1025–1037. 
46. Wu C-J, Wilker JJ, Schmidt G. Robust and adhesive hydrogels from cross-linked 
poly(ethylene glycol) and silicate for biomedical use. Macromol. Biosci. 2013; 13: 59–
66. 
Chapter 3 - pH-Modulating Poly(ethylene glycol)/Alginate Hydrogel Dressings 
 86 
47. Hrynyk M, Martins-Green M, Barron AE, Neufeld RJ. Alginate-PEG sponge 
architecture and role in the design of insulin release dressings. Biomacromolecules 
2012; 13: 1478–1485. 
48. Myung D, Koh W, Ko J, Hu Y, Carrasco M, Noolandi J, Ta CN, Frank CW. 
Biomimetic strain hardening in interpenetrating polymer network hydrogels. Polymer 
2007; 48: 5376–5387. 
49. Cao B, Tang Q, Li L, Humble J, Wu H, Liu L, Cheng G. Switchable antimicrobial and 
antifouling hydrogels with enhanced mechanical properties. Adv. Healthcare Mater. 
2013; 2: 1096–1102. 
50. Haque MA, Kurokawa T, Gong JP. Lamellar–micelle transition in a hydrogel induced 
by polyethylene glycol grafting. Soft Matter 2013; 9: 5223–5230. 
51. Hansen B, Jemec GBE. The mechanical properties of skin in osteogenesis imperfecta. 
Arch. Dermatol. 2002; 138: 909–911. 
52. Silver FH, Christiansen DL. Biomaterials Science and Biocompatability. New York, 
NY, USA: Springer; 1999. 
53. Chang C-W, van Spreeuwel A, Zhang C, Varghese S. PEG/clay nanocomposite 
hydrogel: A mechanically robust tissue engineering scaffold. Soft Matter 2010; 6: 
5157–5164. 
54. Ajji Z, Othman I, Rosiak JM. Production of hydrogel wound dressings using gamma 
radiation. Nucl. Instrum. Meth. B 2005; 229: 375–380. 
55. Hou Y, Schoener CA, Regan KR, Munoz-Pinto D, Hahn MS, Grunlan MA. Photo-
cross-linked PDMSstar-PEG hydrogels: Synthesis, characterization, and potential 
application for tissue engineering scaffolds. Biomacromolecules 2010; 11: 648–656. 
56. Yu F, Cao X, Li Y, Zeng L, Zhu J, Wang G, Chen X. Diels–Alder crosslinked HA/PEG 
hydrogels with high elasticity and fatigue resistance for cell encapsulation and articular 
cartilage tissue repair. Polym. Chem. 2014; 5: 5116–5123. 
57. Mohamad N, Mohd Amin, Mohd Cairul Iqbal, Pandey M, Ahmad N, Rajab NF. 
Bacterial cellulose/acrylic acid hydrogel synthesized via electron beam irradiation: 
Accelerated burn wound healing in an animal model. Carbohydr. Polym. 2014; 114: 
312–320. 
58. Pereira R, Carvalho A, Vaz DC, Gil MH, Mendes A, Bártolo P. Development of novel 
alginate based hydrogel films for wound healing applications. Int. J. Biol. Macromol. 
2013; 52: 221–230. 
References 
 87 
59. Ono S, Imai R, Ida Y, Shibata D, Komiya T, Matsumura H. Increased wound pH as an 
indicator of local wound infection in second degree burns. Burns 2015; 41: 820–824. 
60. Sharpe JR, Harris KL, Jubin K, Bainbridge NJ, Jordan NR. The effect of pH in 
modulating skin cell behaviour. Br. J. Dermatol. 2009; 161: 671–673. 
61. Wiegand C, Heinze T, Hipler U-C. Comparative in vitro study on cytotoxicity, 
antimicrobial activity, and binding capacity for pathophysiological factors in chronic 
wounds of alginate and silver-containing alginate. Wound Repair Regen. 2009; 17: 
511–521. 
62. Lee W-R, Park J-H, Kim K-H, Kim S-J, Park D-H, Chae M-H, Suh S-H, Jeong S-W, 
Park K-K. The biological effects of topical alginate treatment in an animal model of 
skin wound healing. Wound Rep. Regen. 2009; 17: 505–510. 
63. Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue 
engineering - In vivo and in vitro applications. Adv. Drug Deliver. Rev. 2011; 63: 352–
366. 
64. Hayden PJ, Bachelor M, Ayehunie S, Letasiova S, Kaluzhny Y, Klausner M, 
Kandárová H. Application of MatTek in vitro reconstructed human skin models for 
safety, efficacy screening, and basic preclinical research. Appl. In Vitro Toxicol. 2015; 
1: 226–233. 
65. Xie Y, Rizzi SC, Dawson R, Lynam E, Richards S, Leavesley DI, Upton Z. 
Development of a three-dimensional human skin equivalent wound model for 
investigating novel wound healing therapies. Tissue Eng. Part C 2010; 16: 1111–1123. 
66. Nunan R, Harding KG, Martin P. Clinical challenges of chronic wounds: Searching for 
an optimal animal model to recapitulate their complexity. Dis. Model. Mech. 2014; 7: 
1205–1213. 
67. Elbert DL, Hubbell JA. Conjugate addition reactions combined with free-radical cross-
linking for the design of materials for tissue engineering. Biomacromolecules 2001; 2: 
430–441. 
  
  
 
	 
89 
 
 
 
Chapter 4 
 
Systematic Structural Modification of the 
Interpenetrating Polymer Network System 
Poly(ethylene glycol)/Acrylic Acid/ 
Alginate  
		
  
Abstract 
 
91 
 
 
 
Abstract 
Interpenetrating polymer network (IPN) hydrogels are appropriate candidates for wound 
dressing applications, as the optimization of their material properties focuses directly on 
their wound healing capacity. In particular, the mechanical properties and the swelling 
capacity of IPN hydrogels can be adapted by structural changes in the dual network 
architecture, thereby influencing the humidity of the wound milieu and the wearing 
comfort. In this study, the IPN hydrogel formulation poly(ethylene glycol) diacrylate 
(PEGDA)/acrylic acid (AA)/alginate was examined. The conducted systematic network 
modification focused on the impact of the PEGDA molecular weight and variations in the 
initiator system and the cross-linking reaction. PEGDAs with lower molecular weight and 
additional ionic cross-linking of alginate appeared as promising approaches. The recently 
postulated high importance of ionized AA carboxylic acid groups for the outstanding 
PEGDA/AA/alginate hydrogel properties was proven by comparatively analyzing neutral 
poly(ethylene glycol) diacrylate/2-hydroxyethyl methacrylate (HEMA)/alginate IPN 
hydrogels; the uncharged HEMA containing gels showed a significantly reduced swelling 
capacity and mechanical stability. 
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1. Introduction 
In general, hydrogels can be polymerized by two different types of cross-linking reaction. 
Physical cross-linking by molecular entanglements, ionic interactions, or hydrogen bonds, 
and chemical cross-linking by covalent bonds (initiated for example by UV-light, click-
reactions, or redox systems) can be used to form polymer networks.1,2 In classical 
interpenetrating polymer network (IPN) hydrogels, a rigid and densely cross-linked 
primary network and a flexible and loosely cross-linked secondary network are combined. 
This special polymer structure results in a superior new hydrogel material in comparison to 
the single component hydrogels, especially concerning their mechanical performance.3,4 In 
this study, a chemically cross-linked network of poly(ethylene glycol) diacrylate (PEGDA) 
and acrylic acid (AA) and a physically cross-linked network of alginate were combined. 
Recently, these pH-modulating IPN hydrogels were reported to be promising candidates 
for wound dressing applications.5 Amongst others, high liquid uptake, mechanical stability, 
and convincing in vitro wound healing properties were found for a formulation carrying 
9.25% PEGDA with a molecular weight of 6 kDa (PEGDA6k), 0.25% AA, and 0.5% 
alginate.  
Nevertheless, further optimization of the established system should be aspired. Numerous 
formulation parameters are known to have a significant impact on the IPN hydrogel 
properties. Amongst others, the molecular weight of the precursors, their concentration, the 
mass ratio of the primary to the secondary network, and the network cross-linking densities 
can affect the material performance.3,6–11 A systematic adjustment of the listed parameters 
enables the identification of the most favorable IPN formulation in regard to its mechanical 
stability, flexibility, and liquid handling properties. Besides, all listed material 
characteristics have a direct or indirect impact on wound healing.12 Sufficient liquid uptake 
prevents tissue degeneration caused by excessive exudate, whereas an appropriate 
mechanical stability of the dressing material is required during its application and wearing. 
Consequently, the effects of specific structural modifications concerning the 
interpenetrating polymer networks of PEGDA/AA/alginate hydrogels were examined in 
more detail. Optimizations concerning the cross-linking density of the two networks were 
conducted by 1) changing the time scale of the PEGDA/AA polymerization reaction, 
2) using PEGDAs with different molecular weight, and 3) analyzing the impact of divalent 
calcium ions as gelling reactant. To gain further insights into the driving forces of the 
PEGDA/AA/alginate IPN hydrogel properties, the decisive interactions between the 
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individual network components were examined. For this purpose, AA was replaced by the 
carboxylic acid group free monomer 2-hydroxyethyl methacrylate (HEMA) and the 
properties of the resulting neutral IPNs were analyzed. 
 
2. Experimental Section 
2.1 Materials 
Toluene was purchased from Acros Organics (Geel, Belgium). Deuterated chloroform 
(CDCl3) was obtained from Deutero GmbH (Kastellaun, Germany). Alginate (Protanal® 
LF 10/60FT) was kindly provided by FMC BioPolymer (Wallingstown, Ireland). 
Phosphate buffered saline (PBS) was purchased from Life Technologies (Carlsbad, CA, 
USA). Hydrochloric acid, sodium hydroxide, and triethylamine were obtained from Merck 
KGaA (Darmstadt, Germany). Poly(ethylene glycol) with a molecular weight of 4 kDa 
(PEG4k) was purchased from Riedel-de Haën (Seelze, Germany). Deionized water was 
obtained using a Milli-Q water purification system (Millipore, Schwabach, Germany). All 
other chemicals were purchased from Sigma Aldrich (Taufkirchen, Germany). 
Poly(ethylene glycol) was dried by azeotropic distillation in toluene; all other chemicals 
were used as received. 
 
2.2 Precursor Synthesis 
PEGDA6k was synthesized as previously reported.5 PEGDA4k was synthesized 
analogously, however, the ratio of PEG4k (25.01 g, 6.25 mmol) to triethylamine (1742 µL, 
12.50 mmol) and acryloyl chloride (2031 µL, 25.00 mmol) was adapted. The reaction 
yielded 15.82 g PEGDA4k (61.6%). 
1H NMR PEGDA4k (300 MHz, CDCl3, δ): 3.63 ppm (m, 197 H, -CH2CH2O-), 4.30 ppm 
(t, 2 H, -CH2OC(O)-), 5.82 ppm (dd, 1 H, CH2=CHC(O)O-), 6.14 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.41 ppm (dd, 1 H, CH2=CHC(O)O-). 
1H NMR PEGDA6k (300 MHz, CDCl3, δ): 3.62 ppm (m, 310 H, -CH2CH2O-), 4.30 ppm 
(t, 2 H, -CH2OC(O)-), 5.82 ppm (dd, 1 H, CH2=CHC(O)O-), 6.13 ppm (dd, 1 H, 
CH2=CHC(O)O-), 6.41 ppm (dd, 1 H, CH2=CHC(O)O-). 
 
2.3 Preparation of Hydrogels 
Precursor mixtures for UV-polymerized hydrogels were prepared as follows: PEGDA was 
dissolved in PBS and mixed with a 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropio- 
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phenone (HHMP) suspension in PBS, a solution of alginate in PBS (c = 41.68 mg·mL–1), 
and the respective amount of AA or HEMA. If required, a solution of gluconolactone (GL) 
in PBS and a suspension of CaHPO4 · 2 H2O in PBS were pipetted to the stirring mixture. 
Precursor mixtures for N,N,N',N'-tetramethylethane-1,2-diamine (TEMED)/ammonium 
persulfate (APS) polymerized hydrogels were produced in the same way, except that the 
HHMP suspension was replaced by TEMED and a solution of APS in PBS. The utilized 
amounts of initiator were 0.180% HHMP, 0.067% gluconolactone, and 0.130% 
CaHPO4 · 2 H2O. The respective mass of TEMED, m(TEMED), was calculated according 
to Equation (1) ! !"#"$ = 0.0180 ! !"#$%  + 0.2635 ! !!           (1) 
where m(PEGDA) is the mass of PEGDA and m(AA) is the mass of acidic acid in the 
hydrogel formulation; the amount of APS was two times m(TEMED). The hydrogel water 
content was 90% in all cases; further information on the exact hydrogel compositions is 
displayed in Table 1. 
Table 1. Composition and cross-linking agents of the examined hydrogels. 
PEGDA4k 
(%) 
PEGDA6k 
(%) 
AA 
(%) 
HEMA 
(%) 
Alginate 
(%) 
Cross-linking 
agents 
10.00 0 0 0 0 HHMP 
9.50 0 0 0 0.50 CaHPO4/GL, HHMP 
8.75 0 1.00 0 0.25 HHMP 
8.75 0 1.00 0 0.25 CaHPO4/GL, HHMP 
5.00 – 9.25 0 0.25 – 4.50 0 0.50 CaHPO4/GL, HHMP 
8.00 – 9.00 0 0 0.50 – 1.50 0.50 CaHPO4/GL, HHMP 
0 9.25 0.25 0 0.50 TEMED/APS 
0 9.25 0.25 0 0.50 HHMP 
0 8.75 1.00 0 0.25 HHMP 
0 8.75 1.00 0 0.25 CaHPO4/GL, HHMP 
0 8.50 – 9.00 0 0.50 – 1.00 0.50 HHMP 
 
For tensile testing, 8 mL of the precursor mixture were cast into rectangular silicon molds; 
for all other experiments, cylindrical glass molds (1 cm diameter, 0.7 mL volume) were 
used. The polymerization reaction was either initiated by UV-light (HHMP containing 
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gels) at 366 nm for 1 h, or thermally by storing the covered molds at room temperature for 
24 h (TEMED/APS containing gels).  
 
2.4 Tensile Strength 
Rectangular specimens of 1 cm width (d), 8 cm length, and a thickness h (measured with a 
MiniTest 600 gauge, ElektroPhysik, Köln, Germany) were stretched until failure with a 
tensile velocity of 15 mm·min–1. The tensile strain (εt) and the maximum load (Fmax) were 
measured using an Instron 5542 load frame (Instron GmbH, Darmstadt, Germany). The 
tensile stress (σt) was calculated according to Equation (2). !! = !!"#ℎ∙!           (2) 
The elastic modulus of tension (Et) was calculated from the slope of the stress-strain curve 
between 0.05 and 0.15 strain.  
 
2.5 Swelling Capacity 
Hydrogel cylinders (initial mass m0) were incubated in 10 mL of PBS at 37 °C in a shaking 
water bath. The mass of the gels (mt) was measured every 24 h. The swelling capacity (Qt) 
was calculated according to Equation (3). !! = !!!!!!! ∙ 100%          (3) 
 
2.6 Compressive Strength 
If required, the hydrogel cylinders were purified in 10 mL of deionized water for 24 h at 
37 °C. Afterwards, the purified hydrogels were partially dried by a stream of compressed 
air to assure a constant water content of 90% throughout all experiments. Unmodified and 
purified hydrogel cylinders with a height h and a diameter d (measured with a caliper, 
BORT GmbH, Weinstadt-Benzach, Germany) were compressed at 0.5 mm·min–1 using an 
Instron 5542 load frame. The maximum compressive stress (σc) and elastic modulus of 
compression (Ec) were calculated according to Section 2.4. 
 
2.7 Base Neutralizing Capacity 
Static pH titration at pH 7.4 was conducted with purified hydrogel cylinders in 15 mL of a 
0.1 M sodium chloride solution. A 0.1 M sodium hydroxide solution was added over 24 h 
using a BlueLine glass electrode (SI Analytics GmbH, Mainz, Germany) connected to a 
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TitroLine 7000 dosage system (SI Analytics GmbH, Mainz, Germany). The base 
neutralizing capacity (BNC) was calculated from the amount of substance of neutralized 
sodium hydroxide n(NaOH) and the initial mass of the gel cylinder m0, according to 
Equation (4). !"# = !(NaOH)!!           (4) 
 
2.8 Statistical Analysis 
The data are presented as mean ± standard deviation (SD). The number of samples n was 3 
to 6, dependent on the conducted experiment. For statistical analysis, Brown Forsythe tests 
were run followed by one-way ANOVA/Tukey’ test or Kruskal-Wallis-ANOVA. 
Differences were considered statistically significant at p < 0.05. 
 
3. Results 
3.1 Modification of the Network Forming Reaction 
One possibility to alter the network architecture and therefore the material properties of 
IPN hydrogels is a modification of the network forming reaction. Decelerated 
polymerization by the redox system TEMED/APS was examined as an alternative to the 
instantly occurring polymerization induced by HHMP (Table 2).13  
Table 2. Maximum tensile stress σt, strain εt, and E-modulus Et of PEGDA6k/0.25% AA/alginate IPN 
hydrogels, polymerized with different initiators. Data are expressed as mean ± SD (n = 6). 
Initiator σ t (kPa) Et (kPa) ε  t (%) 
TEMED/APS 48.78 ± 9.17 98.31 ± 18.28 60.89 ± 22.10 
HHMP 88.21 ± 12.85 89.11 ± 18.76 161.37 ± 22.32 
 
Yet, TEMED/APS polymerized hydrogels were less stable (lower tensile stress σt) and less 
elastic (higher E-modulus Et and lower elasticity εt) than HHMP polymerized gels. 
Therefore, further research was exclusively conducted with HHMP polymerized hydrogels. 
Moreover, the effect of additional ionic cross-linking with divalent calcium ions was 
examined under tensile load. Besides testing the recently described PEGDA6k IPN 
hydrogels,5 analogous IPN hydrogels containing PEGDA4k were assessed. The acidic 
PEGDA4k IPN gels showed higher σt values with additional Ca2+ gelation, whereas the 
acidic PEGDA6k IPN gels were significantly more stable without Ca2+ incorporation 
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(Figure 1). The E-modulus was slightly higher for Ca2+ containing gels in both cases. 
Consequently, only PEGDA4k containing IPNs should thenceforth be polymerized in the 
presence of calcium ions. 
 
Figure 1. Tensile stress at maximum load (A) and correlated E-modulus (B) of PEGDA/1.00% AA/alginate 
hydrogels with and without Ca2+ polymerization. Data are expressed as mean ± SD (n = 5); * indicates 
statistically significant differences between the selected groups (p < 0.05). 
 
Regarding the mechanical properties, PEGDA4k containing IPN hydrogels are equivalent 
to the already described PEGDA6k containing gels (see Chapter 3 for comparison). 
Therefore, further research focused on the impact of the PEGDA molecular weight with 
regard to the requirements for a potential wound dressing application. 
 
3.2 Modification of the PEGDA Molecular Weight 
The covalent hydrogel network of the IPN system PEGDA/AA/alginate was modified by 
using PEGDA with a molecular weight of 4 instead of 6 kDa. A comprehensive analysis 
concerning mechanical and fluid handling properties was run to gain comparable data for 
an evaluation in contrast to the recently described PEGDA6k/AA/alginate IPN hydrogels.5 
Regarding the swelling capacity of PEGDA4k/AA/alginate IPN hydrogels, the liquid 
uptake was strongly dependent on the amount of incorporated acrylic acid (Figure 2). 
Increasing AA concentrations enabled enhanced swelling, up to 328 ± 62% after one day 
and up to 594 ± 43% after 7 days of incubation. In contrast, pure PEGDA4k (1%) and 
PEGDA4k/alginate (18%) hydrogels had a rather low swelling capacity. 
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Figure 2. Swelling capacity of PEGDA4k/AA/alginate hydrogels with different AA concentrations after 
24 hours and 7 days of incubation. Data are expressed as mean ± SD (n = 3). 
 
The mechanical behavior of PEGDA4k/AA/alginate hydrogels with altering AA content 
was completely different, comparing the effects of tensile and compressive load. The 
tensile stress at maximum load, σt, remains consistent for all samples (around 75 kPa), 
except for the most stable formulation carrying 0.5% AA (Figure 3A). On the other hand, 
the compressive stress, σc, significantly increased with the addition of alginate (Figure 3C). 
The σc values of acidic IPN hydrogels were dependent on the amount of AA, which 
generally had a weakening effect. The calculated E-modulus was related to the AA 
concentration in all cases. Under tensile load, the Et(PEGDA4k/AA/alginate) values were 
lower than Et(PEGDA4k), except for 4.5% AA containing hydrogels (Figure 3B). Under 
compressive load, high AA concentrations caused a reduction of the E-modulus 
(Figure 3D).  
In this context, special consideration should also be given to the potential impact of initial 
hydrogel purification, which is required for biomedical applications. By incubation in 
water, remaining initiator and precursor molecules can be removed, which further assures 
the biocompatibility of the developed material. Yet, purification did not have any impact 
on the mechanical performance of the examined hydrogels (Figure 3C and D). 
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Figure 3. Tensile stress at maximum load (A) and correlated E-modulus (B), compressive stress at maximum 
load (C) and correlated E-modulus (D) of PEGDA4k/AA/alginate hydrogels with different AA 
concentrations. Samples were tested as prepared, and after purification in water (C, D: “incubated 
hydrogels”). Data are expressed as mean ± SD (n = 4); * indicates statistically significant differences versus 
the control PEGDA (p < 0.05); + indicates statistically significant differences between the groups (p < 0.05). 
 
 
Figure 4.	Base neutralizing capacity of PEGDA4k/AA/alginate hydrogels with different AA concentrations. 
Data are expressed as mean ± SD (n = 3); * indicates statistically significant differences versus the lower 
concentrated samples (p < 0.05). 
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The base neutralizing capacity of AA containing PEGDA4k IPN hydrogels, a parameter 
that characterizes their buffer capacity in an alkaline environment, ranged between 0.009 
and 1.159 mmol per gram of hydrogel (Figure 4). Rising AA concentrations resulted in 
rising BNCs; PEGDA/alginate hydrogels had no impact on the environmental pH. 
 
3.3 Modification of the Charge Density 
Finally, the hydrogel charge density was altered by replacing AA with HEMA. HEMA is 
structurally comparable to AA, yet it does not carry an ionizable functional group 
(Scheme 1). Thus, the investigation of the resulting PEGDA/HEMA/alginate IPN 
hydrogels allowed drawing conclusions about the role of incorporated charges in the 
respective AA containing hydrogels. 
 
Scheme 1. Chemical structure of AA (on the left) and HEMA (on the right). 
 
In swelling experiments, HEMA containing IPN hydrogels showed a significantly lower 
liquid uptake than the respective AA containing hydrogels, regardless of the AA/HEMA 
content (Figure 5). Increasing amounts of HEMA only had a little effect on the amount of 
hydrogel swelling. 
 
Figure 5. Swelling capacity of PEGDA4k/alginate hydrogels with different HEMA or AA concentrations. 
Data are expressed as mean ± SD (n = 3). * indicates statistically significant differences between the groups 
(p < 0.05). 
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The impact of ionizable carboxylic acid groups on the mechanical performance of the 
developed IPN hydrogels was examined for both, PEGDA4k and PEGDA6k formulations 
(Figure 6).  
 
Figure 6. Tensile stress at maximum load (A, C) and correlated E-modulus (B, D) of PEGDA/alginate 
hydrogels with different HEMA or AA concentrations. PEGDA with a molecular weight of 4 kDA (A, B) 
and 6 kDa (C, D) was used. Data are expressed as mean ± SD (n = 4); * indicates statistically significant 
differences between the respective HEMA and AA containing hydrogels (p < 0.05). 
  
The conducted experiments demonstrated that the stabilizing effect of AA incorporation 
was more pronounced in PEGDA6k IPNs (Figure 6C). PEGDA6k/HEMA/alginate gels 
could maximally bear 22 to 53 kPa under tensile load, in contrast to PEGDA6k/AA/ 
alginate gels with σt = 82 – 92 kPa. Regarding PEGDA4k IPNs, the stabilizing effect was 
dependent on the amount of substituted PEGDA (Figure 6A). Only little impact on the 
mechanical stability could be detected for hydrogels with 0.25 and 1.0% HEMA/AA 
content. The E-modulus showed similar tendencies to the described σt performance, 
independent from the PEGDA molecular weight (Figure 6B and D). 
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4. Discussion 
Different structural modifications of the recently described IPN hydrogel formulation 
PEGDA/AA/alginate were conducted to obtain a further improved wound dressing 
material.5 First, the alternative initiator system TEMED/APS was examined. TEMED/APS 
is known to give an overall slower reaction in comparison to the HHMP/UV-light induced 
polymerization, which leads to more entangled polymer chains.13–15 Yet, the spatial 
approach of the reactive sites might consequently be impeded, resulting in less cross-linked 
and therefore, less stable hydrogel materials (Table 1). In a second approach, additional 
ionic cross-linking by calcium ions was evaluated. The different outcomes for Ca2+ 
containing PEGDA4k and PEGDA6k IPN hydrogels in tensile tests might likewise be 
related to the primary network mesh size.6,7 Generally, a bigger average mesh size in 
UV-polymerized hydrogels is assumed to facilitate an entanglement of the IPNs 
(PEGDA6k > PEGDA4k; see Chapter 2 for comparison). Calcium ion addition generates 
Ca2+/alginate/AA complexes,5,16 which in contrast might impede this entanglement. 
Additionally, a reduced fluidity of the secondary network was described to reduce the 
mechanical stability of IPN materials.3 Assuming that PEGDA4k/AA/alginate IPNs have 
less entangled networks, load transfer between the two networks and internal slipping 
would play a less important role. Therefore, additional Ca2+ induced cross-links should 
enhance the mechanical stability of PEGDA4k containing gels, whereas it should have a 
weakening effect on PEGDA6k containing gels (see Figure 1 for comparison). 
A reduced PEGDA molecular weight, combined with an increased number of chemical 
cross-links (the applied PEGDA mass ratio stayed unchanged), was systematically 
examined concerning all relevant material properties of wound dressings. The impact of 
different acrylic acid concentrations on PEGDA6k/AA/alginate IPN hydrogels was 
discussed lately.5 The here examined PEGDA4k IPNs exhibited comparable tendencies 
concerning the swelling capacity, the compressive properties, and the BNC. In brief, 
increasing repulsive forces between a rising amount of negatively charged carboxylic acid 
groups in the hydrogel network favor hydrogel swelling.17 Furthermore, rising repulsive 
forces during compression encourage material failure, and the amount of carboxylic acid 
groups is proportional to the number of released protons (BNC). Surprisingly, no 
stabilizing effect due to the formation of a double network hydrogel (PEGDA4k/alginate) 
was visible under tensile load (Figure 3A). However, this further confirms the above 
considered reduced ability of PEGDA4k containing IPNs to form network entanglements. 
The significantly increased maximum tensile stress of PEGDA4k/0.5% AA/alginate IPN 
hydrogels might be explained by a combination of opposing effects concerning the 
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hydrogel structure. With rising AA concentrations, the primary network structure is more 
suitable for entanglements and the increasing amount of (protonated) carboxylic acid 
groups (of alginate and AA) enables additional inter- and intra-network bonds.8,18 In 
contrast, mechanical weakening is induced by the lowered three-dimensional linkage in 
PEGDA/AA/alginate in comparison to PEGDA/alginate gels.19,20 The ratio of all structural 
effects seems to be optimal in the case of 0.5% AA containing IPN hydrogels.9 Correlating 
findings were published by Myung et al., who described a low fracture stress for 
PEGDA/poly(acrylic acid) IPNs with small and high AA ratios, and the highest maximum 
tensile stress for an intermediate AA concentration.8 The loss of cross-links in the primary 
network is also responsible for the enhanced flexibility (ε(PEGDA4k) = 72.1%, 
ε(PEGDA4k/AA/alginate) around 104.2%, data not shown), resulting in reduced values of 
the calculated E-modulus.  
Even though the consequences of altered AA concentrations in PEGDA4k and PEGDA6k 
IPN hydrogels were the same (see Chapter 3 for comparison), the absolute values differed 
among each other. The overall predominant factor in this context is the difference in 
molecular weight between cross-links, which is connected to numerous material 
properties.7,21,22 Hence, PEGDA4k IPN hydrogels with a low AA content showed lower 
swelling capacities than the respective PEGDA6k IPNs. With rising AA content, this effect 
is balanced out or even reversed by the increasing amount of polymer chains (AA), 
substituting the three-dimensionally cross-linked PEGDA network. Concerning the 
compressive properties, the applied load can be transferred more easily to the surrounding 
network in flexible IPNs (PEGDA6k), whereas material failure occurs more probably in 
rigid and less entangled networks (PEGDA4k).6 The findings on the tensile stability of 
differently composed PEGDA4k/AA/alginate IPNs emphasize the above discussed ability 
of Ca2+ ions to overcome weakening effects, induced by the change in PEGDA molecular 
weight. In contrast, no clear tendency could be identified for the base neutralizing capacity 
of PEGDA4k and PEGDA6k IPNs. Comparable BNC vales were expected, as the 
“release” of protons should not be affected by a change in mesh size.  
The importance of carboxylic acid groups for the IPN hydrogel properties was finally 
proven by comparing PEGDA/HEMA/alginate to PEGDA/AA/alginate IPN hydrogels. 
The effect of polymer chain (HEMA, AA) instead of polymer network (PEGDA) 
formation stayed unaffected, allowing conclusions about the chemical structure induced 
effects only. Due to the loss of incorporated negative charges, the swelling ability of the 
HEMA containing hydrogels decreased drastically, underlining that repulsion between 
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carboxylic acid groups plays the major role in the liquid uptake process. Analyzing the 
outcomes of tensile tests with PEGDA4k and 6k/HEMA/alginate IPN hydrogels verified 
that negative charges/additional hydrogen bonding sites are responsible for the superior 
mechanical properties.5 Again, the stabilizing impact on PEGDA6k IPNs was stronger than 
on PEGDA4k IPNs. Effects of a reduced number of cross-links, associated with rising 
HEMA concentrations, are mainly pronounced in PEGDA6k hydrogels (Figure 6C). Both 
results are probably connected to a change in the polymer mesh sizes, as already discussed 
above.  
Despite the detected differences in the PEGDA4k and PEGDA6k IPN’s performance 
concerning mechanical and liquid handling properties, the developed PEGDA4k/AA/ 
alginate hydrogels can likewise be regarded as potential wound dressing materials. 
Therefore, future experiments should focus on the biological evaluation of the altered IPN 
structure.  
 
5. Conclusion 
Taking all findings concerning structurally modified PEGDA/AA/alginate IPN hydrogels 
into account, PEGDA4k-based IPNs are promising candidates for wound dressing 
applications. Analogous to the recently described PEGDA6k/AA/alginate hydrogels,5 they 
fulfill important wound dressing requirements such as mechanical stability and sufficient 
liquid uptake. Yet, no advantageous material properties have been detected in contrast to 
the PEGDA6k-based IPN hydrogels (see Chapter 3 for comparison). Nevertheless, further 
research should assess the wound healing capacity of the here described PEGDA4k/AA/ 
Ca2+ alginate IPNs, as a release of Ca2+ ions can potentially enhance cell migration and 
proliferation, leading to improved wound healing.23 Further changes of the IPN hydrogel 
structure did not have any positive impact on the material properties. However, additional 
information on the polymer network interactions in the IPN hydrogels could be revealed. 
Based on HEMA containing IPN gels, the importance of AA carboxylic acid groups for the 
hydrogel stability and liquid uptake was proven. 
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Abstract 
The number of patients with chronic wounds is increasing constantly in today’s aging 
society. However, little work has been done so far tackling the associated disadvantageous 
shift of the wound pH. In our study, we developed two different approaches on pH-
modulating wound dressing materials, namely bioactive interpenetrating polymer network 
hydrogels based on poly(ethylene glycol) diacrylate/N-vinylimidazole/alginate (named 
VIx) and poly(ethylene glycol) diacrylate/2-dimethylaminoethyl methacrylate/ 
N-carboxyethylchitosan (named DMAEMAx). Both formulations were cytocompatible and 
showed a good wound healing capacity in vitro. The developed dressing materials 
significantly increased the cell ingrowth in wounded human skin constructs, by 364% and 
313% due to VIx and DMAEMAx hydrogel treatment, respectively. Additionally, VIx 
hydrogels were found to be suitable scaffolds for superficial cell attachment. Our research 
on the material properties suggests, that ionic interactions and hydrogen bonds are the 
driving forces for the mechanical and swelling properties of the examined hydrogels. High 
amounts of positively charged amino groups in DMAEMAx hydrogels caused increased 
liquid uptake (around 190%), whereas VIx hydrogels showed a tenfold higher maximum 
compressive stress in comparison to hydrogels without ionizable functional groups. 
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1. Introduction 
Impaired wound healing is a pressing problem in health care.1 Several underlying diseases, 
like diabetes mellitus or venous insufficiency, as well as external causes, like large-scale 
burns, can be a trigger for the retardation or even the lack of wound healing.2,3 One 
contributing factor for impaired healing is the wound pH. The pH value influences decisive 
processes like cell proliferation, cell migration, bacterial colonialization, and enzyme 
activity.4 The direction of the pH shift in chronic wounds (either too acidic or too alkaline 
for a successful healing process) is dependent inter alia on the sort and the amount of 
bacterial load.5 In the past, researchers mainly focused on the impact and the treatment of 
strongly alkaline wounds.3 Yet, Schreml et al. recently identified an acidic pH around 6.5 
at the wound edges being responsible for a reduced cell proliferation and migration into the 
wound area.6 To the best of our knowledge, hardly any work has been done so far 
concerning the development of pH-modulating dressing materials for acidic non-healing 
wounds.7 The application of alkaline wound dressings, which are capable to bring the pH 
back to physiological values (around 7.0 - 7.4), might be a potential treatment option.  
In our work, we focused on the development of alkaline interpenetrating polymer network 
(IPN) hydrogels. IPN hydrogels are suitable wound dressing materials as they provide a 
moist healing environment.8 Moreover, important wound dressing properties such as 
sufficient exudate uptake and mechanical stability can be adapted easily by changes in the 
dual network architecture.9 The primary polymer network of the here examine IPN systems 
consisted of poly(ethylene glycol) diacrylate (PEGDA), combined with the alkaline 
precursor N-vinylimidazole (VI). Horta et al. found that VI containing hydrogels act as 
weak bases (pKa = 7.0) that neutralize the surrounding medium, whilst avoiding to create 
an alkaline environment, which would likewise cause impaired healing.10 
However, an alkaline environment is particularly beneficial for the successful healing of 
skin grafted wounds. Skin grafting is an important treatment option for non-healing 
wounds with severe tissue loss, for example in the case of full-thickness burns.11 The take 
rate of skin grafts is often impaired by low vascularization and insufficient cellular 
in/outgrowth. Yet, both issues can be tackled in alkaline environment (≥ 7.4).3,6,12,13 
Therefore, a second approach on alkaline IPN dressings was taken, including the strong 
base 2-dimethylaminoethyl methacrylate (DMAEMA; pKa = 8.4) as alkaline part of the 
primary network.14 Alginate or modified chitosan were used as secondary network in the 
IPN hydrogels. Both polysaccharides enhance wound healing by encouraging cell 
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proliferation and increasing collagen deposition, amongst others.15,16 Additionally, chitosan 
is a weak base that exhibits a favorable antimicrobial effect.17  
The alkaline IPN hydrogel wound dressings were developed by a bottom-up approach; 
different PEGDA/VI/alginate and PEGDA/DMAEMA/chitosan hydrogels were examined 
for their wound healing ability under acidic conditions in wound healing assays, by their 
ability to serve as cell scaffold and by their impact on wounded human skin constructs. As 
the structure of the human skin is significantly different from typically used animal models 
and the establishment of reproducible and pH-shifted in vivo chronic wound models is 
rather difficult, the use of such wounded human skin constructs is regarded as a valuable 
alternative.18–20 Based on the in vitro experiments, the most promising formulations were 
further characterized for their material properties such as their microstructure, the 
mechanical performance, and the swelling capacity. 
 
2. Experimental Section  
2.1 Preparation of Hydrogels 
A detailed description of the N-carboxyethylchitosan (CEC) and the PEGDA synthesis can 
be found in the supporting information. To prepare the precursor mixtures, a suspension of 
the radical initiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (2.5%, based 
on the total monomer mass) was pipetted to a PEGDA solution in phosphate buffered 
saline (PBS). Depending on the gel formulation, either a solution of alginate in PBS (c = 
41.7 mg·mL–1) or a CEC solution in water (final PBS to water ratio = 0.849) was added. 
Afterward, the required amount of VI, DMAEMA, or the neutral control 2-hydroxyethyl 
methacrylate (HEMA) was added drop-wise. The examined formulations are listed in 
Table 1. For skin construct healing assays, 1.4 mL of the precursor mixture were cast into a 
6 well-plate; for cell adhesion experiments, 1.2 mL of the precursor mixture were cast into 
a 24 well-plate. For all other experiments, cylindrical glass molds (1 cm diameter, 0.7 mL 
volume) were used. All samples were irradiated with UV light (1 h 15, 366 nm, 6 W). If 
not stated otherwise, the hydrogels (with initial weight m0) were purified in 10 mL of 
deionized water for 24 h. To ensure a constant water content of 90% throughout all 
experiments, the purified cylinders were exposed to a stream of compressed air until the 
initial weight m0 had been reached again. The partial drying process was controlled 
gravimetrically. 
Experimental Section 
115 
Table 1. Composition of the examined hydrogel formulations with a total monomer concentration of 10%. 
PEGDA  
(%) 
pH-modulating component/  
neutral control* 
Secondary network  
(0.5%) 
10 - - 
9.5 - CEC or alginate 10/60 
7.0 – 9.0 0.5 – 2.5% DMAEMA 
CEC or alginate 10/60 or 
alginate 200 
7.5 2.0% HEMA* CEC 
6.0 – 8.5 1.0 – 3.5% VI alginate 10/60 
6.0 3.5% HEMA* alginate 10/60 
 
2.2 Cell Viability 
The cell viability (v) was determined according to the ISO 10993-5 extract method.21 In 
brief, extraction was performed in pH-adjusted medium (medium 199 : nutrient mixture 
F-12 (F12) 3 : 1, 10% fetal bovine serum (FBS), 1.10 mM hydrocortisone, adjusted to 
pH 6.5 with 1 M HCl) for 48 h; the extraction medium was exchanged every 12 h. Then, 
24 h cultured adult human dermal fibroblasts (HDFa, Life Technologies, Carlsbad, CA, 
USA; 8000 cells per well) were treated with 100 µL of hydrogel extracts; pH-adjusted cell 
culture medium served as a control. After 24 h of incubation under standard cell culture 
conditions, the extraction medium was removed; 130 µL of Dulbecco’s modified eagle 
medium (DMEM)/F12, 20 µL of FBS, and 50 µL of a 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution (c = 2.5 mg·mL–1 in PBS) were added. The 
resulting blue dye was dissolved in 100 µL of a sodium dodecyl sulfate solution and its 
absorbance (A) at 570 and 690 nm was measured using a FluoStar Omega micro plate 
reader (BMG Labtech, Ortenberg, Germany). The cell viability was calculated according 
to Equation (1). Data are presented as mean ± standard deviation (SD), based on n = 6 
samples. ! = !!"#,!"#!!!"#,!"#!!"#,!"#$!!!"#,!"#$  ∙ 100%          (1) 
 
2.3 2D Cell Migration Assay 
For two-dimensional (2D) cell migration assays, 140 µL of a HDFa suspension 
(300000 cells·mL–1) were pipetted into cell culture inserts (Ibidi GmbH, Martinsried, 
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Germany) adhered to a fibronectin-coated 6-well plate. After 24 h of incubation under 
standard cell culture conditions, the inserts were removed and 8 mL of pH-adjusted 
medium were added. Hydrogels were placed in netwell inserts (Corning, Corning, NY, 
USA) and added to the cells; untreated cells served as a control. Every 12 h, the pH-
adjusted cell culture medium was replaced. The cell migration was observed over 48 h 
using an Axiovert 200 microscope combined with a LSM 510 laser-scanning device (Zeiss, 
Jena, Germany). The area of cell migration was calculated using the LSM image browser 
(Zeiss, Jena, Germany); the cell migration velocity was calculated from the slope of the 
area closure/time curve.  
 
2.4 3D Human Skin Constructs and Healing Assay* 
Human skin constructs were built according to previously published methods.22 Briefly, 
bovine collagen I, Hank’s balanced salt solution, FBS, and primary fibroblasts 
(3.0·105/construct) were brought to neutral pH and poured into cell culture inserts (BD 
Bioscience, Heidelberg, Germany). After 2 h at 37 °C, keratinocyte growth medium 
(KGM) was added and the system was transferred to an incubator (37 °C, 5% CO2 and 
95% humidity) for further 2 h. Primary keratinocytes (4.2·106/construct) resuspended in 
KGM were pipetted on top. After 24 h, skin constructs were lifted to the air-liquid 
interface and KGM was replaced by a differentiation medium (based on high glucose 
DMEM). After 2 days of cultivation, the skin constructs were wounded by cutting the 
epidermal layer with a scalpel. For reproducibility, the operating person and the defect size 
remained unchanged. The injured constructs were incubated with pH-adjusted medium 
(pH 6.5) containing 2.5% hydroxyethyl cellulose. For this purpose, DMEM of the 
differentiation medium was substituted by medium 199 and the pH was adjusted with 1 M 
HCl.6 The respective hydrogels were punched out in circular shape (1 cm diameter) and 
applied onto the wound. The medium was changed daily and the dressings were exchange 
after 2 days. After 4 days, the constructs were embedded in tissue freezing medium, cut 
vertically into slices (7 µm) using a Leica CM1510 S cryotome (Leica Biosystems, 
Nussloch, Germany) and stained with conventional hematoxylin and eosin (H&E) 
according to standard protocols. The length of cell ingrowth was measured with ImageJ 
(National Institutes of Health, Bethesda, Maryland, USA). 
 																																																								
* 3D human skin constructs were generated at the Institute of Pharmacy, Pharmacology and Toxicology, 
Freie Universität Berlin, with support and based on the method of S. Hedtrich and L. Wallmeyer. 
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2.5 Cell Adhesion 
HDFa (27400 cells/well) were seeded on the hydrogel surface and were incubated at 
standard cell culture conditions. After 24 h, the cells were stained with SYTO-13 (2.5 µM) 
and dead cells were stained with propidium iodide (1.5 µM). The fluorescence was 
measured at 488 and 543 nm using an Axiovert 200 microscope combined with a LSM 510 
laser-scanning device (Zeiss, Jena, Germany). 
 
2.6 Scanning Electron Microscopy  
Hydrogel cylinders were shock-frozen in liquid nitrogen and lyophilized. The dried 
cylinders were coated with gold and examined using a Crossbeam XB 340 scanning 
electron microscope (Zeiss, Jena, Germany) at a working voltage of 3.0 kV. 
 
2.7 Compressive Strength 
The diameter (d) and the height (h) of non-purified and purified hydrogels cylinders were 
determined using a caliper (BORT GmbH, Weinstadt-Benzach, Germany). Then, 
compressive testing was carried out in an Instron 5542 load frame equipped with two 
cylindrical plates. The hydrogels were compressed until failure at 0.5 mm·min–1, and the 
maximum load (Fmax) and compressive strain were measured. The compressive stress (σc) 
was calculated according to Equation (2). !! = !!"#ℎ∙!           (2) 
The elastic modulus (Ec) was calculated from the slope of the stress-strain curve between 
0.05 and 0.15 strain. Data are presented as mean ± SD, based on the test results of n = 4 
specimens. 
 
2.8 Swelling Capacity 
Untreated hydrogel cylinders were incubated in 10 mL of PBS and stored in a shaking 
water bath at 37 °C. Every 24 h, the PBS was decanted; the gels were blotted dry and 
weighed. According to Equation (3), where mt is the mass of the gel cylinder at time point t 
and m0 is the initial mass of the gel, the swelling capacity (Qt) was calculated. !! = !!!!!!! ∙ 100%          (3) 
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2.9 Static pH and Equivalence Point Titration 
Hydrogel cylinders were placed in 15 mL of a sodium chloride solution (c = 0.1 M). To 
determine the acid neutralizing capacity (ANC), the pH was kept at 7.0 over 24 h by using 
a BlueLine glass electrode connected to a TitroLine 7000 dosage system (SI Analytics 
GmbH, Mainz, Germany) filled with 0.1 M HCl. The ANC was calculated from the 
amount of neutralized hydrochloride, n(HCl), and the initial mass of the gel cylinder, m0, 
according to Equation (4). !"# = !(HCl)!!           (4) 
For equivalence point (EP) titration, 0.7 mL of the precursor mixture was pipetted to 
15 mL of a 0.1 M NaCl solution. The mixture was brought to pH 11.0 with sodium 
hydroxide solution and titrated with 0.1 M hydrochloride solution until pH 3.0 was 
reached. The EPs were calculated from the slope of the V(HCl)-pH curve, where V(HCl) is 
the volume of neutralized standard solution.23 
 
3. Results  
Different alkaline interpenetrating polymer network hydrogels were analyzed for their 
suitability as bioactive wound dressing materials. In a bottom up approach, promising 
formulations were identified in wound healing assays and then further characterized for 
their relevant material properties. 
  
3.1 Cell Viability and Wound Healing Capacity 
First, IPN hydrogels consisting of PEGDA, alginate, and 1.0 - 3.5% VI were tested for 
their cell compatibility in MTT assays. It was abstained from testing higher VI 
concentrations as the resulting hydrogels showed little mechanical stability and a high sol 
content. Independent of the hydrogel composition, all tested formulations were non-
cytotoxic (93.9 – 125.1% cell viability; Figure 1A). As a maximal pH activity was desired 
and VI containing hydrogels do not bear the risk of pH overmodulation,10 
PEGDA/3.5% VI/alginate (subsequently named VI3.5) was the most interesting hydrogel 
composition. 
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Figure 1. Cell viability in MTT assays (A). The broken line (---) marks the critical value of 70% cell 
viability.21 Wound healing capacity in 2D migration experiments (B) for different PEGDA/VI/alginate 
hydrogels. Data are expressed as mean ± SD (A: n = 6; B: n = 3); * indicates statistically significant 
differences versus the untreated control (p < 0.05); ^ indicates statistically significant differences to all 
samples (p < 0.05); + indicates statistically significant differences between the groups (p < 0.05). 
 
VI3.5 hydrogels were further analyzed for their wound healing capacity in 2D cell migration 
assays. This experimental setup can be regarded as simplified wound model with easily 
adaptable wound healing conditions; in our study, the “wounds” suffered from an acidic 
pH. The application of non pH-modifying PEGDA/alginate hydrogels already enhanced 
the cell migration velocity (Figure 1B). With VI incorporation, however, the migration 
velocity as well as the gap closure further increased, by 44.0 and 79.1%, respectively.  
In contrast, the application of PEGDA/0.5 – 2.0% DMAEMA/0.5% CEC IPN hydrogels 
caused a significantly enhanced cell migration velocity (around 11.7 µm·h–1; Figure 2A), 
combined with an almost complete gap closure (78.7 - 97.0%; Figure 2B) in acidic 2D 
migration experiments. The application of highly alkaline IPNs with 2.5% DMAEMA 
content enabled a comparable cell migration velocity, but suppressed the amount of gap 
closure. Furthermore, the cytocompatibility of the most promising hydrogel formulation 
PEGDA/2.0% DMAEMA/CEC (subsequently named DMAEMA2.0) was verified in MTT 
assays. The detected cell viability ranged between 119.4 and 132.9%, dependent on the 
incubation time (see supporting information, Section 6.3, Figure S1). 
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Figure 2. Cell migration velocity (A) and percentage of gap closure (B) in 2D migration experiments with 
different PEGDA/DMAEMA/CEC hydrogels applied. Data are expressed as mean ± SD (n = 3); * indicates 
statistically significant differences versus the untreated control (p < 0.05); ^ indicates statistically significant 
differences to all samples (p < 0.05). 
 
The wound healing capacity of the two most promising hydrogel formulations VI3.5 and 
DMAEMA2.0 was more precisely assessed by wounded human skin constructs, which can 
be seen as an alternative to animal testing.18 Since the skin constructs suffered from an 
acidic environment, the cell ingrowth in the untreated control was very poor (Figure 3B). 
Wound closure could be enhanced by the treatment with PEGDA/alginate and 
PEGDA/CEC hydrogels (Figure 3A). Due to the addition of pH-modifying components, 
cell ingrowth further increased by 46.2% with VI3.5 and by 89.1% with DMAEMA2.0 gels 
(Figure 3C and D). 
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Figure 3. Percentage cell ingrowth in differently treated skin constructs (A). * indicates statistically 
significant difference versus the untreated control, set as 100% (p < 0.05); + indicates statistically significant 
differences between the groups (p < 0.05). H&E stained histological images of injured skin constructs after a 
healing period of 4 days (B – D); treatment as indicated in the upper left corner. The length of cell ingrowth 
is indicated by triangles. The length of the scale bars is 50 µm. 
 
3.2 Microstructure and Cell Adhesion 
The hydrogel microstructure is related to numerous material properties. Therefore, 
lyophilized hydrogel samples were examined by scanning electron microscopy (Figure 4A 
and B). Since VI3.5 and DMAEMA2.0 hydrogels showed major structural differences, their 
performance as cell scaffold in cell adhesion tests was complementary as well (Figure 4C 
and D). Primary human dermal fibroblasts were able to adhere and spread at the rough and 
porous VI containing IPN hydrogel surface, whereas no adhesion was detected at the 
smoother and less porous DMAEMA containing IPN hydrogel surface. 
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Figure 4. SEM images of lyophilized VI3.5 (A) and DMAEMA2.0 (B) hydrogels. The length of the scale bars is 
100/10/1 µm. HDFa cells seeded on the VI3.5 (C) and DMAEMA2.0 (D) hydrogels. In clockwise direction: 
HDFa stained green, bright field, merged images, dead cells stained red. 
 
3.3 Mechanical Properties 
Wound dressing materials must withstand the applied forces during application and 
wearing. Furthermore, they should be flexible enough to follow the patients’ movements 
and to fit even irregular wound shapes. Hence, the hydrogel performance under 
compressive load was evaluated for the most promising alkaline hydrogels VI3.5 and 
DMAEMA2.0. Insights into the mechanism of hydrogel stabilization were expected from the 
comparison to their neutral analogues, carrying 3.5% and 2.0% 2-hydroxyethyl 
methacrylate (HEMA3.5 and HEMA2.0) instead.  
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The maximum compressive stress, σc, of the VI3.5 hydrogels was 0.371 ± 0.185 MPa with a 
corresponding elastic modulus, Ec, of 39.7 ± 3.6 kPa (Figure 5A and B). The substitution 
of VI by HEMA caused a significant reduction of the σc and Ec values, whereas 
purification in water had no impact on the mechanical properties of these hydrogels.  
 
Figure 5. Compressive stress σc at maximum load (A, C) and calculated E-modulus Ec (B, D) of different 
alkaline hydrogels with and without prior purification in water. Data are expressed as mean ± SD (n = 4); 
+ indicates statistically significant differences between untreated and purified samples (p < 0.05); * indicates 
statistically significant differences between the groups (p < 0.05). 
 
The DMAEMA2.0 gels were less stable (σc = 0.096 ± 0.020 MPa) and less stiff (Ec = 9.6 ± 
3.3 kPa) than the VI3.5 and the respective HEMA2.0 hydrogels (Figure 5A and B). Yet, in 
contrast to all other formulations, purification in water led to an improved maximum 
compressive stress of the DMAEMA2.0 hydrogels (σc = 0.166 ± 0.024 MPa; Figure 4A). 
These findings could be further emphasized when the DMAEMA content was increased to 
2.5% (Figure 5C and D). Hydrogels with varying secondary network (alginate 10/60, 
alginate 200, or CEC) were affected differently by the purification step and in a higher 
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extent than the DMAEMA2.0 gels. Both purified alginate containing formulations showed 
decreased values for σc and Ec, whereas a strengthening effect of 232% was detectable for 
the purified PEGDA/2.5% DMAEMA/CEC formulation. 
 
3.4 Swelling and Buffer Capacity 
The fluid handling properties of dressing materials are of special interest when chronic 
wounds are targeted. All examined IPN hydrogels showed a significantly higher swelling 
capacity than the pure 10% PEGDA hydrogels (Figure 6). Addition of VI (VI3.5) or HEMA 
(HEMA3.5) did not have any further impact on the amount of liquid uptake (around 35%). 
In contrast, DMAEMA2.0 hydrogels could absorb up to 189% PBS.  
 
Figure 6. Swelling capacity of different alkaline hydrogels and control samples. Data are expressed as mean 
± SD (n = 3). * indicates statistically significant differences to all samples (p < 0.05). 
 
Static pH titration, which can be seen as an indicator for the ability of pH-modification, 
underlined, that PEGDA/alginate hydrogels are not pH active, whereas PEGDA/CEC 
hydrogels were able to neutralize 0.004 mmol hydrochloride per gram of hydrogel 
(Figure 7). Furthermore, the ANC measurements emphasized the differing buffer strength 
of the two alkaline substances; DMAEMA2.0 gels were able to neutralize three times more 
hydrochloride, even though VI3.5 gels carried approximately three times more amino 
groups.  
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Figure 7. Acid neutralizing capacity of different alkaline hydrogels and control samples. Data are expressed 
as mean ± SD (n = 3); * indicates statistically significant differences versus the respective control (p < 0.05). 
 
Furthermore, the equivalence points of the VI3.5 and DMAEMA2.0 formulation were 
assessed, indicating pH 2.67 (-COOH, alginate), 4.18 (-COOH, alginate), and 8.44 (-NR2, 
VI); and pH 4.02 (-COOH, CEC), 5.79 (-NH2, CEC), 7.23 (-NHR’, CEC), 8.97 (-NR’2, 
CEC), and 10.43 (-NR*2, DMAEMA), respectively. The pH of the VI3.5 precursor mixture 
was 8.5, which implies -COO-/-NR2 > -NHR2+ as main ionic structure, and 10.0 for the 
DMAEMA2.0 precursor mixture, which implies -COO-/-NH2/-NR’H/-NR’2/-NHR*2+ as 
main ionic structure of the IPN systems (see Figure 8 for illustration). 
 
Figure 8. Schematic structure of the alkaline IPN hydrogels PEGDA/VI/alginate and PEGDA/DMAEMA/ 
CEC. 
 
4. Discussion 
Based on our bottom-up approach by initially analyzing different hydrogel formulations in 
cell-based assays, we identified two different hydrogel formulations as potential 
pH-modulating wound dressings. The first one consisted of 3.5% VI, 0.5% alginate, and 
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6.0% PEGDA, an IPN hydrogel with slightly buffering pH-modulating precursor (VI) and 
a non pH-active secondary network (alginate). The second formulation consisted of 2.0% 
DMAEMA, a strong base and buffering substance, 0.5% CEC, a derivate of chitosan 
which is water soluble at neutral pH and can also take part in pH-regulation, combined 
with 7.5% PEGDA. The well-known wound healing ability of alginate was confirmed for 
PEGDA/alginate hydrogel samples in 2D wound healing assays.16 Since the “wounds” 
suffered from an acidosis, a treatment with pH-modulating VI3.5 hydrogels enhanced the 
cell migration even further. In contrast to alginate, chitosan has lost its supportive healing 
ability, probably related to the conducted structural modifications. As DMAEMA is a 
stronger base than VI, the optimal DMAEMA ratio (2.0%) was lower than the optimal VI 
ratio (3.5%). Hydrogels carrying 0.5 – 2.0% DMAEMA were able to rise the in vitro 
“wound” pH toward physiological values in 2D healing assays (pH = 7.1 – 7.3, data not 
shown), which was reflected in a significantly enhanced cell migration velocity and gap 
closure. A pH over-regulation (pH 7.8 for 2.5% DMAEMA containing hydrogels) resulted 
in a gap closure comparable to that of the untreated, acidic control. However, one should 
keep in mind that an alkaline pH value is favorable for the aimed application as skin graft 
dressing and the detected medium pH is lower than the actual pH in immediate 
surroundings to the hydrogel dressing. More application-orientated healing experiments 
were therefore conducted on wounded human skin constructs, used as an alternative to the 
only limited reliable animal model.19 The detected findings underlined the hydrogels’ 
promising performance in 2D migration assays. The ability of alginate to enhance the cell 
migration was confirmed once more. The slightly enhanced cell ingrowth after PEGDA/ 
CEC treatment might be related to the small pH-modulating effect of CEC containing 
hydrogels (see Figure 6 for comparison). On the other hand, the strongly pH-modulating 
VI3.5 and DMAEMA2.0 hydrogels significantly enhanced the wound healing in the treated 
skin constructs.  
Further enhancement of the healing process in chronic wounds might be achieved by 
wound dressings with incorporated cells.24 Therefore, the developed hydrogels were 
additionally examined for their ability to serve as HDFa scaffolds. The successful cell 
adhesion on VI3.5 hydrogels can be explained by their favorable porous and fibrous 
structure, which enables the exchange of metabolites, gas, and nutrients.25,26 Microfiber 
formation might occur due to intermolecular hydrogen bond interactions between amino 
and carboxyl groups.25 The smooth and far less porous surface of the DMAEMA2.0 network 
might be owed to DMAEMA and CEC as film formers.27,28 A comparable structure was 
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already described by Liu et al.29 In contrast to porous surfaces, these materials inhibit 
cellular attachment. Further, enhanced amounts of positive charges at the material surface 
might be responsible for the damage of cell membranes.25 
In a second step, the developed hydrogels were evaluated for their suitability as wound 
dressings concerning their physiochemical properties. Specific mechanical requirements of 
wound dressings are difficult to define. Dependent on the formulation and the water 
content, fragile materials, bearing only 1 to 6 N, as well as very tough dressing materials, 
bearing up to 3.7 MPa, were described in literature.30,31 In any case, the dressings have to 
withstand the applied load during application, wearing, and removal. As radical initiator 
and unreacted monomer need to be removed prior to a medical application, a potential 
impact of purification on the mechanical properties should be examined as well.31 VI3.5 
hydrogels showed sufficient stability and high elasticity, regardless of the incubation 
process (Figure 5A and B). The mechanism of hydrogel stabilization in VI containing gels 
was clarified by compressive tests of hydrogels carrying HEMA instead. Like the VI 
molecules, HEMA influences the network formation of PEGDA by only contributing to 
linear chain growth. Both molecules can engage in stabilizing hydrogen bonds (via -NR2 or 
-OH/-C(O)O-) with the PEG backbone and the alginate network, yet only VI molecules 
can form additional ionic interactions. Their partially ionized amino groups might bind to 
the deprotonated carboxylic acid groups of alginate (see Figure 8 for comparison).32,33  
DMAEMA containing hydrogels, on the other hand, showed a significantly weakened and 
more flexible texture in comparison to the HEMA containing control gels. This might be 
due to the fact that the DMAEMA amino groups in DMAEMA2.0 hydrogels are mainly 
present in their protonated form (EP = 10.43, pH = 10.0, see Figure 8 for comparison). 
Apparently, resulting repulsive forces between DMAEMA ammonium groups soften the 
hydrogel material. The data in Figure 5A indicate that incubation in water has nevertheless 
a strengthening effect on DMAEMA2.0 hydrogels. We hypothesize that facilitated ionic 
interactions between DMAEMA ammonium groups and CEC carboxylic acid groups play 
a role in this process. The reduction of the counter ion concentration and a possible 
geometrical reorganization during incubation in water might cause readily accessible ionic 
groups.34 With an enhanced amount of positive charges in the hydrogel (2.5% DMEMA 
content; Figure 5C and D), the strengthening effect by incubation is even more 
pronounced, which pleads for this theory. Additionally, the compressive stress is 
dependent on the character of the secondary network. With rising accessibility of the 
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carboxyl groups (alginate 200, low α-L-guluronate (G) content < alginate 10/60, high G 
content < CEC), the compressive stress increased many times over.35  
An appropriate liquid uptake by the applied dressing is inevitable as many chronic wounds 
and skin grafted injuries secrete a high amount of wound exudate. Otherwise, remaining 
exudate harms the surrounding tissue or included inflammation factors inhibit the healing 
process.36,37 For instance Neoheal® hydrogel (Kikgel), a commercially available PEG-
based dressing, has a swelling capacity of around 70% in 24 h, which is proven to be 
suitable for strongly exuding burns.38 Therefore, VI3.5 hydrogels (33% in 24 h) might be 
used for low or medium exuding wounds, whilst DMAEMA2.0 hydrogels (177% in 24 h) 
might also be applied on strongly exuding wounds. The swelling capacity of the examined 
hydrogels is, like the mechanical properties, dependent on the amount and the strength of 
the ionizable groups incorporated into the polymer network. The driving force of the 
osmotic pressure is the aimed reduction of electrostatic repulsions between positively 
charged amino groups.39 The incorporated amount of ammonium groups (CEC < VI < 
DMAEMA) also drives the acid neutralizing capacity, which was the far largest for 
DMAEMA2.0 hydrogels. Again, no desired value might be given. The ANC requirements 
differ for varying wound types and patients.3,6 In clinics, the individual needs of each 
wound might be determined by the use of pH-responsive wound sensors prior to dressing 
application.6  
 
5. Conclusion 
PEGDA/3.5% VI/alginate hydrogels are promising pH-modulating materials, which should 
be considered for the treatment of acidic chronic wounds. The hydrogels were able to bring 
the pH value of in vitro wounds back to neutral, thereby enhancing cell migration and 
proliferation. Furthermore, their material properties like liquid uptake and mechanical 
stability corresponded with the requirements of wound dressings, and the supplementary 
addition of cells might be a promising strategy to create a bioactive dressing that further 
stimulates the healing process. Therefore, future research should focus on the impact of 
these cell-laden VI3.5 hydrogels in vitro and in vivo. PEGDA/2.0% DMAEMA/CEC 
hydrogels likewise showed convincing results in wound healing assays. Owing to the 
elevated pH-modulating ability, their application field might more likely be seen in the 
treatment of skin grafted wounds, where an alkaline environment is aimed. Since these 
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wounds are commonly covered by an additional backing dressing, reduced mechanical 
resistance might not be seen as a drawback.  
 
6. Supporting Information  
6.1 Materials 
Toluene was purchased from Acros Organics (Geel, Belgium). Bovine collagen I 
(PureCol®) was obtained from Advanced BioMatrix (San Diego, USA). Fetal bovine 
serum for skin constructs was obtained from Biochrom (Berlin, Germany). Formaldehyde 
solution (4%) and reagents for hematoxylin and eosin staining were purchased from Carl 
Roth (Karlsruhe, Germany). Deuterated chloroform (CDCl3) and water (D2O) were 
purchased from Deutero GmbH (Kastellaun, Germany). Alginate (Protanal® LF 10/60FT 
and LF200 FTS) was kindly provided by FMC BioPolymer (Wallingstown, Ireland). 
Dichloromethane (DCM), diethyl ether, and ethanol were obtained from CSC 
Jäcklechemie (Nürnberg, Germany). Hydroxyethyl cellulose was obtained from Fagron 
(Barsbüttel, Germany). Dulbecco’s modified eagle medium/nutrient mixture F-12 
(DMEM/F12), Hank’s balanced salt solution, high glucose DMEM, nutrient mixture F-12, 
penicillin–streptomycin, and phosphate buffered saline were purchased from Life 
Technologies (Carlsbad, CA, USA). Keratinocyte basal medium and keratinocyte growth 
medium supplements were obtained from Lonza (Basel, Switzerland). Dimethyl sulfoxide 
(DMSO), glacial acetic acid, hydrochloric acid, sodium hydroxide, and triethylamine were 
purchased from Merck KGaA (Darmstadt, Germany). Deionized water was obtained using 
a Milli-Q water purification system (Millipore, Schwabach, Germany). All other chemicals 
were obtained from Sigma Aldrich (Taufkirchen, Germany). If not stated otherwise, 
chemicals were used as received. 
 
6.2 Precursor Synthesis 
For the synthesis of N-carboxyethylchitosan (CEC), 2.00 g medium molecular weight 
chitosan (75 - 85% acetylation degree) was dissolved in 100 mL of an aqueous acrylic acid 
solution (0.10 mol·L–1) and stirred at 50 °C. After 65 h, 11.0 mL of a 1 M sodium 
hydroxide solution were added dropwise, the product was precipitated in ice-cool acetone, 
vacuum-dried, and redissolved in water. The product solution was purified in a 50 h 
dialysis against water (molecular weight cut-off 12000), dried under vacuum, and 
lyophilized to yield 2.01 g (85.0%).  
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1H-NMR (300 MHz, D2O, δ): 2.03 ppm (s, 0.27 H, -NHC(O)CH3), 2.37 ppm (m, 
0.32 H, -NHCH2CH2-), 2.70 ppm (m, 0.41 H, -NH(CH2CH2-)2), 3.02 - 4.10 ppm (m, 
H polysaccharide), 4.35 - 4.70 (m, 1 H, H-1 polysaccharide). A ratio of 63.8% -NH2, 
9.3% -NHC(O)CH3, 16.2% -NHR, and 10.7% -NR2 with R = -NHCH2CH2- was calculated 
from the respective peak areas in relation to the peak area of H-1. 
Poly(ethylene glycol) diacrylate was synthesized as previously reported.40 In brief, 
poly(ethylene glycol) with a molecular mass of 6 kDa (PEG6k) was dried by azeotropic 
distillation in toluene. A solution of dry PEG6k in anhydrous DCM (100 mL, 42 mM) was 
cooled to 0 °C, and 1400 µL of triethylamine (10.0 mmol) and 1625 µL of acryloyl 
chloride (20.0 mmol) were added drop-wise. The solution was stirred overnight under 
argon atmosphere, filtered, washed with 2 M potassium carbonate solution, and dried over 
anhydrous magnesium sulfate. The product was precipitated in ice-cold diethyl ether and 
dried under vacuum to yield 17.02 g (66.3%).  
1H-NMR (300 MHz, CDCl3, δ): 3.62 ppm (m, 310 H, -CH2CH2O-), 4.30 ppm (t, 
2 H, -CH2OC(O)-), 5.82 and 6.41 ppm (dd, 1 H, CH2=CHC(O)O-), 6.13 ppm (dd, 1 H, 
CH2=CHC(O)O-). 
 
6.3 Cell Viability 
 
Figure S1. Cell viability in MTT assays referred to VI3.5 and DMAEMA2.0 hydrogels. The broken line (---) 
marks the critical value of 70% cell viability.21 Data are expressed as mean ± SD (n = 6); * indicates 
statistically significant differences versus the untreated control (p < 0.05). 
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6.4 Statistical Analysis 
If not stated otherwise, data are presented as mean ± standard deviation. For statistical 
analysis, Brown-Forsythe test was run followed by one-way ANOVA/Tukey’ test or 
Kruskal-Wallis-ANOVA. Differences were considered statistically significant at p < 0.05. 
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Abstract 
A frequently neglected problem of chronic wounds is the associated shift of the wound pH. 
Yet, an excessively acidic or alkaline wound environment inhibits crucial healing 
processes such as cell migration, cell proliferation, and the proper activity of important 
enzymes. In this study, the development and characterization of buffering wound dressing 
materials is described. Poly(ethylene glycol) diacrylate (PEGDA) and alginate were 
combined with two different buffer systems, either modified 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) or acrylic acid (AA)/N,N-dimethylaminoethyl 
methacrylate (DMAEMA), to form pH-modulating hydrogels together. A variety of gels 
were analyzed in a bottom up approach, applying them in different wound healing assays. 
Thereby, the hydrogel composition 6.0% PEGDA/0.7% AA/2.8% DMAEMA/ 
0.5% alginate was identified to be the most promising approach. The formulation was 
further examined for its material properties, showing an excellent fluid handling capacity 
in swelling (around 90% after 24 h) and water vapor transmission (304 g·h–1·m–2) 
experiments. An additional antimicrobial activity was achieved by the incorporation of 
poly(hexamethylene biguanide) hydrochloride (PHMB). The detected PHMB release was 
3.8 – 7.0 mg per gram of hydrogel, dependent on the environmental pH. Considering all 
findings, the developed buffering hydrogel materials provide promising properties to serve 
as bioactive wound dressings for the treatment of chronic wounds. 
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1. Introduction 
The pH value is an important parameter that characterizes the respective wound healing 
phase and might help predicting its success.1 Normal wound healing is divided in three 
major phases: inflammation, proliferation, which includes granulation and epithelization, 
and remodeling of the original tissue.2 The wound pH changes in accordance with the 
respective cellular processes over time (Figure 1), altered by different endogenous 
molecules like amino acids, fatty acids, lactic acid, and the sodium/hydrogen exchanger 
NHE1.3,4 
 
Figure 1. pH progression during normal wound healing. 
 
The time course of the pH value in chronic wounds is different. Several clinical studies 
indicate that an alkaline pH is maintained permanently in the center of non-healing wounds 
(Figure 2).3,5 A more recent study additionally identified a disadvantageous acidic 
environment (pH around 6.5) at the edges of chronic venous ulcers.6 External factors 
which unbalance the wound pH are bacterial infections, necrosis, pus, and a disturbed skin 
barrier function.3,7,8 In both cases (increased/decreased pH value), the interruption of the 
normal pH progression during wound healing causes numerous unfavorable effects. The 
migration and proliferation ability of dermal fibroblasts and keratinocytes are strongly 
dependent on the surrounding pH.9 Furthermore, the optimal efficiency of human enzymes 
occurs at a very specific pH range. As a consequence, a pH shift might, amongst others, 
result in extracellular matrix degeneration by matrix metalloproteinases.4 Biofilm 
production, an increased vulnerability to infections, and insufficient oxygen availability 
come along with it as well.10  
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Figure 2. pH progression in chronic wounds suffering from an alkaline environment. 
 
A precise pH-modifying treatment of chronic wounds might be a promising tool to finally 
enable wound healing. Some approaches were already described in literature. Chronic leg 
ulcers treated with an acidic rinsing solution (pH 6.0) showed an elevated epithelization 
and healing tendency in comparison to ulcers treated with a neutral emulsion (pH 7.3).11 
Furthermore, Leung et al. investigated the impact of acetic acid against bacterial load, 
finding an eradication rate of 97% after 5 weeks.12 On the other hand, Sharpe et al. 
described a higher fibroblast and keratinocyte proliferation between pH 7.2 and 8.3.9 Yet, a 
universal method for the successful treatment of pH-shifted chronic wounds is still 
missing. 
Therefore, the aim of this study was the development of hydrogel wound dressing 
materials that are capable to act as interactive buffer in both, acidic and alkaline wound 
milieu. Hydrogels are particularly advantageous wound dressing materials, because they 
create a moist wound environment, which enhances for instance the re-epithelization.13 
Furthermore, their material properties are easily adaptable to the particular requirements by 
a precise modification of the polymer network. By this means, important wound dressing 
characteristics such as the exudate handling by evaporation/retention and uptake, and the 
mechanical stability and flexibility can be tuned.14 Here, the recently described 
interpenetrating polymer network (IPN) hydrogel system poly(ethylene glycol) diacrylate 
(PEGDA)/alginate (see Chapter 2 for comparison) was supplemented with different buffer 
systems; modified 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) or a 
mixture of acrylic acid (AA) and N,N-dimethylaminoethyl methacrylate (DMAEMA) were 
incorporated in different concentrations. In a bottom-up approach, starting with cell-based 
assays, the developed hydrogels were analyzed for their ability to serve as buffering wound 
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dressing material. Based on the performance in contact with acidic and alkaline, two- and 
three-dimensional human skin wound models, a promising hydrogel formulation was 
identified. Further analysis was done concerning the important wound dressing material 
properties, such as the liquid uptake and the buffer capacity. To battle frequently occurring 
bacterial infections in chronic wounds, the buffering hydrogels were also examined for 
their suitability as antimicrobial drug release materials.15 
 
2. Experimental Section 
2.1 Materials 
N,N-dimethylformamide extra dry (DMF) and toluene were obtained from Acros Organics 
(Geel, Belgium). Formaldehyde solution (4%) and reagents for hematoxylin and eosin 
(H&E) staining were obtained from Carl Roth (Karlsruhe, Germany). Diethyl ether and 
ethanol were purchased from CSC Jäcklechemie (Nürnberg, Germany). Deuterium oxide 
(D2O) was purchased from Deutero GmbH (Kastellaun, Germany). Hydroxyethyl cellulose 
and poly(hexamethylene biguanide) hydrochloride (PHMB) solution were purchased from 
Fagron (Barsbüttel, Germany). HEPES was obtained from Fisher Scientific (Schwerte, 
Germany). Alginate (Protanal® LF 10/60FT) was kindly provided by FMC BioPolymer 
(Wallingstown, Ireland). Dulbecco’s modified eagle medium/nutrient mixture F-12 
(DMEM/F12), nutrient mixture F-12, and phosphate buffered saline (PBS) were obtained 
from Life Technologies (Carlsbad, CA, USA). Dimethyl sulfoxide (DMSO), glacial acetic 
acid, hydrochloric acid, sodium hydroxide, and triethylamine were purchased from Merck 
KGaA (Darmstadt, Germany). Deionized water was obtained using a Milli-Q water 
purification system (Millipore, Schwabach, Germany). All other chemicals were purchased 
from Sigma Aldrich (Taufkirchen, Germany).  
 
2.2 Precursor Synthesis 
HEPES acrylate (HEPESac) was synthesized under argon atmosphere (water and oxygen 
free conditions). For this purpose, 3.56 g HEPES (14.94 mmol) and 75 mL dry DMF were 
cooled down to 0 °C. 4.989 mL triethylamine (35.79 mmol) and 5.850 mL acryloyl 
chloride (58.02 mmol) were slowly pipetted to the solution. The reaction mixture was 
stirred overnight, filtered, and precipitated in 900 mL of ice-cold diethyl ether. The product 
was recrystallized from ethanol and dried under vacuum to yield 2.01 g (46.1%).  
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1H NMR (300 MHz, D2O, δ): 3.35 ppm (t, 4 H, -CH2CH2N-), 3.62 ppm (m, 
10 H, -NCH2CH2N- and -CH2CH2S-), 4.53 ppm (t, 2 H, -OCH2-), 6.00 ppm (d, 1 H, 
CH2=CHC(O)O-), 6.20 (dd, 1 H, CH2=CHC(O)O-), 6.46 ppm (d, 1 H, CH2=CHC(O)O-). 
Poly(ethylene glycol) diacrylate (PEGDA) was synthesized as previously reported.16  
 
2.3 Preparation of Hydrogels 
The precursor mixtures were prepared as follows. PEGDA was dissolved in PBS and a 
suspension of the radical initiator 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropio-
phenone (HHMP) in PBS was pipetted to the stirring solution. Then, a solution of alginate 
in PBS (c = 41.7 mg·mL–1) and the required amount of AA, DMAEMA, or HEPESac 
solution were added drop-wise. The overall concentration of the polymer components was 
10% in all groups. The assessed hydrogel formulations are listed in Table 1. 
Table 1. Composition of the examined hydrogels. * The amount of radical initiator was related to the total 
monomer mass. 
 Control gel HEPESac gel AA DMAEMA gel 
PEGDA (%) 9.50 8.00 – 9.00 6.00 
Alginate (%) 0.50 0.50 0.50 
AA (%) 0 0 0.35 – 1.05 
DMAEMA (%) 0 0 2.45 – 3.05 
HEPESac (%) 0 0.50 – 1.50 0 
HHMP (%)* 1.80 1.80 2.50 
 
For skin construct healing assays, 1.4 mL of the precursor solution were cast into a 6 well-
plate; for tensile testing and water vapor transmission studies, 8 mL of the precursor 
solution were cast into rectangular silicon molds. For all other experiments, cylindrical 
glass molds (1 cm diameter, 0.7 mL volume) were used. All samples were irradiated with 
UV light (366 nm, 6 W, 1 h 15). When indicated, the hydrogels (initial mass mi) were 
purified for 24 h at 37 °C in 10 mL of PBS. Afterward, the induced weight gain was 
reversed by exposing the hydrogels to a stream of compressed air until mi had been 
reached again.  
 
Experimental Section 
 
 145 
2.4 Dynamic and Static pH Titration 
For dynamic titrations, a mixture of the respective buffer (HEPES, HEPESac, or 
AA/DMAEMA with a mass ratio of 1:9, 1:4, or 3:7) and 15 mL of a 0.1 M sodium 
chloride solution was brought to pH 2.0 with 0.1 M HCl. The titration against 0.1 M NaOH 
was performed with a BlueLine glass electrode connected to a TitroLine 7000 dosage 
system (SI Analytics GmbH, Mainz, Germany). The buffer capacity range was identified 
based on the slope of the recorded titration curves.17  
For static pH titrations, purified hydrogel cylinders were added to 15 mL of a 0.1 M 
sodium chloride solution. The pH was kept constant for 24 h by adding 0.1 M HCl 
(pH 7.0) or 0.1 M NaOH (pH 7.4). The acid (ANC) and base (BNC) neutralizing capacity 
were calculated according to Equation (1) and (2), respectively, !"# =  ! !"#!!           (1) !"# =  ! !"#$!!           (2) 
where n is the amount of neutralized titrant and m0 is the initial mass of the gel cylinder. 
 
2.5 Cell Viability and Healing Assays 
In vitro cell viability and healing assays were conducted as described previously.16 In brief, 
the cell viability was evaluated in a common extract MTT assay.18,19 For this purpose, 
hydrogel extracts (pH-modified extraction medium consisting of medium 199/F12 3:1, 
10% fetal bovine serum (FBS), and 1.10 mM hydrocortisone, adjusted to pH 8.0 with 
1 M NaOH or pH 6.0 with 1 M HCl) of different incubation intervals were pipetted to 
cultured adult human dermal fibroblasts (HDFa); pH-modified medium served as a control. 
After 24 h, the extract medium was exchanged by 130 µL of DMEM/F12, 50 µL of a MTT 
solution (c = 2.5 mg·mL–1 in PBS), and 20 µL of FBS. After further 4 h, the resulting blue 
dye was dissolved in 100 µL of a sodium dodecyl sulfate solution (c = 0.35 mmol·mL–1 in 
glacial acetic acid/DMSO 1:159) and the absorbance (A) at 570 and 690 nm was measured 
after 3 h of incubation at room temperature using a FluoStar Omega micro plate reader 
(BMG Labtech, Ortenberg, Germany). The cell viability (v) was calculated according to 
Equation (3). The data are presented as mean ± standard deviation (SD; n = 6). ! = !!"#,!"#!!!"#,!"#!!"#,!"#$!!!"#,!"#$  ∙ 100%           (3) 
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For two-dimensional (2D) cell migration assays, HDFa were seeded in cell culture inserts 
(Ibidi GmbH, Martinsried, Germany). After 24 h, the inserts were removed, and 8 mL of 
pH-modified medium (pH 6.0 or 8.0) and purified hydrogels in netwell inserts (Corning, 
Corning, NY, USA) were added; untreated cells served as a control. Every 12 h, the 
pH-modified medium was replaced. The cell migration was observed over 48 h using an 
Axiovert 200 microscope with a LSM 510 laser-scanning device (Zeiss, Jena, Germany). 
The area of cell migration was calculated using the LSM image browser (Zeiss, Jena, 
Germany); the cell migration velocity was calculated from the slope of the area 
closure/time curve.  
Human skin constructs* were built according to the previously published method,16 and 
wounds were induced by cutting the epidermal layer with a scalpel. The injured constructs 
were incubated with pH-adjusted medium (pH 6.5 or 8.0) containing 2.5% hydroxyethyl 
cellulose. The purified hydrogels were punched out in circular shape (1 cm diameter) and 
applied onto the wound. The medium was exchanged daily; the dressings were exchange 
after 2 days. After a healing period of 4 days, the constructs were embedded in tissue 
freezing medium, cut vertically into slices (7 µm) using a Leica CM1510 S cryotome 
(Leica Biosystems, Nussloch, Germany), and stained with conventional H&E according to 
standard protocols. The length of cell ingrowth was measured on microscope images (BZ-
8000 microscope, Keyence, Neu-Isenburg, Germany) with ImageJ (National Institutes of 
Health, Bethesda, Maryland, USA).  
 
2.6 Fluid Handling Capacity 
Hydrogel cylinders were incubated in 10 mL of PBS at 37 °C in a shaking water bath. 
Every 24 h, the hydrogels were gently blotted dry and weighed. The swelling capacity (Qt) 
was calculated according to Equation (4),  !! = !!!!!!! ∙ 100%          (4) 
where mt is the mass of the gel cylinder at time point t and m0 is the initial mass of the gel. 
The water vapor transmission rate (WVTR) was determined according to the ASTM 
E96/E96M-12 inverted water method.20 Hydrogel sheets were fixed at a circular WVTR 
test dish (test area A = 10.18 cm2) carrying 5 mL of deionized water. Water loss at 37 °C 
																																																								
* 3D human skin constructs were generated at the Institute of Pharmacy, Pharmacology and Toxicology, 
Freie Universität Berlin, with support and based on the method of S. Hedtrich and L. Wallmeyer. 
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and 21% relative humidity was measured every hour (0 – 10 h and ≥ 24 h) and the WVTR 
was calculated from the slope of the time/water loss curve (G) according to Equation (5). !"#$ =  !! ∙ !!           (5) 
 
2.7 Mechanical Properties and Microstructure 
The mechanical performance of the hydrogels was examined under tensile and 
compressive load with and without prior purification. The detailed procedure was 
described recently.16 In brief, the hydrogel samples were loaded until failure, using an 
Instron 5542 load frame (Instron GmbH, Darmstadt, Germany). The detected maximum 
load under compression (Fmax,c) and tension (Fmax,t) was used to calculate the respective 
maximum stress (σc and σt) according to Equation (6) and Equation (7), !! = !!"#,!ℎ∙!           (6) !! = !!"#,!ℎ∙!           (7) 
where h is the height and d is the diameter of the examined hydrogel sample. The elastic 
moduli (Ec and Et) were calculated from the slope of the stress-strain curves between 0.05 
and 0.15 strain. 
Scanning electron microscopy (SEM) was conducted on lyophilized, gold-coated hydrogel 
cylinders. The samples were examined with a Crossbeam XB 340 scanning electron 
microscope (Zeiss, Jena, Germany) at a working voltage of 3.0 kV. 
 
2.8 Drug Release 
Hydrogel cylinders were loaded at 37 °C in 10 mL of a PHMB solution (c = 2 mg·mL–1 in 
saline) for 24 h. The antimicrobial drug release was detected in 10 mL of PBS (pH 
adjusted to 6.0/7.4/8.0) at 33 °C in a shaking water bath. Over a period of 7 days, 200 µL 
samples were taken and replaced by fresh buffer solution. The samples were stored at 4 °C 
until the experiment was completed. For the colorimetric concentration measurements, 
10 µL of a sodium acetate solution (10 w% in deionized H2O), 25 µL of an Eosin Y 
solution (0.025 w% in deionized H2O), and 200 µL of diluted PHMB solution were mixed 
and stored in the dark for 15 min.21 The altered Eosin Y absorbance at 545 nm was 
measured with a FluoStar Omega micro plate reader (BMG Labtech, Ortenberg, 
Germany). The PHMB release was calculated based on calibration measurements; the 
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amount of the initial PHMB load was calculated from the remaining volume of the 
incubation solution and its concentration.  
 
2.9 Statistical Analysis 
If not stated otherwise, the experiments were done in triplicate and the data are presented 
as mean ± SD. For statistical analysis, Brown Forsythe tests were run followed by one-way 
ANOVA/Tukey’ test or Kruskal-Wallis-ANOVA. Differences were considered statistically 
significant at p < 0.05. 
 
3. Results 
3.1 Monomolecular Buffering System 
Two different strategies for the development of buffering hydrogel materials were pursued. 
The first approach was an incorporation of the zwitterionic and biocompatible buffer 
molecule HEPES (pKa = 7.5)22 into the covalent network of the previously developed 
PEGDA/alginate IPN hydrogel system (see Chapter 2 for comparison). For this purpose, 
HEPES was chemically modified by introducing a reactive double bond, yielding HEPES 
acrylate (HEPESac) (Scheme 1). 
 
Scheme 1. Synthesis of HEPES acrylate. 
 
The maximally possible HEPESac concentration in PEGDA/HEPESac/alginate hydrogels 
was 1.5%. At higher HEPESac ratios a great amount of white precipitation occurred in the 
precursor mixture. Therefore, further experiments were conducted with hydrogels carrying 
0.5 - 1.5% HEPESac only. 
 
3.1.1 Wound Healing Capacity 
The time- and pH-dependent wound healing capacity of PEGDA/HEPESac/alginate IPN 
hydrogels was examined in 2D cell migration assays. 2D wound models suffering from 
non-physiological pH values (control pH 6/pH 8 in Figure 3) showed a slow cell migration 
into the “wound” area and a closure of only 29 and 51%, respectively. The application of 
PEGDA/alginate control hydrogels significantly enhanced the cell migration velocity in 
both groups and enabled a complete gap closure in spite of an alkaline environment. 
N N
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Further improvement of the healing process by the addition of buffering HEPESac 
containing hydrogels could not be achieved. 
 
Figure 3. Cell migration velocity (A) and percentage of “wound” closure (B) in 2D migration assays with 
different IPN hydrogels applied. Data are expressed as mean ± SD (n = 3). + indicates statistically significant 
differences versus the untreated control (p < 0.05); * indicates statistically significant differences to all group 
members (p < 0.05). 
 
The hydrogel cytotoxicity was determined via dye conversion in MTT assays. The results 
in Figure 4 indicate that none of the developed HEPESac gels were cytotoxic, as a cell 
viability of around 100% was maintained for all samples. 
 
Figure 4. Viability of HDFa in contact with different PEGDA/HEPESac/alginate hydrogel extracts. The 
broken line (---) marks the critical value of 70% cell viability.18 Data are expressed as mean ± SD (n = 6). 
 
3.1.2 Buffer Capacity 
The buffer capacity range of HEPES and HEPESac was verified in a titration against 
sodium hydroxide (Figure 5). Sections with a reduced slope, calculated by the first 
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derivation of the titration curve (data not shown), correspond to the buffer range.17 In 
accordance to the literature, unmodified HEPES had a buffering effect between pH 6.8 and 
8.2,23 whereas a solution of modified HEPESac showed a flattened curve at a much more 
alkaline pH (pH > 8). 
 
Figure 5. Titration of HEPES (grey curve) and HEPESac (black curve) solution against 0.1 M NaOH. Red 
horizontal lines mark the buffer capacity range. 
 
As no satisfactory buffer and wound healing capacity could be detected for HEPESac and 
HEPESac containing hydrogels, further research focused on hydrogel formulations with a 
different, bimolecular buffering system. 
 
3.2 Bimolecular Buffering System 
A second approach to develop buffering hydrogel wound dressings was based on the 
previous work concerning acidic and alkaline hydrogels.16,24 The IPN hydrogel formulation 
PEGDA/alginate (see Chapter 2 for comparison) was complemented with acrylic acid and 
2-dimethylaminoethyl methacrylate as bimolecular buffering system (Scheme 2).  
 
Scheme 2. Structural formula of AA (on the left) and DMAEMA (on the right). 
 
OH
O
O
O
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3.2.1 Buffer Capacity 
Potentially effective AA/DMAEMA ratios were determined in dynamic titrations against 
sodium hydroxide (Figure 6). As described above, the titration curve sections with a 
reduced slope correspond to the buffer capacity range. The results for the AA/DMAEMA 
buffer system are listed in Table 2. Based on these findings, three promising hydrogel 
formulations (0.35/0.70/1.05% AA content) were chosen for further investigations. The 
total buffer concentration in all hydrogel formulations was set to 3.5%, thus combining 
sufficient hydrogel mechanical stability with the greatest possible buffer content. 
 
Figure 6. Titration of different AA/DMAEMA mixtures with 0.1 M NaOH. Red horizontal lines mark the 
buffer range of 10% and 20% AA mixtures; black horizontal lines mark the buffer range of 30% and 40% 
AA mixtures. 
Table 2. pH-range of the buffer capacity of different AA/DMAEMA buffer systems, and the consequently 
examined hydrogel formulations. 
Buffer system pH (buffer capacity) Hydrogel formulation 
10% AA 
90% DMAEMA  
4.0 – 4.2, 7.8 – 9.2 
0.35% AA 3.15% DMAEMA  
6.00% PEGDA 0.50% alginate 
20% AA 
80% DMAEMA 
3.5 – 4.6, 7.8 – 9.1 
0.70% AA 2.80% DMAEMA  
6.00% PEGDA 0.50% alginate 
30% AA 
70% DMAEMA 
3.4 – 4.8, 7.9 – 9.0 
1.05% AA 2.45% DMAEMA  
6.00% PEGDA 0.50% alginate 
40% AA 
60% DMAEMA 
3.3 – 4.9, 8.1 – 9.0 - 
 
Chapter 6 - Buffering Hydrogel Wound Dressing Materials 
 152
3.2.2 Wound Healing Capacity 
Analogous to the experiments on HEPESac containing hydrogels, the ability of AA/ 
DMAEMA containing gels to promote wound healing in 2D migration assays was 
determined at first (Figure 7).  
 
Figure 7. Cell migration velocity (A, C) and percentage of “wound” closure (B, D) in 2D migration assays 
with different AA/DMAEMA containing hydrogels applied at pH 6 (A, B) and pH 8 (C, D). Data are 
expressed as mean ± SD (n = 3); + indicates statistically significant differences versus the untreated control 
(p < 0.05); * indicates statistically significant differences to all group members (p < 0.05); ^ indicates 
statistically significant differences between the selected groups. 
 
The most effective buffer system was the formulation with an AA/DMAEMA ratio of 
20/80%; significantly enhanced cell migration velocities of 9.7 ± 1.1 µm (pH 6) and 9.3 ± 
2.5 µm (pH 8) could be achieved in comparison to the respective controls (Figure 7A and 
C). The “wound” closure could not be improved significantly in acidic environment 
(around 44%); however, a complete gap closure occurred in alkaline environment 
(Figure 7B and D). Therefore, further tests were conducted with the PEGDA/ 
0.7% AA/2.8% DMAEMA/alginate hydrogel formulation only. In comparison to the non 
pH-modifying hydrogel PEGDA/alginate (0% buffer), the cell migration velocity could be 
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enhanced by AA/DMAEMA (0.7/2.8%) containing hydrogel treatment at pH 6, but 
showed reduced values at pH 8; the amount of gap closure was slightly higher after the 
treatment with the buffering material. 
The cytotoxicity of AA/DMAEMA (0.7/2.8%) containing hydrogels was determined in 
MTT assays. The cell viabilities were around 100% in all cases, indicating that the 
developed buffering hydrogel materials are non-cytotoxic (Figure 8).  
 
Figure 8. Cell viability of HDFa in contact with AA/DMAEMA containing (0.7/2.8%) IPN hydrogel extracts 
with different pH values. The broken line (---) marks the critical value of 70% cell viability.18 Data are 
expressed as mean ± SD (n = 6). 
 
A more detailed impression on the wound healing capacity of AA/DMAEMA (0.7/2.8%) 
containing IPN hydrogels was gained by applying them on three-dimensional (3D) 
wounded human skin constructs. Human skin models were chosen instead of animal 
models as the pH value of the in vitro wounds can easily be adapted by changes in the 
supplying cell culture medium. Representative images from the acidic and the alkaline 
control in comparison to the buffer hydrogel treated constructs are given in Figure 9. The 
natural structure of the skin, including the stratum corneum (S), the epidermis (E), and the 
dermis (D), was clearly visible (see Figure 9A for details). Wounds suffering from an 
acidic pH only showed a marginal tendency of keratinocyte migration. In contrast, 
complete wound closure with a thin layer of keratinocytes occurred already four days after 
AA/DMAEMA containing hydrogel treatment (Figure 9B). The significantly enhanced cell 
ingrowth amounted 402 ± 173% (Figure 10).  
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Figure 9. H&E stained histological images of injured skin constructs after a healing period of 4 days. The 
stratum corneum (S), epidermis (E), and dermis (D) equivalents are clearly visible. The untreated controls are 
shown on the left; skin constructs treated with AA/DMAEMA (0.7/2.8%) containing hydrogels are shown on 
the right. The length of cell ingrowth is indicated by triangles; the insets show a magnification of this area. 
The length of the scale bars is 50 µm. 
 
The absolute amount of wound closure in alkaline wounds appeared to be higher than in 
acidic wounds (Figure 9C). As a result, the relative enhancement of wound closure caused 
by buffering hydrogel treatment at pH 8 was only around 68% (Figure 9D and Figure 10). 
Unlike 2D migration experiments indicated, applying non pH-modifying PEGDA/alginate 
hydrogels (“0% buffer” in Figure 10) had a smaller effect on wound closure than the 
treatment with buffering dressing materials. 
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Figure 10. Ingrowth length in the untreated controls (mean set as 100%), and in skin constructs treated with 
0% and 3.5% AA/DMAEMA containing hydrogels at pH 6.5 and pH 8. Data are expressed as boxplot 
(10 - 90%); + indicates statistically significant difference versus the untreated control (p < 0.05); * indicates 
statistically significant differences to all group members (p < 0.05). 
 
3.2.3 Fluid Handling Capacity 
Since the hydrogel formulation PEGDA/0.7% AA/2.8% DMAEMA/alginate was proven to 
be a promising treatment option for wounds suffering from non-physiological pH values, 
its material properties were subsequently examined. Indispensable properties of wound 
dressings are their liquid uptake (swelling), their water vapor transmission rate (WVTR) 
and, in the case of buffering dressings, their acid and base neutralizing capacity (ANC, 
BNC).25,26 The partial replacement of PEGDA by AA/DMAEMA influenced all listed 
parameters (Table 3); the swelling capacity more than doubled after 24 hours and 7 days, 
the WVTR increased by 77%, and the buffer capacity rose from 0 to 0.025 (ANC) and 
0.008 mmol·g–1 (BNC). 
Table 3. Fluid handling characteristics and buffer capacity of different IPN hydrogels. 
 
9.5% PEGDA/  
0.5% alginate 
9.5% PEGDA/0.7% AA  
2.8%DMAEMA/0.5% alginate 
Swelling 24 h (%) 40.05 ± 5.75 89.39 ± 4.72 
Swelling 7 d (%) 41.19 ± 5.74 93.01 ± 5.98 
WVTR (g·h–1·m–2) 171.40 ± 0.30 304.14 ± 1.58 
ANC (mmol·g–1) 0 0.025 ± 0.006 
BNC (mmol·g–1) 0 0.008 ± 0.002  
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3.2.4 Mechanical Properties and Microstructure 
In accordance with the highly porous and fibrous microstructure of the favorable AA/ 
DMAEMA (0.7/2.8%) containing IPN hydrogels (Figure 11A – C), the maximum tensile 
stress, σt, was rather low (29.1 ± 7.7 kPa; Figure 11D). The maximum compressive stress, 
σc, decreased from 199.1 ± 21.2 kPa to 118.5 ± 34.9 kPa due to an additional purification 
step in PBS. The calculated E-modulus was around 40 kPa for applied tensile and around 
20 kPa for applied compressive load. 
 
Figure 11. SEM images of lyophilized AA/DMAEMA (0.7/2.8%) containing IPN hydrogels with 50x (A), 
500x (B), and 2000x (C) magnification. The length of the scale bars is 100/20/2 µm, respectively. Maximum 
stress σt/σc and calculated E-modulus Et/Ec of AA/DMAEMA (0.7/2.8%) containing hydrogels under tensile 
and compressive load (D). Data are expressed as mean ± SD (n = 3). * indicates statistically significant 
differences between the selected groups (p < 0.05).  
 
3.2.5 Drug Release 
Apart from their pH-modulation capacity, the developed IPN hydrogels were also 
examined for their potential ability to release the antimicrobial drug PHMB to the wound 
site. The release rate of PHMB was strongly dependent on the surrounding pH (Figure 12). 
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Figure 12. Percentage PHMB release from PEGDA/0.7% AA/2.8% DMAEMA/alginate IPN hydrogels at 
different pH values. 
 
The highest maximal release of 64.2 ± 5.2% was detected in an acidic environment at 
pH 6.0. With rising pH, the PHMB release dropped to 43.0 ± 2.4% (pH 7.4) and 33.0 ± 
0.7% (pH 8.0). Related to the initial load of approximately 11.2 mg PHMB per gram of 
hydrogel, a release of 7.0, 4.8, and 3.8 mg per gram of hydrogel could be achieved, 
respectively. 
 
4. Discussion 
4.1 Monomolecular Buffering System 
The developed HEPES acrylate containing hydrogels did not show a convincing 
performance in wound healing assays. Since potential cell toxicity can be excluded (see 
Figure 4 for comparison), other factors must be responsible for these findings. One 
difficulty is displayed in the titration experiments. The buffer capacity of HEPES (pH 6.8 – 
8.2) was shifted to higher pH values after the addition of the acrylate group. This might be 
due to steric hindrance, affecting the protonation of the preferred amino group (Scheme 3). 
After the polymerization of HEPESac, the spatial extent of the residue R is even more 
pronounced.  
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Scheme 3. (De-)Protonation of HEPES (R = H) and HEPESac (R = C(O)C2H3).27 
 
Furthermore, complexation between HEPESac and alginate is an unwanted side effect 
during hydrogel formation.28 Even though a white precipitation is only visible for high 
HEPESac concentrations (> 1.5%), precursor mixtures with lower HEPESac 
concentrations showed an elevated turbidity, pleading for the appearance of complexes as 
well. Occurring complexation is also in accordance with the findings in 2D wound healing 
assays. When alginate is taken out of the system by complexation with HEPESac, its 
ability to enhance the cell migration is suppressed. Considering all findings, the examined 
HEPESac containing hydrogels are not suitable for a buffering wound dressing application. 
 
4.2 Bimolecular Buffering System 
Alternatively, hydrogels with the bimolecular buffer AA/DMAEMA were analyzed. In 2D 
wound healing assays, the hydrogel formulation with a molar AA to DMAEMA ratio of 
0.55 (0.70% AA/2.8% DMAEMA) appeared to be the most effective buffer system. 
Although, the amount of carboxylic acid groups is 45% lower than the amount of amino 
groups, the buffer capacity is balanced out for both, an acidic and an alkaline environment. 
This can be explained by the dominant AA acidity (pKa = 4.3) which is significantly higher 
than the DMAEMA alkalinity (pKb = 5.6).29,30 In hydrogels with higher (1.05%) or lower 
(0.35%) AA concentrations, one part of the bimolecular buffer systems is predominant and 
therefore, an adequate pH regulation cannot take place. However, the supportive healing 
effect of the favorable pH-modulating hydrogel formulation is slightly reduced in alkaline 
medium, compared to the non pH-modifying PEGDA/alginate control gel. As already 
described for HEPESac containing gels, there might be a complexation between 
DMAEMA amino groups and alginate carboxylic acid groups. Yet, diffusing alginate 
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enhances the cell proliferation,31 explaining the high wound healing capacity of PEGDA/ 
alginate gels. The findings on 3D wounded human skin constructs underline that the 
favorable PEGDA/0.7% AA/2.8% DMAEMA/alginate IPN hydrogels are non-cytotoxic. 
With the reduction of the liquid/hydrogel interface, the positive effect of diffusing alginate 
is reduced. In this more realistic chronic wound model, the supportive healing effects of 
alginate containing and pH-modulating wound dressings can clearly be separated.  
Besides actively supporting the wound healing process, wound dressing materials must 
also fulfill several requirements concerning their material properties. The dressings should 
guarantee a moist wound bed environment, but at the same time, they should be capable to 
absorb excessive amounts of wound exudate.2,26 Hydrogels enable both processes, liquid 
uptake and release, determinable via swelling and WVTR experiments. The WVTR of 
commercially available products ranges from 3.75 to 390 g·h–1·m–2, dependent on their 
composition.32 The required liquid uptake for chronic wound dressings was recently 
calculated to be 57% or higher, related to the here examined sample size and shape.16 
Thus, the described buffering hydrogels perfectly meet both demands.  
The ability of a material to intercept increased acid and base concentrations can be 
quantified by the acid and base neutralizing capacity.25,33 Only little data can be found in 
literature describing ANCs or BNCs of wound dressings. Recently, comparable values 
were reported on promising acidic (BNC = 0.012 mmol·g–1) and alkaline (ANC = 0.010 - 
0.031 mmol·g–1) hydrogel wound dressing materials.16,24 The buffer capacity of the 
described AA/DMAEMA containing hydrogels was further evaluated in an indirect way, 
based on the conducted cell assays. Hence, the designed hydrogels are competitive 
buffering wound dressings. 
The microstructure of the buffering hydrogels is related to the incorporation of AA and 
DMAEMA molecules. In comparison to non-buffering PEGDA/alginate gels (see 
Chapter 2 and 3 for comparison), great changes in the gel architecture are estimated. The 
buffer monomers AA and DMAEMA, which carry only one double bond per molecule in 
contrast to PEGDA, can contribute to chain growth, but cannot contribute to the three-
dimensional network formation.34 Additional superficial fiber formation (Figure 11C) 
might be caused by intermolecular interactions between DMAEMA amino groups, and AA 
and alginate carboxylic acid groups.35,36 The resulting porous microstructure has, together 
with the incorporated charges, a positive impact on the osmotic pressure, driving the 
swelling capacity.37,38  
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The mechanical performance of the buffering gels is comparable to already described 
PEG-based hydrogels, which generally fail between 4 and 201 kPa with an E-modulus of 
20 to 230 kPa.39–43 Furthermore, the developed materials can maximally be deformed by 
92% (data not shown), which is consistent with the elasticity of the human skin (70 – 
100%).44,45 Incubation in PBS, an essential step of purification from initiator and unreacted 
monomer prior to a biomedical application, effected significantly reduced σc values. These 
changes might be caused by ion exchange processes between PBS (K+, Na+, Cl–, HPO4–) 
and the hydrogels, resulting in a break of stabilizing ionic interactions between carboxylic 
acid and amino groups.46,47 Nevertheless, the mechanical properties still fit the described 
ranges of PEG-based hydrogels and fulfill the needs of wound dressing materials 
(elasticity ≥ 70%, sufficient mechanical stability for handling, application, and 
removal).14,48 
The microbial infection of a wound has a wide range of consequences.49 Bacterial waste 
products impair the healing process. Furthermore, the wound pH is shifted versus acidic or 
alkaline values, dependent on the sort and the amount of the present microbes. For not only 
treating the consequences, but also handling the initial cause of the pH-shift in infected, 
chronic wounds, the promising AA/DMAEMA (0.7/2.8%) containing IPN hydrogels were 
loaded with the antimicrobial drug PHMB. The detected drug release from the buffering 
hydrogels ranged between 33 and 64%. The incomplete PHMB release is related to 
hydrogen bonds and ionic interactions between the drug molecules, which carry positively 
charged imine groups, and the hydrogel, which carries negatively charged carboxylic acid 
groups (alginate, AA).50 With increasing pH, the amount of protonated carboxyl groups is 
rising. Furthermore, the amount of positively charged amino groups of the hydrogel 
(DMAEMA) is rising as well. The resulting reduced attractive and increased repulsive 
forces enable an enhanced drug release at lowered pH values. The initial amount of PHMB 
in the hydrogels (approximately 1.12%) was higher than in commercially available 
dressings (0.10 – 0.65% PHMB, e.g., Suprasorb X + PHMB (Lohmann & Rauscher), 
Kendall (AMD), Prontosan (B. Braun Medical Ltd)). However, the effective PHMB 
concentration was 0.38 – 0.70%, which perfectly matches the aimed concentration range. 
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5. Conclusion 
Due to the combination of acidic and alkaline monomers with PEGDA and alginate, 
buffering IPN hydrogel wound dressings could be developed. Their wound healing 
capacity was proven by 2D and 3D wound models, based on primary human dermal 
fibroblasts and keratinocytes. The performance of the buffering hydrogels was competitive 
with the recently examined performance of acidic wound dressings applied on alkaline 
wound models and alkaline dressings applied on acidic wound models.16,24 Consequently, 
the described dressings might be applied in either case, representing a universal treatment 
option for wounds suffering from a non-physiological pH-shift. Moreover, the material 
properties were found to be sufficient for the desired application, allowing a high liquid 
uptake, mechanical flexibility, and antimicrobial drug release. Further research should 
focus on the variation of the incorporated pH-active monomers, targeting even higher 
buffer capacities for longer lasting wearing times.	  
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1. Summary 
Hydrogels are suitable base materials for various biomedical applications.1 Because of 
their chemical versatility, good biocompatibility, and high water content (around 90%), 
hydrogels are particularly relevant to wound dressing applications. Thus, a high 
commercial and scientific interest in new hydrogel-based dressing materials has recently 
been observed. Special attention has been paid to the challenging treatment of complex 
acute wounds, e.g. suffering from deep tissue loss or heavy infection, and non-healing 
chronic wounds, e.g. induced by an underlying disease or bacterial colonization. As 
summarized in Chapter 1, bioactive hydrogel wound dressings are a particularly 
promising treatment option in this context.2 Their supportive healing properties can be 
induced by bioactive hydrogel precursors, incorporated drugs, stem cells, and cell-derived 
proteins, such as growth factors. Despite the sustained research effort, a lot of these 
advanced approaches fail to be translated to a standard procedure in clinics. Impeding 
factors are inter alia the complexity of the manufacturing process, high costs, or a potential 
health hazard.2–4 Moreover, hydrogel-based materials frequently suffer from rather low 
mechanical stability. Yet, mechanical resistance and flexibility is required for convenient 
application and wearability of wound dressings.  
To overcome the described issues, new and applicable concepts of bioactive hydrogel 
wound dressings are urgently needed. One possible approach towards stable, yet flexible 
hydrogels is the use of interpenetrating polymer network (IPN) structures, typically 
showing enhanced material properties in comparison to single network hydrogels.5 The 
concept of IPNs was therefore applied to hydrogel precursors which are suitable for wound 
dressing applications, namely synthetic, biocompatible poly(ethylene glycol) diacrylate 
(PEGDA) and naturally derived, bioactive alginate. By this means, the mechanical 
weakness of the single component PEGDA and alginate hydrogels was overcome, as the 
resulting IPN hydrogel dressings, assessed in Chapter 2, showed suitable maximal stress 
and strain values under compressive and tensile load. Additionally, the high swelling 
capacity of photopolymerized PEGDA (molecular weight ≥ 4 kDa)/alginate IPNs 
considerably exceeded the marginal liquid uptake of pure PEGDA hydrogels, which makes 
these IPN hydrogels suitable for wound dressing applications. The most promising 
PEGDA/alginate IPN hydrogel formulation was furthermore loaded with 0.34% 
poly(hexamethylene biguanide) hydrochloride (PHMB), allowing a medically relevant 
antimicrobial drug release for acute wound care. 
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In Chapter 3, the concept of PEGDA/alginate IPN hydrogel wound dressings was further 
developed to meet the special requirements for chronic wound dressings and particularly 
target the recently described non-physiological pH shift in chronic wounds.6,7 In the case 
of an alkaline pH shift, acidic dressings could be beneficial for the healing process. 
Consequently, different acidic IPN hydrogel formulations consisting of PEGDA, alginate, 
and acrylic acid (AA) as the pH-modulating component, were developed and assessed, 
regarding their material and bioactive properties. The conducted experiments revealed that 
the swelling capacity, the mechanical performance, the microstructure, and the base 
neutralizing capacity were highly dependent on the exact hydrogel formulation, with 
0.25% AA containing IPN hydrogels performing best. In addition to their excellent 
material properties, they were non-cytotoxic and could significantly enhance the wound 
healing in pH-shifted, in vitro wound models, which makes this formulation a promising 
approach to acidic chronic wound dressings. 
A deeper understanding of crucial inter- and intra-network interactions helps to modify the 
IPN hydrogel material properties in such way that their active intervention in the healing 
process is optimized. Therefore, the influence of the two major effects in the investigated 
PEGDA/AA/alginate IPNs, namely ionic interactions via negatively charged carboxylic 
acid groups of AA and reduced network branching due to the incorporation of one-
sided (AA) instead of two-sided (PEGDA) functionalized precursors, were distinguished 
by analyzing uncharged 2-hydroxyethyl methacrylate (HEMA) instead of AA containing 
IPN hydrogels. This comparison, drawn in Chapter 4, clearly illustrated that all material 
properties of the developed IPNs were almost exclusively dependent on the incorporated 
carboxylic acid groups. Further research focused on the impact of the primary network 
density, which was altered by changing the precursor molecular weight, comparing 
PEGDA with a molecular weight of 4 and 6 kDa, and the time frame of the radical 
polymerization, comparing thermally and UV-light activated reactions. The network 
density of the secondary network was additionally altered by changing the type of alginate 
polymerization, comparing physical entanglements with and without supplementing Ca2+ 
induced ionic interactions. These controlled adjustments of the hydrogel network structure 
permitted the adaption of important material properties such as the liquid uptake, the 
mechanical stability and flexibility, and the base neutralizing capacity to the wound 
dressing requirements. By this means, a new pH-modulating PEGDA4k/AA/Ca2+ alginate 
IPN hydrogel formulation with promising wound dressing properties was identified.  
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On the other hand, alkaline dressing materials should be beneficial to the healing process 
of acidic chronic wounds. Dependent on the pKb value of the chosen pH-modifying 
precursor (N-vinylimidazole (VI), pKb = 7.0; 2-dimethylaminoethyl methacrylate 
(DMAEMA), pKb = 5.6), the alkaline PEGDA-based IPN hydrogels, discussed in 
Chapter 5, influenced the in vitro wound pH to a different extent. VI containing dressings 
had a less intensive effect, but in return, did not bear the risk of pH over-modulation. 
Furthermore, PEGDA/VI/alginate IPNs were used as human dermal fibroblast scaffolds, 
which is another strategy to actively improve the wound healing process. A stronger pH 
response was received by DMAEMA containing IPN hydrogels. Here, a precise choice of 
the right wound dressing buffer capacity is vital for avoiding an alkaline pH-shift in the 
treated lesion. However, this effect is aimed for skin grafted wounds, as an alkaline pH 
enables a successful growth and vascularization of skin grafts.8,9 Based on the discussed 
approach, a promising alkaline PEGDA/DMAEMA/N-carboxyethylchitosan IPN hydrogel 
wound dressing formulation with proper material properties, no cytotoxicity, and a high 
supportive healing capacity could be developed.  
Universal buffer hydrogel materials were developed in Chapter 6, aimed at achieving a 
pH-modulating chronic wound dressing which is independent from the direction of the pH 
shift. Following this strategy, less effort is needed for monitoring the patient’s individual 
wound pH. To this end, the monomolecular buffer molecule 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) was chemically modified and thus covalently 
incorporated into the favorable PEGDA/alginate IPN hydrogel system. Yet, the HEPES 
buffer capacity was altered by this process, causing a loss of its beneficial impact on the 
wound pH. In contrast, the alternate bimolecular buffer system AA/DMAEMA retained its 
pH-modulating properties even after the polymerization process and the developed IPN 
hydrogels containing 0.7% AA and 2.8% DMAEMA showed convincing material and 
wound healing properties, as well as good suitability as antimicrobial PHMB delivery 
matrices.  
The overall concept of the thesis is also summarized in Figure 1. 
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Figure 1. Applied concept of developing bioactive hydrogel dressings for acute and chronic wounds. 
 
2. Conclusion  
In conclusion, the formation of interpenetrating polymer network hydrogels from select 
biocompatible and bioactive precursors offers the possibility to develop new, highly potent 
treatment options for advanced wound care. Thereby, a proper understanding of the crucial 
material parameters and network interactions in the IPN structure is required to precisely 
adapt the material properties, synonymous with the hydrogel wound healing capacity. 
Specifically, by developing PEGDA/alginate IPN hydrogels with an adapted network 
structure, the advantageous properties from the single components were combined, whilst 
their former drawbacks were overcome, such as the common mechanical weakness of 
hydrogel materials. A supplementary incorporation of acidic and alkaline, pH-active 
monomers into the IPN hydrogel system furthermore enabled the creation of buffering 
hydrogel dressing materials for the treatment of pH-shifted non-healing wounds. 
Additional, bioactive healing properties were successfully accomplished concerning 
controlled drug release of antimicrobial PHMB and cell seeding. 
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Future research should focus on two main issues. First, the developed hydrogel wound 
dressing materials should be further optimized concerning the maximal possible wearing 
time, which is dependent inter alia on the duration of drug release, the buffer capacity 
strength, and the rate of cell survival when used as a cell scaffold. For this purpose, the 
existing formulations should be modified with regard to the decisive functional groups that 
are connected to the material’s cell compatibility or can interact with drug molecules, 
influencing their release. Furthermore, alternative pH-modifying precursors might be 
screened. The second, more urgent target is a fast and effective progress of the described 
materials from a research level to reliable clinical treatment options. This includes 
experiments on significant animal models and, in a next step, the application in clinical 
studies. 
Even though complementing research on the developed bioactive IPN hydrogel wound 
dressing materials is necessary, the significant potential of the here applied concept was 
clarified. Precisely modified IPN hydrogel structures provide a versatile, cost-effective, 
and promising approach to new and urgently needed treatment options for acute and 
chronic wounds. 
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Abbreviations 
2D   two-dimensional 
3D   three-dimensional 
AA  acrylic acid  
AMA  alginate methacrylate 
ANC  acid neutralizing capacity 
ANOVA analysis of variance  
APS  ammonium persulfate 
ASCs  adipose-derived stem cells 
ASTM  American society for testing and materials 
BNC  base neutralizing capacity 
CEC  N-carboxyethylchitosan 
D  dermis 
DCM  dichloromethane 
DMAEMA 2-dimethylaminoethyl methacrylate 
DMEM Dulbecco’s modified eagle medium 
DMF  N,N-dimethylformamide 
DMSO dimethyl sulfoxide 
DN  double network 
DPZ  dense polymer zone 
E  epidermis 
ECM  extracellular matrix 
EGF  epidermal growth factor 
E-modulus elastic modulus 
EP  equivalence point 
F12  nutrient mixture F-12 
FBS  fetal bovine serum 
FGF  fibroblast growth factor 
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G  α-L-guluronate 
GF  growth factor 
GL  gluconolactone 
HA  hyaluronic acid 
HDFa  adult human dermal fibroblast 
H&E  hematoxylin and eosin 
HEMA 2-hydroxyethyl methacrylate 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HEPESac 4-(2-ethyl acrylate)-1-piperazineethanesulfonic acid 
HHMP 2-hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone 
1H NMR proton nuclear magnetic resonance  
IGF-1  insulin-like growth factor-1 
IL-1  interleukin-1 
IPN  interpenetrating polymer network 
ISO  international organization for standardization 
KBM  keratinocyte basal medium 
KGF  keratinocyte growth factor 
KGM  keratinocyte growth medium 
MMP  matrix metalloproteinase 
MRSA  methicillin-resistant Staphylococcus Aureus 
MSC  mesenchymal stem cells 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
NHE1  sodium/hydrogen exchanger 
NIPAAm N-isopropylacrylamide 
NPs  nanoparticles 
PAA  poly(acrylic acid)  
PAAm  polyacrylamide  
PAMPS poly(2-acrylamido-2-methylpropanesulfonic acid)  
PBS  phosphate buffered saline 
PDGF  platelet-derived growth factor 
PEG  poly(ethylene glycol) 
PEG2k poly(ethylene glycol) with a molecular weight of 2 kDa 
PEG4k poly(ethylene glycol) with a molecular weight of 4 kDa 
PEG6k poly(ethylene glycol) with a molecular weight of 6 kDa 
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PEGDA poly(ethylene glycol) diacrylate 
PEGDA2k poly(ethylene glycol) diacrylate with a molecular weight of 2 kDa  
PEGDA4k poly(ethylene glycol) diacrylate with a molecular weight of 4 kDa  
PEGDA6k  poly(ethylene glycol) diacrylate with a molecular weight of 6 kDa 
PEO  poly(ethylene oxide) 
PHMB  poly(hexamethylene biguanide) hydrochloride 
PLA  poly(lactic acid) 
PRP  platelet-rich plasma 
PU  polyurethane 
PVA  poly(vinyl alcohol) 
PVP  poly(vinyl pyrrolidone) 
S  stratum corneum 
SD  standard deviation 
SEM  scanning electron microscopy 
TEMED N,N,N',N'-tetramethylethane-1,2-diamine 
TGF-β  transforming growth factor-β 
TIMPs  tissue inhibitors of metalloproteinases 
TN  triple network 
TNF-α  tumor necrosis factor-α 
UV  ultraviolet 
VEGF  vascular endothelial growth factor 
VI  N-vinylimidazole 
WVTR water vapor transmission rate 
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